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INTRODUCTION 
The siddha science is the oldest traditional treatment system 
generated from Dravidian culture.  Siddha medicine is claimed to 
revitalize and rejuvenate dysfunctional organs that cause the disease and 
to maintain the ratio of three vital humours Vatha, Pitha and Kapha. 
According to siddha medicine psycological and physiological 
functiions of the body are attributed to the combination of seven body 
constituents.  First is Saaram(Nutrient), Senneer (Blood), Oon(Muscle), 
Fat(Kozhuppu), Enbu(Bone), Moolai (Bone Marrow) and Sukkilam, 
Suronitham (Semen and Ovum). 
Three humours are classified as Vatha(air), Pitha(fire) and Kapha     
( earth and water).  Concept of disease and its causes in Siddha Medicine 
is assumed that when the normal equilibrium of the three humours 
(Vatha, Pitha and Kapha) is disturbed, the disease is caused.  The factors 
which assumed to affect this equilibrium are environment, climatic 
conditions, diet, physical activities and stress. 
The Drugs used by siddhars are classified into three groups.  
Thathu (Inorganic Substance), Thavara (herbal product) and Sangamam 
(animal products).  The drugs used in Siddha system are classified on the 
basis of five properties suvai (taste), guna (character ), Veerya (potency), 
pirivu (class) and mahima (action). 
The treatment in siddha medicine is aimed at keeping the three 
humours in equilibrium and maintenance of seven body constituents.  So 
proper diet, medicine and a disciplined regimen of life are advised for a 
healthy living and to restore equilibrium of humours in diseased 
condition. Madhumegam is most common disease leading to more 
complication characterized by increased blood sugar. 
Here I have brought out the efficacy of herbal drug Vellallipoo 
Chooranam for the treatment of madhumegam with it promising result.   
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AIM AND OBJECTIVES  
A STUDY ON VELLALLIPOO CHOORANAM  
Now - a - days the whole world is expecting very much a special 
and safety care without side effects from the traditional system of 
medicine that too from siddha system of medicine.  
As a scholar of P.G gunapadam the author had many oppurtunities 
to study many literatures having number of medicinal preparation.  
Madhumegam is most common disease leading to more 
complication. Megam noi is classified into 20 types. Among this 
madhumegam comes under Azhal type of megam.  In modern aspect this 
can be correlated with Diabetes mellitus.  
The main aim and objectives of this dissertation is to do a scientific 
review of Vellallippo Chooranam in treating Madhumegam.  
Diabetes is the metabolic disease affecting nearly every organ 
system in the body.  
Diabetes is a metabolic disorder characterized by increased blood 
sugar, resulting from defects in insulin production, insulin action or both.  
Diabetes can lead to serious complication and premature death, 
Diabetes threatens to overwhelm developing nations as they switch to 
westernized life styles that emphasizes rich foods and sedentary life.  
Vellalli is one of an aquatic plant.  Siddhars have mentioned 
vellallipoo in their text effective in treating right from Mega diseases,  
urinary tract infection to Diabetes.  
So, I have selected this disease to treat it with vellallipoo 
chooranam for my dissertation work.  
References are found in  
Gunapadam Mooligai Vaguppu  [Page No - 43 ] regarding its 
anti – diabetic property.  
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 In my dissertation work study on Vellallipoo chooranam is done in 
the fallowing aspect.  
1. Botanical Aspect  
2. Gunapadam Aspect  
3. Phyto – Chemical Analysis.  
4. Quantitave & Qualitative Analysis.  
5. Bio – chemical Analysis  
6. Pharmacological Analysis  
7. Microbiological analysis.  
8. Clinical Assessment.  
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BOTANICAL ASPECT 
1)  1BOTANICAL NAME: NYMPHAEA ALBA  
CLASSIFICATION: 
According to Bentham and Hooker’s classification 
Kingdom   :  Plant kingdom 
Division   :  Flowering Plant (Magnoliophyta) 
Class    :  Dicotyledons (Magnoliospida) 
Subclass   :  Polypetalae 
Series   :  Thalamiflorae 
Order   :  Ranales 
Family   :  Nymphaeaceae. 
Genus   :  Nymphaea 
Species   :  alba 
DISTRIBUTION: 
 This plant is globally distributed in Europe, North Africa, 
Southwest Asia, India, China and Russia.  
Morphological distribution: 
 Nymphaea alba commonly known as white water lilly in English is 
an aquatic herb with perennial rhizome or rootstocks anchored with mud. 
 Rhizome 10-50 mm thick.  
Leaves: 
 Rounded, cordate, entire glossy floating on the surface of with long 
stout flexible stems.  
Flowers: 
 White, about 5-11cm diameter solitary, floating on the surface of 
water at end of a long stout flexible leafless stem. 
 
                                                           
1
 Indian Medicinal Plants Volume 1   (Kritikar and Basu) Pg 230 
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Sepals: 
 4 green and brownish outside white on inner surface inserted on the 
base of torus.  
Petals: 
 Many in numbers (10-20) in many series, the inner petals are 
transformed into stamen, all adnate to the base of disc. 
Stamens: 
 Many, the outer one being transformed successively from petal to 
stamen.  Anther without appendage.  
Ovary: 
 Carpels many.  The ovaries many immersed in fleshy torus and 
with it forming a many called ovary crowned by a large stigma with 16 
rays which have cylindrical appendages. 
Fruit: 
A soft spongy berry, ripening under water but irregularly. 
Seed: 
Minute nesting in a pulp enclosed in a sac like fleshy aril. 
2) 2Anatomical Description of Flower: 
Flowers solitary, large, often fragrant, regular, partially acyclic. 
The perianth acyclic and the androecium acyclic.  Free hypanthium 
absent.  
Perianth with distinct calyx and corolla, or petaline (Nuphar) 5> or 
20-50 (many) free.  Calyx as commony interperated 4 or 5 Polysepalous, 
imbricate  
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 http//delta-intkley.com/angio/www/NYMPHAEA The Families of Flowering Plants (Watson and 
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Androecium 40-80. Androecial members maturing centripetally 
free of the perianth, free of one another, spiraled.  Androecium including 
staminodes (with transition from petals to stamens) 
Staminodes 11-20 (in the form of nectariferous scales) external to 
the fertile stamens in Nuphar petaloid.  Stamens 40-80: petaloid, or 
laminar, or filantherious.  Anthers adnate, non versatile dehiscing via 
longitudinal slits. Intorse tetrasporangiate Endothelium developing 
fiberous thickenings.  Anther epidermis present.  The initial microspore 
tetrads tetrachedral o;r isobilateral.  Anther wall initially with more than 
one middle layer pollen shed as single grain pollen grains aperturate, 1 
aperturate sulcate, 2-celled. 
1. Gynoecium 5-35 carpelled. The pistil 5-35 celled.  Gynoecium 
syncarpus, superior to partly inferior.  Ovary 5-35 locular  
2. Placentation more or less parietal. Ovules 10-100 per locule, arillate, 
or non arillate, orthotropus or anatropous, bitegumient not 
contributing to the microphyle.  Embryo – sac development 
polygonum – Type antipodal cells formed, not proliferating very 
ephemeral synergids pear shaped. 
3. Endosperm formation cellular Embryogeny asterad.  
3) Cultivation and Propagation: 
A water plant requiring a rich soil and a sunny position in still or 
slowly moving waters.  Best grown in 2-2.5m of water.  Prefers a PH 
between 6 and 7.  Dislike acid condition according to another report.  
This species is hardly to about - 200C.  This species with horizontal roots 
athat often spread freely with new plants being formed at intervals along 
the root.  These species are useful for naturalizing.  
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Propagation 
Seed-sow as soon as it is ripe in a greenhouse pots submerged 
under 25mm of water.  Prick out into individual pots as soon as the first 
true leaf appears and grow them in water in a green house for atleast 2 
years before planting them out in a late spring.  The seed is collected by 
wrapping the developing seed head in a muslin bag to avoid the seed 
being lost.  Harvest it 10 days after it sinks below the soil surface or as  
soon as it reappears (200) Division in May.  Each portion have atleast one 
eye.  Submerge in pots in shallow water until established.  
 
PHARMACOGNOSY 
Nymphaea alba is large cup shaped, white flowers upto 20cm 
across, irth a double ruff of white petals enclosing a yellow centre. Sit 
like a crowns  top around.  Stamens are bright yellow in colour.  Flowers 
are visited by bees, flies, beetles due to its aromatic fragrance.  When 
flowers are dried they become less weight (more or less shrunken 
appearance).  Taste is Astringent. 
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3PHYTOCHEMICAL ASPECT CHEMICAL CONSTITUENTS 
PRESENT IN FLOWER OF NYMPHAEA ALBA 
Alkaloids  
1) Nupharine 
2) Nymphaeine  
Aglycons 
1. quercetin 
2. kaempferol 
3. I sokaempferide 
4. Apigenin 
Glycosides: 
1. quercetin 4’β xyloside 
2. 3 Methyl quercetin  
3. 3βxyloside  
4. quercetin 3 galactoside and 3 glucoside 
Flavanoids 
1) 3 glucoside of 3,5,7,3`,4`, Pentahydroxy flavone (Isoquercetin) 
2) 3 galactoside of 3,5,7,3`,4`,Pentahydroxy flavone 
(Hyperoside) 
3) 4`βxyloside of 3,5,7,3,4,Pentahydroxy flavone( 4’βxyloside of 
quercetin) 
4) 3’β xyloside of 5,7,3`,4` tetra hydroxyl 3 methoxy flavone 
(quercetin 4 xyloside) 
Others: 
 P-hydroxy benzoic acid 
 P coumaric acid 
 Vanillic acid.  
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 Flavanoids from the flowers of Nymphaea alba. Jercy Jambu Luto slawa. 
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GUNAPADAM ASPECT 
1. 4NtW ngah;fs; :; ;; ;; ;  
 My;gk; 
 FKjk; 
 ifutk;.      
2. Vernacular Names : 
Eng   - The (white) Water Lilly.  
Tel   - Kalava  
Mal   - Allit – tamara 
Kan   - Nyadale huvu 
Arab and pers  -   Nili far  
Urd    - Challani 
Hindi   - Kanva, Chhotta kanva 
Sans   - Kumudam.          
3. 5Vernacular Names : 
 Eng   - Indian White Water Lilly.  
 Hindi   - Kanva, Kokka  
 Kan   - Bilenaydilic, Biletavaral 
 Mal   - Ampal 
 San   - Kumudam 
 Tam   - Vellampal, Allitamarai  
 Tel   - Allikada, Tellakaluva  
  
                                                           
4
 Fzghlk; %ypif tFg;G  gf;fk; vz; 43. 
5
 Indian medicinal plants vol – 4  page No 153.  
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4. 6fhZkplk; :;;;  
 Mk;gw;nfhb Fs;shd ed;dPh; epuk;gpa Fsq;Fl;ilfspy; 
tsUk;.  
 ‘mw;w Fsj;jpy; mUePh;g;gwit Nghy;  
  cw;Wopj; jPh;thh; cwty;yh; mf;Fsj;jpy;  
  nfhl;bAk;> Mk;gYk;> nea;jYk; NghyNt  
  xl;bAWthh; cwT” 
Mk;gw;nfhb> nfhl;b> nea;jy; Kjypa ePh;tho; jhtuq;fSld; 
Fsq;fspy; tsUk;. 
5. 7tiffs; :;;;  
 ntz;ikAQ; nrk;ikAq; fye;j epwk; Mfpa G+f;fisAila 
tiffs; ,jpy; cz;L. Fsph;fhyj;jpYk; kiof;fhyj;jpYk; ,J 
Vuhskha; G+f;Fk;.   
6. 8tiffs; :;;;  
 Mk;gy; tifspy; jkpo;ehl;by; ntz;zpw kyiuAila 
nts;shk;gYk;> ePy epw kyiuAila ePy Mk;gYk; nre;epw 
kyiuAila muf;fhk;gy; (nrt;ty;yp) cs;sd.  nghJthf Mk;gy; 
vd;why; rq;f ,yf;fpaq;fs; nts;shk;giyf; Fwpf;fpd;wd. ePy 
Mk;gYk; muf;fhk;gYk; nts;shk;giy ngupJk; xj;jit.     
7. 9gad;gLk; cWg;G :; ; ;; ; ;; ; ;  
G+> nfhb> ,iy> fpoq;F> fha;  
Rit (Taste)   - rpW Jth;g;G (Slightly  astringent ) 
jd;ik (Potency)   -  jl;gk; (Coolant) 
gpupT (Bio – Transformation)   - ,dpg;G (Sweet) 
nra;if :;;;  
 twl;rpafw;wp 
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 rq;f ,yf;fpa jhtuq;fs; gf;fk; vz; 23 
7
 Fzg;ghlk; %ypif tFg;G gf;fk; vz; 43 
8
 rq;f ,yf;fpa jhtuq;fs; gf;fk; 13 
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 Fzg;ghlk; %ypif tFg;G gf;fk; vz; 43 
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8. Pharmacological activities  
1. Cardiotonic 
2. Astringent  
3. Demulcent  
4. Anodyne 
5. Aphrodisiac 
6. Anti – inflammatory  
7. Sedative  
8. Anti – oxidant.  
9. 10nts;sy;ypapd; G+f;Fzk; :; ; ; ; ;; ; ; ; ;; ; ; ; ;  
‘NkfkWk; Gz;zhWk; tpl;NlFk; ePupopT   
 jhfe; jzpAk; joyfYk; - thfhd  
 nky;ypaNy! MAs;kiw Ntjpa nuyhKiuf;Fk; 
 my;yp kyuhy; mwp  
(m.F) 
,jdhy; Nkfk;> ePh;Gioapd; Gz;> ePupopT> ePh;Ntl;if> cl;#L 
Mfpa ,itfs; tpyFk;.  
1. 11Therapeutic uses : 
1. White lilly is considered to be an astringent, antiseptic, anesthetic, 
and sedative  
2. It can be used in treatment of bronchial congestion, and it can 
disperse the stagnated mucus from the chest.  
3. The flowers can be used in treatments of insomnia and different 
sort of anxieties.  
2. 12Herbal medicine : 
 Medicinal properties of white lilly include astringent, antiseptic, 
sedative. Soaking the persian white lilly flower petals or leaves in wine 
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 Fzghlk; %ypif tFg;G   g.vz; - 44 
11
 White Water lilly – nymphaea alba / Medicinal use. http / 1 health – from – nature, net /white lotus – 
water lily html. 
12
 Buy white lotus Nymphaea alba  http // www iamshamam.com/lotus/white lotus html 
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and then ingesting the extract also lent its self well as an aid in meditation 
and relaxation.  
 It has been said that powerful extracts of dried white lilly flowers 
were used in the first world war as an admixture to opium for surgery or 
even as substitute when opium was not available.               
3. 13Nymphaea alba : 
 The water lilly was invoked in numerous mayan magical 
conjugrations to heal ulcers and skin diseases.   
4. 14Nymphaea alba 
Flowers and rhizomes astringent, demulcent mild sedative, 
spasmolytic, antiseptic, antimicrobial – used in the form of an infusion 
internally for chronic diarrhoea, as a douche for leucorrhoea and 
vaginitis, as a gargle for sore throat.  
5. Nymphaea alba  
 Constituents : Alkaloids and glycosides.  
Properties and action :  
 Rasa    : Madhura, Tikta, Kashaya 
 Guna   : Laghu, Pichila, Snigdha  
 Viriya   : Sita 
 Vipaka  : Madhura  
 Kanma  :  Balya, Hridya, Pittahara, Stambhama, Vatahara,  
Garbha  sthapana, sramahara.  
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 http // www shamans garden . com/p-143 white – lotus – flowers - nymphaea - alba 
14
 Nymphaea alba – logayurveda.com www.logayurveda.com/probiles / 260 nymphaea alba. 
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Important formulations : 
Triphaladi Taila  
Bala Asvagandha Lakshadi taila 
Therapeutic uses  : Raktadosha  
    Daha 
    Hridroga  
    Raktapita 
Dose: 3 – 6 gm  
The reason for using water as vehicle: 
 Now days we are using Deep spring well (bore) water or shallow 
spring (normal) well water for drinking purpose. As per the siddha 
science both of them were used for reducing heavy thirst and normalize 
deranged pitha humour which is the basic cause to persude diabetes in 
seven vital things (sabtha thathus) of human body.  Also used as nutrition 
liquid refreshment.  
15fpzw;W ePh; : ; P ;; P ;; P ; (Shallow spring water) 
‘Mrhuf; $gj; jwyhy; mjpjhfk;  
 tPrhr; #Lgrp nka;f;fhe;jy; - kh#iy 
 nka;g;Gs; ,ilj;Jisg;G tPo;kaf;FQ; Nrhig gpj;jk; 
 igatU kPisAk; ghh;” 
16Cw;W ePh; :; P ;; P ;; P ;  
‘Cw;W ePh; gpj;jk; xopf;Fk;> ,dpg;ghFk; 
 Mw;wptpLk; jhfj;ij mg;nghONj - $w;Wtpopf; 
 nfhk;g ilaha; Fzq;Fzq; itj;njsptha;  
 ek;gp Ayfwpa ehl;L.  
Meaning: 
From the above classical siddha literatures both waters are 
reducing most of the diabetic complaints increased hunger (polyphagia) 
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increased thirst (polydipsia), dizziness, peripheral neuropathy and also 
normalize the deranged pitha humour.  So, I have selected water as a 
vehicle.  
nts;sy;ypg;g+ NrUk; ePhpoptpw;fhd kUe;Jfs;; ; ; ; P ; ; ;; ; ; ; P ; ; ;; ; ; ; P ; ; ; 
1. fe;jhjp ,sfk;;; ; 
msT  : nfhl;il ghf;fsT 
jPUk; Neha; :P ; ;P ; ;P ; ;  ePhpopT %yk;> fpuhzp jPUk;> Njf G~;b 
cz;lhFk;. 
2. ePhpopTf;F kUe;JP ; ;P ; ;P ; ;  
msT   :  Kf;foQ;R 
JizkUe;J ;;;  :  gtsgw;gk; 
ehs; msT ;;;  :  1 kz;lyk; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  rfy NkfKk; jPUk; 
gj;jpak; ; ;; ;; ;   :  ifg;G> Gspg;G jtpHf;fTk;. 
3. fw;g+urpyhrj;J gw;gk;; ; ; ;; ; ; ;; ; ; ; 
msT   :  2 – 4 mhprp vil 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Nkfg;gpzpfs;> Nkf moy;> cl;#L>  
ePHNtl;if> FUjpaoy; jPUk;.  
4. fy;ahzf;fpUjk;; ; ;; ; ;; ; ; 
msT   :  1 fuz;b> 2 Ntis 
mDghdk; ;;;   :  gRk;ghy; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Nrhig> cd;khjk;> fhkhiy> ghz;L>  
mr;ruk;> c~;zk;> NkfNeha;fs;> 
%j;jpufpur;rurk; 
1 Mj;kul;rhkpHjk; vd;Dk; itj;jpa rhu rq;fpufk; gf;fk; vz; 457; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ;  
2 Mj;kul;rhkpHjk; vd;Dk; itj;jpa rhu rq;fpufk; gf;fk; vz; 367; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ; ;  
3 Fzg;ghlk; %ypif tFg;G gf;fk; vz; 44; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
4 mfj;jpaH ;;; – 2000> gf;fk; vz; 273; ; ;; ; ;; ; ;  
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ePhpoptpy; P ;P ;P ; fhZk; gpsitf;fhd kUe;Jfs;; ; ; ;; ; ; ;; ; ; ; 
5. gpsit tPf;fk; g+r;R:P ; ; ;P ; ; ;P ; ; ;  
gpuNahfk;> g+r;rpid ,Nyrhf ,sf;fpg; g+rTk;. 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ;  
gpsit tPf;fk;> fl;b 
6. ngUk; gpsitf;F kUe;J:; ; ;; ; ;; ; ;  
msT  :  Gd;idf;fhasT 
mDghdk; ;;;   :  Gspj;jNkhH 
jPUk;Neha; P ; ;P ; ;P ; ;   :  Ks;nsYk;gpd; Njhd;wpa ngUk;  
gpsitapd vhpr;ry; ePq;fp jPUk;. 
nts;sy;ypg;g+ NrUk; gpwNeha;f;fhd kUe;Jfs; Nfhgpf;Fk; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;
gpuNkfk;>         ;;;  
1. thjg;gpuNkfj;jpw;F kUe;J ; ; ; ;; ; ; ;; ; ; ;  
msT   :  jf;f msT 
Jiz kUe;J ;;;  :   Njdpy; Fioj;J mUe;j Nfhgpf;Fk;  
gpuNkfk; jPUk; ney;ypf;fhapd; rhw;wpy; 
mUe;j gpj;j gpuNkfk; jPUk;. NkhUld; 
mUe;j thjg;gpuNkfk; jPUk;. 
2. gpj;jj;Jf;F Fkhpj;ijyk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
gpuNahfk; ;;;   :  ntspg;gpuNahfkhf jiy%o;fp tu gpj;j  
rk;ge;jg;gl;l gpzpfs; midj;Jk; jPUk;. 
3. ghjg;gpsg;Gf;F kUe;J:; ; ; ;; ; ; ;; ; ; ;  
gpuNahfk; ;;;   :  nghbfis xd;W NrHj;J ghypy;  
miuj;Jg;g+rTk; cgNahfpf;Fk; Kd; 
fhiyf;foTk; 
mfj;jpaH 2000 gf;fk; vz; 37>43; ; ; ;; ; ; ;; ; ; ;  
ruNge;jpuH ePhpopT rpfpr;ir 107; P ;; P ;; P ;  
NjiuaH thflk;> gf;fk; vz; 117>179; ; ; ;; ; ; ;; ; ; ;  
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4. jhk;gpuhjp khj;jpiu:; ;; ;; ;  
gpuNahfk; ;;;  :  jf;f mDghdq;fspy; ciuj;J fz;zpypl  
fz;Nzha;fs; - 96 jPUk;. 
5. rk;gPuj;ijyk;:; P ; ;; P ; ;; P ; ;  
gpuNahfk; ;;;   :  thuk; 1 Kiw jiy%o;fp tu Ntz;L;k; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  gpj;j rk;ge;jkhd gpzpfs; jPUk; %isapd;  
nfhjpg;G FiwAk;. 
gj;jpak; ; ;; ;; ;   :  Gsp js;sp> ,r;rh gj;jpak;. 
6. kfu RjHrdr; #uzk;:; ;; ;; ;  
msT   : ¼ Njhyh> 2Ntis 
mDghdk; ;;;   :  nte;ePH 
jPUk; Neha; P ; ;P ; ;P ; ;  :  thjRuk;> gpj;jRuk;> fgRuk;> njhe;jRuk;>  
m];jpRuk;> ,uj;jf;nfLjy;> fhkhiy> 
gf;f#iy 
gj;jpak; ; ;; ;; ;   :  ,r;rhgj;jpak; 
NjiuaH Fzthflk; gf;fk; vz; 144; ; ; ;; ; ; ;; ; ; ;  
rpfpr;rh uj;d jPgk; ; ; P ;; ; P ;; ; P ; - 2ghfk; gf;f vz; 199; ; ;; ; ;; ; ;  
rpfpr;rhuj;d jPgk; gf;f vz; 120; ; P ; ; ;; ; P ; ; ;; ; P ; ; ;  
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SIDDHA ASPECT OF DISEASE 
17ePhpopTPPP  
NtW ngah;fs; :; ;; ;; ;  
kJNkfk;> ,dpg;G ePh;. 
,ay; :;;;  
mbf;fb rpW ePh; ngUthhpaha; ,opjy;> ePhpoe;j ,lj;jpy; <> 
vWk;Gfs; nkha;j;jy;> mjidf; fha;r;rpd; rh;f;fiu kzk; tPry;> 
cly; ehSf;F ehs; ,isj;jy; vd;Dkpay;Gila jhk;. 
Neha; tUk; top :; ;; ;; ;   
‘fd;dp kaf;fj;jhy; fz;bLk; NkfNk.” vd ehb E}Yk;> 
‘fpue;jpg; Gz;zpuz Nkff; fPr;rf ndd;De; Jd;khh;f;fdUe;jjp 
nad;Dk; ghQ;rhyp ad;idiaf; fz;Zw;whNd.” vd kUj;Jg; 
ghujKk; $wpajhy;> ePhpopT Neha; msT fle;j fytpahy; 
Nkfj;ijj; njhlur; nra;J tUk; Neha; vdf; nfhs;sg;gLk;. 
md;wpAk;> kpF czT> Nrhk;gpj; jphpjy;> kdf;fyf;fk;> nghUspd; 
kPJ kpFe;j ,r;ir vd;Dk; ,tw;whYk; jha; je;ijapd; topahTk; 
tuf; $Lnkd mwpjy; Ntz;Lk; <jd;wp nea;> ghy;> fs; ,iwr;rp> 
kpf;f RitAs;s kPd;fs; ,dpg;Gr; RitnghUe;jpa czTfs; 
vd;Dk; ,itfSk; Neha; tUtopf;Ff; fUthk;.  
Kw; Fwpfs; :; ;; ;; ;  
rpW ePh;> njspe;j ePh;Nghy; mbf;fb gbf;fzf;fpy; ,opjYk;> 
,ope;j ePh;j;Jspfs; rw;W cyhpd; gpRgpRj;Jf; fhZjYk; cly; 
td;ik ehSf;F ehs; Fiwe;J nfhz;Nl tUjYk;> ehtwl;rpAk; 
Mfpa Kw;Fwpfisf; fhl;Lk;.  
Nehapd; FwpFzq;fs; :; ; ;; ; ;; ; ;  
Nkw;$wpa Fwpfisf; fhl;b> ePh; kpFe;j mstpy; ,wq;Fk;> 
ePUf;Ff; $wpa> epwk;> epiw> vil> kzk; vd;Dkptw;Ws;> epwk; 
jz;zPiug; NghYk;> epiw msT fle;Jk;> vil fdj;Jk;> kzk; 
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Njd; NghYk; fhzg;gl;L> fha;r;rpd; Njd; kzk; tPRjYk; 
cz;lhFk;. cly; ehsf;F ehs; nkyptile;J nfhz;Nl 
tUtJld;> Njhypy; nea;g;giraw;W twz;L RUq;fpf; fhz;gJld; 
ntSj;j kQ;rs; epwj;ijAkilAk;. ehtwl;rp> kpFe;j ePh; Ntl;if> 
kpFe;j grp> Grpj;j rw;W Neuj;jpw;Fs; grpnaLg;gJ Nghd;w Njhw;wk; 
cz;lhk;.  nea;> ghy; Kjypa Cl;lk; jUk; nghUs;fis 
cz;zpDk;> cly; Cl;lk; ngwhik Kjypa Fwpfis epiyf;fr; 
nra;Ak;. ,e;Neha; ngUk;ghd;ikAk;> Iaf;fhykhfpa 
KJikapYz;lhk; Nehahk;.  rpWghd;ik ,sikapYk; 
tUtJz;lhapDk;> jf;f kUj;Jtj;jpy; Nghk;. eLtajpy; 
cz;lhapDk; vspjpy; jPUtJz;L.  ,‡J kUj;Jtj;jpy; vspjpy; 
jPuhtpbd; Neha; Kjph;e;J jdf;Fj; Jizahfg; gytifg; gl;l 
NfLfisAk; tUtpf;Fk;.  rpW ePh; mbf;fb kpFe;J ntspahtJld; 
m‡J cly; rj;ij cUf;fpr; rh;f;fiuaha; ePh; topNa 
ntspahf;fptpLk;.  kaf;fk;> jiy Rw;wy;> fisj;J tPo;jy;> tPry;> 
fz; kq;fy; my;yJ fz;zpy jpiuAz;lhjy; (glyk; Mfpa 
Fzq;fisf; fhl;b> kpFe;j mstpy; Ngha;f;nfhz;bUe;j rpW 
ePuhdJ> ehSf;F ehs; mstpy; Fiwe;Jnfhz;Nl te;J ePh;f;fl;L 
Nehia cz;lhf;fp> grpapd;ik> nrhpahik> Xf;fhsk;> the;jp> 
tapw;WNeha;> kdf;fyf;fk;> rpdk;> kaf;fk;> Mfpa Fwpfisf; 
fhl;bg; gLf;ifapy; fplj;jp %r;Rj; jLkhwp> jpzuy; nra;J 
nfhy;Yk; my;yJ ,Uky;> ,iug;G> (fgk;~ak;)> jkuf thA> 
euk;Gj;jsh;r;rp Kjypa Neha;fisj; Jiz nfhz;L nfhy;Yk;.  
 rpy Ntis nrhwp> rpuq;F> fl;b Kjypaitfis tUtpj;J 
Jd;gk; gy fhl;Lk;. ,e;Nehapy; cz;lhk; fl;b tiffs; jdpj;Jf; 
$wg;gl;Ls;sd.  
Fw;w Kjypa NtWghLfs; :; ;; ;; ;  
Neha; tUtopapy; $wpathW jd; tpid gpw tpidfspd; 
msthf Iak; jd;dpiyapy; Nflile;J fPo; Nehf;Ff;fhy;> 
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mj;Jld; nfl;l> clw;fl;Lfs; VioAk; xd;wd;gpd; 
Xd;wha;f;nflr; nra;J ehsiltpy; grpj;jPiaf; nfLf;Fk;. Cl;lk; 
jUk; nghUs;fis cz;zpDk;> cly; td;ikailjpy;iy. 
Nflile;j mf;Fw;wj;jhy; kw;w tpuz;Lk; jd;dpiy gpwo;e;J 
jq;fSf;Fj; Jizaha;f; fhy;fis (thAf;fis)Ak; $l;b VO 
clw;fl;Lfspd; td;ikiaf; nflr;nra;J gy 
tifg;gl;lNeha;fisAk; Kjy; Neha;f;Fj; Jizahf;Fk;. ,jidf; 
‘FwpAlNk Nkfe;jhd; nfhLik nra;J> Fiwe;J te;J tUe;jhJ 
nty;yhq; Fd;wpg;NghFk;.” vdg; gjpndd; rpj;jh; ehb E}ypy; 
$wpajhy; mwpf.  
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MODERN ASPECT OF DISEASE 
18Diabetes Mellitus: 
Diabetes mellitus is  a clinical syndrome characterised by 
hyperglycaemia caused by obsolute  or relative deficiency of insulin. 
There are 2 types: 
Type -1 Insulin Dependent Diabetes Mellitus 
Type -2 Non-Insulin Dependent Diabetes Mellitus. 
IDDM: 
Pathology: 
It is a T-cell mediated autoimmune disease involving destruction of 
insulin secreting β cell in Pancreatic islets. 
Hyperglycemia with classical symptoms occurs only when 70 -
90% destroyed. 
Pathology in Pre-diabetic Pancreas: 
1) Insulitis - Infiltration of Islets with mono nuclear cells 
containing activated macrophages, suppressor T-cells Natural killer 
cells. 
2) Intial Patchiness then lobules containing heavily infiltrated Islets. 
3) β-cells specifically of destructive process glucagon and other secreting 
harmone remain intact. 
Detection: 
1) Islet cell antibody can be detected before clinical development of 
Type I DM. 
2) Glutamic acid Decarboxylase antibodies have a role in identifiying 
Type I DM in middle aged people. 
It is also associated with other autoimmune disease Thyroid, 
addison disease etc. 
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Causes: 
1) Genetic Pre-disposition: 
Genetic factors account for 1/3 of suspectibility of Type I diabetes. 
Main genome is focused on HLA region with major 
histocompatibility complex on the short arm of chromosome 6. 
Environmental factor: 
1) Reduced exposure to micro – organism in early childhood limits the 
maturation of immune system and increase suspectability to auto 
immune disease. 
2) Viral infection of β cell of Pancreas ex mumps, Rubella, Retroviruses, 
CMV. 
3) Dietary factors: 
Various nitrosamines present in smoked meats, coffee have been 
proposed as potentially diabatogenic toxins. 
4. Bovine Serum Albumin (BSA) a major constituent of cow’s milk has 
been early in infancy are more likely to develop Type I DM than those 
who are breast fed.  BSA may cross neonatal get and raise antibodies 
which cross reat with a heat shock protein expressed β-cells. 
Metabolic disturbances in Type IDM: 
1) Symtoms usually seen only when 50 -70%  β cells destroyed. 
2) Severe insulin deficiency is associated with metabolic sequale. 
3) Hyperglycemia leads to glycosuria dehydration induces secondary 
hyperaldosteronism.  
4) Unrestrained lipolysis and proteolysis result in weight loss increased 
gluconeogenesis and ketogenesis. 
5) Ketoacidosis occurs when generation of ketone bodies exceed the 
capacity of their metabolism. 
Elevated H+ ions drive K+ out of the intracellular compartment.  
While secondary hyperaldosteronism encourage urinary loss of K+. 
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Thus patients usually present with a short history [typically few 
weeks] of hyperglycemic symptoms [thirst, polyuria, nocturia and 
fatigue] infection, wt loss. 
Type 2 Diabetes: 
Pathology: 
Insulin resistance is the cause of type-2 DM. 
1) Primary cause of Insulin resistance becomes unclear. 
2) Intra-abdominal “Central adipose tissue” is metabolically active and 
release large quantity of FFAs which may induce insulin resistance 
because they compete with glucose as a fuel supply for oxidation in 
peripheral tissue such as muscle. 
3) In addition adipose tissue release number of harmones called 
adipokenes which structurally resembles cytokines which is necessary 
for insulin sensitivity. 
4) Physical activity is another importance determinant of insulin 
sensitivity. 
5) Inactivity is associated with down regulation of insulin receptor and 
promote accumulation of FFAs in skeletal muscles. 
6) Sedentary people are more insulin resistant than active people even 
with same degree of obesity. 
7) Many patient with Type-2 Diabetes have evidence of fatty infiltration 
of liver [Non-Alcoholic fatty liver]. 
8) Genetic factors also play important role. 
9) Type-2 Diabetes associated with overeating especially when combined 
with obesity and underactivity. 
10) The risk of developing Type-2 DM increases 10 fold in people with 
BM1>30Kg1/m2. 
11) The constituents of the diet and style of eating may be important. 
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12) Sweet food rich in carbohydrates consumed frequently may increase 
the demand for insulin secretion, while high fat – food may increase 
FFAs and exacerbate insulin resistant. 
Age: 
Type-2 Diabetes is more common in middle aged and elderly. 
Pregnancy: 
1) During normal pregnancy insulin sensitivity is reduced through 
placental harmone and this affects glucose tolerance. 
2) The insulin secreting cells of pancreatic islets may be unable to meet 
this increased demand in women genetically pre-disposed to develop 
diabetes. 
3) Repeated pregnancy increases likelihood of developing irreversible 
diabetes.  particularly in obese women. 
Metabolic disturbances: 
1) Patient with Type 2 Diabetes have slow onset of relative insulin 
deficiency compared to Type I. 
2) Severity of classical osmotic symptoms of Polyurea and Polydypsia is 
related to degree of glycosuria. 
3) In Type 2 DM, hyperglycemia develops slowly over months or years.  
There is rise in renal threshold for glucose.  So glycosuria is limited. 
4) Patients are aften asymptomatic and usually present with a long 
history of fatigue with or without symptoms. 
5) In some patient with Type 2 diabetes presentation is late and 
pancreatic  β cell failure has an advanced stage of insulin deficiency. 
6) Weight loss is common, keto acidosis is uncommon. 
7) Intercurrent illness, with infection increase the production of counter 
regulatory harmone such as cortisol, growth harmone.  This increase 
insulin resistance, insulin deficiency, result in severe dehydradation, 
hyperglycemia. 
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Acute complication of DM: 
Diabetic ketoacidosis and Hyperglycemic 
Hyperosmolar state 
1) Diabetic Ketoacidosis[DKA]: 
Diabetic ketoacidosis was formerly considered a hallmark of Type 
I DM. 
1. DKA result from relative or absolute insulin deficiency combined 
with counter regulatory harmone excess [glucagon, cortisol and 
growth harmone] 
2. Both insulin deficiency and glucagon excess, in particular are 
necessary for DKA to develop. 
3. Decreased ratio of insulin to glucagon promote gluconeogenesis, 
glycogenolysis and ketonebody formation in liver. 
Precipitating events: 
 Inadequate insulin administration 
 Infection [UTI, sepsis, gastroenteritis] 
 Drugs [cocaine] 
 Pregnancy 
 Infarction [cerebral, coronary] 
Symptoms: 
1) Nausea/vomiting 
2) Thirst/polyurea 
3) Abdominal pain 
4) Shortness of breath 
Physical findings: 
1) Dehydration/Hypotension 
2) Dry mucous membrane 
3) Tachycardia 
4) Tachypnea 
25 
 
5) Lethargy 
6) Cerebral odema 
Hyperglycemic Hyperosmolar state: 
1. It is mostly seen in elderly individual with type 2 DM, with several 
week history of polyuria, weight loss and diminished oral intake 
that culminates in mental confusion, lethargy or coma. 
Precipitating factor: 
1) Myocardial infarction 
2) Smoke 
3) Sepsis 
4) Pneumonia 
Physical examination: 
1) Dehydration 
2) Hyperosmolality 
3) Hypotension 
Nausea, vomiting, abdominal pain and kussmaul respiration absent. 
Pathophysiology: 
Relative insulin deficiency and inadequate fluid intake are causes of 
HHS. 
1) Insulin deficiency increase hepatic glucose pdn [glycogenolysis and 
gluconeogenesis] and impairs glucose utilisation in skeletal muscle. 
2) Hypoglycemia 
Osmotic diuresis 
Intravascular volume depletion. 
3) Insulin deficiency is only relative and less severe than in DKA. 
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Chronic complication of DM. 
Micro-vascular 
1) Diabetic Retinopathy 
2) Diabetic Nephropathy 
3) Diabetic Neuropathy 
Macro-vascular: 
1. Coronary artery disease 
2. Peripheral vascular disease 
3. Cerebro vascular disease. 
Other: 
1. Gastrointestinal [diarrhoea, gastropareses] 
2. Genitourinary [ uropathy/ sexual dysfunction] 
3. Dermatology 
4. Infections 
5. Cataract 
6. Glaucoma. 
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Lateral Research work on Vellallipoo Chooranam 
1. Anticarcinogenic effect of nymphaea alba against oxidative damage, 
heperproliferative response and renal carcinogenesis in wistar rats.  
(khan N, sultana S) mol cell biochem, www.ncbl.nlm.nih.gov 
/pubmed/15881650. 
2. Anxiolytic activity of nymphaea alba in mice as expiremental models 
of anxiety.  B.S. Thippeswamy et al.  www.ijp-online.com feb 01, 
2011. 
3. Evaluation of analgesic and antioxidant potential of ethanolic extract 
of Nymphae alba. 
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MATERIALS AND METHODS  
Preparation of Drug 
Collection of the Drug : 
Flowers of Alli plant (Flower of Nymphaea alba) were collected 
during winter and spring seasons in the ponds of in and around area of 
veeramudiyanatham village cuddalore district.  It was shown and 
identified by the staff of PG Gunapadam Department and Botanist.  
Purification of the Raw drug : 
After collection flowers were cleaned thoroughly with freshwater 
and floral parts were separated.  Floral parts were allowed to dry 
completely under shade until the moisture was completely lost.  
Preparation of the test drug : 
The purified drug was made into powder and filtered with clean 
white cloth (Vasthirakayam).  Then the powder was collected and 
preserved in an air tight container  
Indication : 
Madhumegam.  
Route of Administration : 
Enteral. 
Dose : 
 One gram twice a day with hot water before meals.  The prepared 
vellallipoo chooranam was used within 3 months since the self life of 
chooranam is 3 months.  This medicine was used for the following 
procedures.  
1. Bio – chemical analysis  
2. Pharmacological analysis  
3. Clinical assessment 
4. Quantitative and qualitative chemical analysis.  
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5. Microbiological analysis  
6. Biostatical analysis  
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PHYSICO-CHEMICAL STANDARDIZATION 
The standardization parameters of  Vellallipoo Chooranam 
(Nymphaea) was done at Sastra universityThanjavur. 
The tests done are as follows. 
pH at 10% of aqueous solution: 
Five grams of Vellallipoo Chooranam  is weighed accurately and 
placed in clear 100 ml beaker. Then 50 ml of distilled water is added to it 
and dissolved well. Wait for 30 minutes and then apply in to pH meter at 
standard buffer solution of  4.0, 7.0 and 9.2 
Loss on drying@ 1050 C: 
Five gram of Vellallipoo Chooranam is heated in a hot oven at 
1000 C to constant weight. The percentage of loss of weight was 
calculated as 10.35 %. 
Determination of ash value: 
Weighed accurately 2 grams of Vellallipoo Chooranam in tarred 
platinum or silica dish and incinerate at a temperature not exceeding 
4500C until free from carbon, cooled, and weighed. Calculate the 
percentage of ash as 3.975 with reference to the air dried drug. 
Water soluble ash: 
To the gooch crucible containing to the total ash, added 25 ml of 
water and boiled for 5 minutes. Collected the insoluble matter in a 
sintered glass crucible or on ash less filter paper. Wash with hot water 
and ignite in a crucible for 15 minutes at a temperature not exceeding 450 
0
 C substract the weight of the insoluble matter from the weight of the ash 
the difference of the weight represents the water soluble ash. Calculate 
the percentage of water soluble ash as 305 with reference to the air dried 
drug. 
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Alkalinity as CaCO3 in water soluble ash: 
Five grams of Vellallipoo Chooranam  converted to ash, boiled 
with water filtered. Filtered was tilt rated against 0.1 N of HCl using 
phenophthalin as an indicator. 
Alkalinity of water soluble ash         = X x of acid/ 0.1 x W 
X –Titre value 
W - Weight of material taken 
Alkalinity is given as 1.14 % of 0.1 N of HCl equated to 1 gm. 
Acid in soluble ash; 
Boiled the ash 5 minutes with 25 ml of dilHCl. Collect the 
insoluble matter in gooch crucible on an ash less filter paper wash with 
hot water and ignite. Cooled in a dessicator and weighed. Calculated the 
percentage of acid insoluble ash as 1.96% with reference to the air dried 
drug. 
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BIO – CHEMICAL ANALYSIS OF  
VELLALLIPOO CHOORNAM 
PREPARATION OF THE EXTRACT 
5gms of the drug was weighed accurately and placed in a 250ml 
clean beaker.  Then 50ml of distilled water is added and dissolved well.  
Then it is boiled well for about 10 minutes.  It is cooled and filtered in a 
100ml volumetric flask and then it is made up to 100ml with distilled 
water.  This fluid is taken for analysis. 
QUALITATIVE ANALYSIS 
S. NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube.  To this 
add 2ml of 4 % ammonium oxalate 
solution 
No white 
precipitate is 
formed 
Absence of 
calcium 
2.  TEST FOR SULPHATE: 
2ml of the extract is added to 5% 
barium chloride solution. 
No white 
precipitate is 
formed 
Absence of 
Sulphate 
3.  TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
No white 
precipitate is 
formed  
Absence of 
chloride 
4.  TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl 
No brisk 
effervescence is 
formed 
Absence of 
Carbonate 
5.  TEST FOR STARCH 
The extract is added with weak 
iodine solution. 
No blue colour is 
formed 
Absence of  
Starch. 
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6.  TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and Potassium ferro 
cyanide. 
No blue colour is 
formed  
Absence of 
Ferric Iron 
7.  TEST FOR FERROUS IRON 
The extract is treated with 
concentrated Nitric acid and 
ammonium thiocyanate solution. 
Blood red colour 
is formed 
Indicates the 
presence of 
Ferrous Iron. 
8.  TEST FOR PHOSPHATE 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed 
Absence of 
Phosphate. 
9.  TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed. 
 
Absence of 
Albumin 
10. 
 
TEST FOR TANNIC ACID 
The extract is treated with ferric 
chloride. 
Blue black 
precipitate is 
formed 
Indicates the 
presence of 
tannic acid 
11. TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets 
decolourised 
Indicates the 
presence of 
Unsaturated 
compound. 
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12. TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and added 
8-10 drops of the extract and again 
boil it for 2 mts. 
No colour change 
occurs. 
Absence of 
Reducing 
Sugar. 
13. TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried it 
well.  After drying, 1% Ninhydrin is 
sprayed over the same and dried it 
well. 
Violet colour is 
formed 
Indicates the 
presence of 
Amino acid 
 
14. TEST FOR ZINC: 
The extract is treated with potassium 
ferro cyanide 
No white 
precipitate is 
formed 
Absence of 
Zinc. 
 
Inference: 
The given sample “Vellallipoo Chooranam” indicates the 
presence of  Ferrous iron, Tannic acid, Unsaturated compound  and 
Amino acid. 
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PHARMACOLOGICAL ANALYSIS 
HYPOGLYCEMIC STUDY OF VELLALLIPOO CHOORANAM 
As per the “GUNAPADAM MOOLIGAI VAGUPPU” reference 
Vellallipoo Chooranam is treated for Hypoglycemic study in rabbits.  
Reasons for choice of rabbit: 
1. Can be handled easily. 
2. Several number of blood samples can be taken.  
3. Blood sugar regulation is more stable and more predictable than rat 
or mice.  
AIM : 
To evaluate Hypoglycemic activity of vellallipoo chooranam.  
MATERIALS AND METHODS: 
 The test drug 100mg of Vellallipoo chooranam in 10ml of water. 
2ml of test drug was given to test group.  
Procedure : 
 Six healthy young rabbits fastened for 18 hrs weighing 1-1 ½ kg 
was selected Rabbits were kept in a clean condition.  Before drug 
administration fasting blood samples were drawn from marginal ear vein 
of rabbits for blood sugar analysis. 
 Then 6 rabbits are divided into 3 groups.  Each containing 2 
groups.  2 rabbits received 5 ml of water and kept as a control group.  The 
second group of rabbits received 1 mg of Dianil per 1 kg body weight and 
kept as a standard group.  Third group of rabbits received 1gm/kg of test 
drug.  Then the blood samples were collected at 1 ½ and 3 hrs after drug 
administration.  During the experiment period the rabbits were fasted till 
the net blood sugar was estimated according to enzymatic method.  
 Study of Hypoglycemic effect in Rabbits using the drugs of 
Vellallipoo chooranam.  
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S.No 
Name of 
Drugs / 
groups 
Dose/kg 
of body 
weight 
Value 
of 
fasting 
samples 
Value 
of P.P 
samples 
after 
1½ hrs 
Reduction 
difference 
in mgs 
Percentage 
reduction Remarks 
1 Control (water) 5 ml 72 mg 72 mgs - - 
Significant 
action 2 Standard 1.25 mg 109 mg 62 mgs 47 43% 
3 Vellallipoo Chooranam 100mg 107mg 77mgs 30 28.3% 
 
Inference : 
 The test drug vellallipoo chooranam, 28.3% reduction in blood 
sugar level when compared with standard drug.  It shows significant 
Hypoglycemic action.  
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ANTI-MICROBIAL ACTIVITY OF VELLALLIPOO 
CHOORANAM 
AIM : 
 To identify the anti – microbial (Bacterial) activity of Vellalli 
Poo Chooranam against streptococcus, proteus, staphylococcus, 
pseudomonas, E.coli.  
Medium : 
 Muller Hinton Agar.  
Components of medium: 
Beef Extracts  :  300 gms / lit. 
Agar    :  17 gms / lit. 
Starch   :  1.50 gms / lit.  
Casein Hydroxate :  17.50 gms / lit 
Distilled water  :  1000 ml 
Ph   :  7.6. 
Procedure : 
The media was prepared from the above components and poured 
and dried on a petri dish.  The organism was streaked on the medium and 
the test drug (1 gm drug in 10ml of water) was placed on the medium.  
This is incubated at 370 for one overnight and observed for the 
susceptibility shown up clearance around the drug.  
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Anti – microbial susceptibility test report. 
S.No Organism Susceptibility 
Zone of  inhibition 
in mm 
1 
Streptococcus  
pneumoniae 
Sensitive 11 mm 
2 Proteus Resistant - 
3 Staphylococcus Sensitive 10 mm 
4 Pseudomonas Resistant - 
5 E.coli Resistant - 
 
Result : 
The test drug vellallipoo chooranam was sensitive for 
streptococcus pneumoniae and staphylococcus aureus.  
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SCANNING ELECTRON   MICROSCOPIC    
ANALYSIS (SEM) 
A scanning electron microscope (SEM) is a type of electron 
microscope that produces images of a sample by scanning it with a 
focused beam of  electrons. The electrons interact with electrons in the 
sample, producing various signals that can be detected and that contain 
information about the sample's surface topography and composition.  
The electron beam is generally scanned in a raster scan pattern, and 
the beam's position is combined with the detected signal to produce an 
image. SEM can achieve resolution better than 1 nanometer. Specimens 
can be observed in high vacuum, low vacuum and in environmental SEM 
specimens can be observed in wet condition. 
 
PRINCIPLE: 
The types of signals produced by a SEM include secondary 
electrons (SE), back-scattered electrons (BSE), characteristic X-rays, 
light (cathodoluminescence) (CL), specimen current and transmitted 
electrons.  
Secondary electron detectors are standard equipment in all SEMs, 
but it is rare that a single machine would have detectors for all possible 
signals. The signals result from interactions of the electron beam with 
atoms at or near the surface of the sample. In the most common or 
standard detection mode, secondary electron imaging or SEI.  
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SAMPLE PREPARATION 
For scanning electron microscopy (SEM), Dried herbal powder of 
vellali poo chooranam was fixed to aluminum stubs with double sided 
cellophane tape, air dried at room temperature and coated with a very thin 
layer of gold (JFC-1100). The specimens were examined using a 
scanning electron microscope (JEOL-JSM 5910), at 2000x, 5000x and 
10000xmagnification.  
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SCANING ELECTRON MICROSCOPIC ANALYSIS OF 
VELLALI POO CHOORANAM 
  
 FOURIER TRANSFORM INFRARED SPECTROSCOPIC 
[Infrared Rays] 
Infrared (IR) lights are electromagnetic radiation with thier 
wavelength longer than those of visible lights, 
measured from the nominal edge of visible red light at 0.74 micrometers, 
and extending conventionally to 300 micrometres. 
(In the visible light region, lights' color change from red to violet as their 
wavelength become shorter, and finally become invisible again. Then 
come the Ultraviolet (UV) lights whose wavel
rays, ranging 10 nm to 400 nm. Rays ranging from 0.01 to 10 na
are classified into X-rays.  
shorter than X-rays are called Gamma rays.)
[FT-IR spectroscopy]
FT-IR Spectroscopy is the abbreviation
InfraredSpectroscopy". This is the analytical 
1970s to qualify and quantify compounds utilizing in
molcules.  
Absorption occurs when the energy of the beam of light (photons)
are transferred to the molecule. The molecule gets ”excited ”and moves to 
a “higher” energy state. The energy transfer takes place in the form of 
electron ring shifts, molecular bond vibrations, rotations, and translations. 
IR is mostly concerned with vibrations and stretching.
42 
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engths are longer than X
Electromagnetic rays whose wavelengths are
 
 
 of "Fourier Transform 
technique developed in 
frared absorption of 
 
 
 
-
nometers 
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FTIR analysis Vellalli Poo Chooranam 
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O-H bend (out-of-
plane) Alcohols & 
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1037.5 C–O stretch (alcohols, 
carboxylic acids, esters, 
ethers) 
 
1227.3 C-O (Alcohols & 
Phenols) 
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1635.4  NH2 scissoring (1°-
amines) (Amines) 
2343.7 Si-H silane                 
(Silicon Function) 
 
2360.9 Si-H silane                      
(Silicon Function) 
 
2924.9 CH3, CH2 & CH 
2 or 3 bands (Alkanes) 
 
3405.0 N-H (1°-amines), 2 
bands or N-H (2°-
amines) (Amines) 
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CLINICAL ASSESSMENT 
DESIGN OF THE STUDY: 
Open clinical trial, phase II B 
A Clinical trial on hypoglycemic activity of vellallipoo 
chooranam in treating madhumegam was carried out at the Govt. Siddha 
medical college, Hospital – Palayamkottai.  This study was carried out 
under the proper guidance of teaching staff of the post graduate, 
Gunapadam department.  
40 cases with clinical signs and symptoms of madhumegam of both 
sexes with age ranging from 40-80 years were selected and treated.  
31 cases were treated as out patients and 9 cases were treated as 
Inpatients. 
The patients were selected as having madhumegam according to 
following including and excluding criterias.  
Inclusion Criteria: 
 Age 40 to 70 years.  
 Patients willing to attend the OPD and IPD  
 Polyuria 
 Polydipsia  
 Tiredness  
 Nocturia  
 Fatigue  
 Recent changes in weight  
 Peripheral neuritis 
 Increased Blood sugar levels  
i) Fasting more than 110 mg% 
ii) Post prandial more than 150 mg% 
 Positive family history 
  
46 
 
Exclusion Criteria : 
1. Diabetes Insipidus. 
2. Diabetes Ketoacidosis  
3. Early onset of DM (IDDM) 
4. Iatrogenic Diabetes. 
5. Hyperglycemia due to other hormonal disorders like acromegaly, 
cushing’s syndrome, hyperthyroidisiom.  
6. Pancreatic carcinoma 
7. Gestational diabetes. 
Clinical Pathological Examinations : 
Blood Test : 
1. Fasting Blood sugar  
2. Post Prandial blood sugar  
3. Blood urea  
4. Serum Cholesterol  
5. WBC, TC, DC  
6. ESR  
7. Hb urea done  
Urine analysis: 
• Albumin 
• Sugar : Fasting and post prandial  
• Deposits  
Drug : 
 The patients were orally administrated vellallipoo chooranam 1 gm 
b.d with hot water twice a day before meals.  
Pattern of study: 
 Bio – chemical analysis of blood sugar (Fasting and Post prandial 
were carried out before and after treatment.  
In the case of outpatient urine sugar. 
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• Not to take any other anti-diabetic drug of any other system 
whether in indigenous of modern when they are on trial.  
• Incidental ailments are treated with appropriate siddha medicine. 
• Advised to attend out patients department every week for the 
collection of medicine, urine examination and the blood sugar 
examination for every fifteen days.  
• Advised to follow the diabetic regimen given to then or registration 
under this clinical trial.  
• Advised to yoga therapy  
Results :  
 In the clinical trial done for 40 patients, 77.5% (31pts) showed 
good response, 17.5% (7pts) showed fair response and 5% (2pts) showed 
poor response.  
 No untoward incidents were reported by any of the patient. 
Table illustrating Gender wise age distribution 
Age 
Group 
(Years) 
Male Female Total 
No. % No % No % 
30-39 1 4.6 - - 1 2.5 
40-49 3 13.6 3 16.7 6 15.0 
50-59 9 40.9 8 44.4 17 42.5 
60-69 3 13.6 4 22.2 7 17.5 
70-79 6 27.3 3 16.7 9 22.5 
Total 22 100.0 18 100.0 40 100.00 
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Table illustrating Response of the drug 
S.No Response No of Persons Percentage 
1 Good 31 77.5 
2 Fair 7 17.5 
3 Poor 2 5.0 
 Total 40 100.0 
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DIABETIC DIETETIC REGIMEN 
The Siddha System plays a great importance on the observation of 
rules regarding diet in everyday life. Because the siddha system has 
rightly 
realized that the basic factor of the body is food.  
‘kUe;Nj czT czNt kUe;J” 
As over intake or consuming unbalanced and incomplete diet is 
considered to be the prime causative factor for upsetting the tiridosa 
balance leading to manifestations of various ailments. Diet helps to 
achieve quick and effective control of diabetes. 
 The diet should be adjusted to bring the weight of diabetics (up or 
down) to the optimum weight and to maintain it there. 
 Obese diabetics are to be given a reducing diet, on the other hand lean 
and thin diabetics should receive a weight gaining diet. 
 Ideal calorie 40% of the total calorie should come from carbohydrate. 
 Regarding fat, is better to prescribe unsaturated fat to keep 
thecholesterol level under control. 
 For sweeting agent patient may use sorbitol or fructose in the diet 
many patients require between 1800-2500 kilo calories where as aged 
women require a little less than this. 
 The total daily intake should be avoided into three meals and two 
snacks. Over eating and fasting must be avoided. 
Dialy diabetic diet chart: -Morning 6 Am: 
Bed tea or coffee without sugar - 1 cup 
Breakfast: 
Toast 2 or Atta  : 60 gm 
Channa   : 50gm 
Boiled vegetables  : 100  gm 
Tea without sugar  : 1 cup 
Milk (Skimmed)  : 1 cup 
50 
 
Mid Morning: 
Sugar less biscuits  : 2 
Milk (Skimmed)  : 1 cup 
Lunch: 
 Rice or Atta   : 70gm 
 Dal    : 1 cup 
 Channa Curry  : 100gm 
 Green Vegetables  : 250gm 
 Butter milk   : 1 cup 
Evening: 
 Sugar less biscuits  : 2  
 Tea without sugar  : 1 cup 
Dinner: 
 Atta    : 70gm 
 Green Vegetables  : 250gm 
 Channa Curry  : 50gm 
Advice : 
 To take tea or coffee without sugar. 
 Breakfast - wheat preparations. 
 Lunch - Rice preparations. 
 Dinner - Kelvaragu Preparations. 
 Direct sugar intake in the form of refined carhohydrates should 
totally be avoided. This includes table sugar, sweet, honey and 
jaggery. 
 To omit sweet vegetables and most of the underground vegetables. 
 The total quantity of food must be restricted. 
 Green leafy vegetables and other low calorie food can be taken 
in unlimited quantities. 
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 Addition of vegetables protein in the form of Bengal gram, 
green gram. 
 Daily regular exercise like walking. 
cztpy; Nrh;f;f Ntz;ba fha;fwpfs;:; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
frg;G> JtHg;G RitAs;s fha;fwpfs; ey;yJ. 
ghfy; gpQ;R> Glyq;fha;> ntz;lf;fha;> nrsnrs> 
fhypgpstH> fj;jpup> thioj;jz;L> nts;supf;fha;> Rz;iltw;wy; 
,tw;iw NrHj;Jf; nfhs;sTk;. 
cztpy; NrHf;f Ntz;ba fPiu tiffs;:; ; ; P ;; ; ; P ;; ; ; P ;  
nghJthf vy;yh fPiu tiffisAk; Nrh;j;Jf; nfhs;sTk;.  
cztpy; rpwpa mstpy; ntq;fhak;> kQ;rs;> G+z;L> fLF> Vyk;> 
nte;jak;> rPufk;> thiog;G+> fwpNtg;gpiy> ky;yp> fhak; ,itfis 
NrHf;f Ntz;Lk;.  fha;fwpfis Fiwe;j msT vz;nzapy; Ntf 
itf;f Ntz;Lk;. 
Help of excricise in Mahumegam: 
 Lowers the blood glucose level quickly  
 Improves the body's ability to use insulin 
 Reduces insulin requirement 
 Reduces the risk of heart diseases.  
Yoga and Diabetes: 
#hpa ek];fhuk; ;;; : (Sun salutation) 
Sun  salutation is very good exercise for people suffering 
from diabetes. It increases the blood supply to various parts of body, 
improving insulin administration in the body. It gives all the benefits 
of exercise if practised at 4 rounds per minute. \ 
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Asanas: 
 Dhanurasana 
 Ardhamatsyendrasana 
 Vajarasanayogamudra 
 Pavan muktasana 
 Sarvangasana 
 Halasana 
 Matsyasana 
These asanas have positive effect on pancreas and also insulin 
functioning. Pranayama: 
Pranayama is Nadi Shodhan pranayama or alternate nostril 
breathing, this type is found useful in diabetes as alternate nostrlis 
breathing has calming effect on nervous system, which reduces stress 
levels, helping in diabetes treatment. 
Meditation: 
Practice of meditation is especially useful in management of stress. 
Especially for diabetes, concentration on pancreas during the meditation 
practice has shown positive effects on sugar levels. 
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BIOSTATISTICAL ANALYSIS 
VELLALLI POO CHOORANAM 
The clinical trials were described according to their demographic 
profiles such as age and sex in terms of percentage. They were compared 
and contrasted according to their age between the gender by unpaired 
students't' test. The effectiveness of drug Vellalli Poo Chooranam was 
proved in controlling the fasting and post prandial by student's paired `t' 
test The above statistical procedures,. Were performed by the S.P.S.S. 
Statistical package. The p- values < 0.05 were considered as significant. 
Results: 
Description of study subjects: 
The study subjects of the madhumegam diagnosis were described 
according to their sex wise age distribution. They were compared in 
respect of theire age between the gender. 
Table 1 gender wise age distribution 
Age Male Female Total 
Group 
(Years) 
No. % No. % No. % 
30-39 1 4.6 - - 1 2.5 
40-49 3 13.6 3 16.7 6 15.0 
50-59 9 40.9 8 44.4 17 42.5 
60-69 3 13.6 4 22.2 7 17.5 
70-79 6 27.3 3 16.7 9 22.5 
Total 22 100.0 18 100.0 40 100.0 
 
The gender wise age distribution was shown in the above table 1. 
The males participation was 22 (55%) trials and females participation was 
18 (45%) trials.  
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Table 2 : Comparison between sexes according to their age 
Sex 
Age (Years) Difference 
of means 
‘t’ d.f Significance 
Mean S.D 
Males 58.0 12.3 
0.6 0.162 38 P>0.05 
Femals 57.4 9.1 
  
 The above table 2 compares the study subjects in respect of the age 
between the sexes. 
 The mean age the male was 58.0 ± 12.3 years and the mean ages of 
females were 57.4 ± 9.1 years. The difference between the mean ages was 
0.6 years and the same was not statistically significant (P>0.05) 
Assessment of fasting and postprandial blood sugar before and after 
treatment: 
 The blood sugar level of the subjects was assessed before and after 
treatment of both occasions. 
Table 3: The Blood sugar level of fasting and postprandial before and 
after treatment 
Blood Sugar 
level(mg/dl) 
Fasting Postprandial 
Before After Before After 
No % No % No % No % 
70-110 5 12.5 33 82.5 - - - - 
110-140 12 30.0 7 17.5 - - 21 52.5 
140 and above 23 57.5 - - 40 100.0 19 47.5 
Total 40 100.0 40 100.0 40 100.0 40 100.0 
 
The table -3 states the assessment of the blood sugar level before 
and after treatment. The fasting sugar was normal in 5 (12.5%) persons. 
Before treatment and after treatment the same was increased to 33 
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(82.5%). No person’s blood sugar was normal before treatment and the 
same was increased to 21 (52.5%) of persons after treatment. 
Table 4: Effectiveness of the drug in the management of blood 
sugar 
Variables 
Before After Differences 
`t' d.f Significance 
Mean S.D Mean S.D Mean S.D 
Fasting 
Sugar 
146.4 27.4 88.0 17.2 58.4 24.0 15.353 39 P<0.001 
P.P Sugar 246.8 46.4 148.1 33.7 98.8 44.1 14.157 39 P<0.001 
Weight(kg) 67.2 5.8 67.3 5.6 0.1 0.7 0.650 39 P>0.05 
 
 The table 4 states the effectiveness of the drugs by means of 
fasting, postprandial sugar level and improvement of the weight. The 
mean fasting blood sugar was 146.4 ± 27.4 and same was reduced to 88.0 
± 17.2 mg / dl with a reduction of 58.4 ± 24.0 mg/dl. Similarly the post 
prandial sugar level was reduced from 246.8 ± 46.4 mg/dl after treatment 
148.1 ± 33.7 with the mean reduction of 98.8 ± 44.1. The above 
reductions were statistically very highly significant (p<0.001). But there 
was no significant improvement was observed between the before and 
after treatment in respect of their weight.  
Response of the drug 
 The response of drug was graded as good, fair and poorly 
considering the effectiveness of the drug in related variables. 
Table 5: Response of the drug 
S.No Response No.of Persons Percentage 
1 Good 31 77.5 
2 Fair 7 17.5 
3 Poor 2 5.0 
 Total 40 100.0 
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 The above table 5 graded to the response of the drug as good 31 
(77.5%) patients. The remaining were graded as fact and poor as 7 
(17.5%) and 2 (5.0) respectively. 
Discussion 
 The male and female participation of the study were 55% and 45% 
respectively. But there was no significant difference was observed 
statistically between the age of male and females (p>0.05) 
 The fasting sugar was controlled after undergoing the treatment 
from 12.5% to 82.5% and the post prandial sugar was controlled from 10 
persons to 21 (52.5%) persons. This sugar level controlled was attributed 
to effectiveness of the drug. 
 The Mean fasting sugar was 146.4 ± 127.4 mg/dl and the same was 
reduced to 88 ± 17.2 and the reduction of 58.4 ± 24.0 mg/dl was 
statistically very significant (p<0.001) similarly the P.P sugar was also 
reduced statistically very highly significant (P<0.001) their was no 
significant weight gain between before and after treatment. (P<0.05) The 
response of the drug in controlling the blood sugar was 77.5% good, 
17.5% fair and 5% only poor. 
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RESULTS & DISCUSSION 
1. ‘jd;tpid gpwtpid jhopDk; kpfpDk; 
   cliyg; gpzpf;F Kd;ikapJ jhNk” 
ifnaOj;Jg; gpujp ; ;; ;; ; rpj;j kUj;Jt Neha; ehly;; ; ; ;; ; ; ;; ; ; ; 
According to the above verse, disease occurs due to imbalance of 
extrinsic and intrinisce factors.  The imbalance of the three humours 
occur due to either excessive or decreased intake of food, working 
beyond one’s physical limit or living sedentary life.  
 The causative factor for the occurrence of Madhumegam is pitha 
which lead to derangement of  abana vayu and seven udal thathus.  
2. ‘gpj;j kjpfupg;gpd; NgRk; ghpfhuk;  
    Rj;jj; JtNuhL nrhy;ypdpg;Gr; - rj;jhFk; 
    ifg;Gr; RitNa fUJtjd; tPW” 
(fz;Zrhkpak;); ;; ;; ;  Neha;ehl;;; y; Neha; Kjy; ehly; jpul;L; ; ; ; ;; ; ; ; ;; ; ; ; ;  
ghfk; ;;; - 1> gf;fk; vz; ; ; ;; ; ;; ; ; - 24 
According to the above verse, to neutralize the vitiated pitha 
humour, medicine having Astringent, sweet, bitter, taste can be given. 
Thus vellallipoo chooranam having Astringent taste can be given to 
neutralize pitha humour.  
Jth;g;gpd; ,ay;G :; ; ; ;; ; ; ;; ; ; ;  
3. fl;LtJ rw;Wf; fufug;ghf;FtJ  
   jpl;lkha; Njhw;gjdQ; nra;tJ - kl;bw; 
   nfhOg;G ePh; ky;Fq; nfhOg;Gk; tul;ly;  
   njhopyhe; Jth;g;Gr; Ritf;F 
(k.j.gh) 
rpj;j kUj;Jthq;fr; RUf;fk; gf;fk; vz; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; - 40 
nghUs; :;;;  
fl;Lf;flq;fhky; ntspahFk; kyk;> ePh; Kjypaitfis fl;b 
kl;Lg;gLj;JtJk;> Njhiyg; gjkhf;FtJ> nghUs;fspd; 
,rpTj;jd;ik> nea;g;Gj;jd;ik ePf;FtJ> kpFg;ngUFfpd;w 
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epzePiuAk; epzj;ijAk; twsr; nra;tJ Jth;g;Gr; 
Ritf;Fz;lhd njhopy;.  
Jth;g;gpd; nra;if :; ; ; ;; ; ; ;; ; ; ;  
‘FUjp Rj;jp ahf;Fk; 
 nfhba gpj;jk; Nghf;Fk; 
 nghUj;Jg; Gz;iz ahw;Wk; 
 nghy;yh itak; khw;Wk;  
 kUT ke;jk; Njf;Fk; 
 tsh;f;F khkk; ahh;f;Fk;  
 FUtpd; Fzj;j jhNy   
 Fsph;e;j Jth;g;gpd; Ntiy”  
(k.j.gh) 
rpj;j kUj;Jthq;fr; RUf;fk; gf;fk; vz; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; - 40 
nghUs; :;;;  
,uj;jj;ijr; Rj;jpailar; nra;Ak;. gpj;jk; nfl;bUe;J kpf;f 
Jd;gk; tpistpg;gjdhy; mijg; Nghf;Fk;. ,d;dy; jUk; 
,uzq;fisg; Nghf;Fk fgNjhlj;ijg; Nghf;Fk;.  
According to the above two verses, Astringent taste neutralizes 
the pitha humour (gpj;jj;ij Nghf;Fk;) which is the cause of 
madhumegam.  It also regulates excessive urination (polyurea) 
(fl;Lflq;fhky; NghFk; ePh; kl;LgLj;Jk;) purifies the blood, 
(,uj;jij; Rj;jp nra;Ak;), controls ketosis resulting from a marked 
increase in free fatty acid release from adipocytes, with a resulting shift 
towards ketone body synthesis in the liver (kpfg; ngUFfpd;w 
epzj;ijAk; epzePiuAk; twsr; nra;Ak;) The most common skin 
manifestation of DM are protracted wound healing and skin ulceration 
(,d;dy; jUk; ,uzq;fisg; Nghf;Fk;). 
According to potency (jl;gk;; ;; ;; ; - coolant) also intensify the pitha 
humour and Biotransformation is also sweet which neutralize the pitha 
humour Astringent taste neutralize the kaba humour which will be 
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increased later .  In that way, I have selected “Vellallipoo Chooranam” 
to test its efficacy in treating mahumegam.  
 According to physico – chemical analysis acid insoluble ash is 
only (1.12%) indicates that trial drug will digest completely in human 
Gastro intestinal tract.  
 According to Biochemical analysis presence of Ferrous Iron 
improves the hematological level in most of the patients; Iron is 
associated with effective immune competence of the body.  The 
presence of Amino acids are useful for energy purpose, one of the 
nutrients that evokes insulin.  Amino acids will promote the immune 
system.  In the body Amino acids are responsible for the tissue repair and 
body building.  The presence of tannic acid have anti diabetic property 
(Javan mardi Jet al). 
According to pharmacological analysis, the study of vellallipoo 
chooranam has got significant anti – diabetic activity. 
Microbiological analysis of vellallipoo chooranam shows 
sensitivity for staphylococcus aurceus and streptococcus pneumoniae.  
According to Scanning Electron Microscopic result in the picture 
of vellallipoo chooranam particles size in noted in nanometer.  The 
average value of particle size is 53.6nm since the trial drug consists of 
particles in nano size, then we came to know that the trial drug has 
finished perfectly and able to produce good therapeutic value.  
In Fourier Transform infrared spectroscopy, it showed the presence 
of  functional groups related to vellallipoo chooranam.  
For clinical trial cases 40 cases were selected, out of this 33 
patients were treated as outpatients and 7 cases as inpatients in clinical 
evaluation the response of the drug in controlling the blood sugar was 
77.5% good, 17.5 fair and only 5% poor.  
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No untoward incidents were reported by any of the patients.  
According to Biostastical analysis, the mean fasting sugar was 
reduced to  88 ± 17.2 and the reduction of 58.4 ± 24.0mg/ dl was 
stastically very significant (P<0.001) similarly the post prandial sugar 
was also reduced stastically highly significant (P<0.001) 
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SUMMARY 
 The test drug “Vellallipoo Chooranam” was selected for the study 
to establish its efficacy in treating “Madhumegam” 
Reference were found in Gunapadam Mooligai Vaguppu - Page 
No – 43 
The dose of drug is 1gm b.d daily with lukewarm water before 
meals.  
In the review of literature  section, Gunapadam Botanical aspects 
and Phytochemical aspects lateral Research work of  trial drug Siddha 
and Modern aspects of Madhumegam are being discussed and updates 
from internet have also been added.  
The Physicochemical analysis indicates the presence of very low 
acid insoluble ash.  
The bio-chemical analysis indicates the presence of Ferrous Iron, 
Amino acid and Tannic acid.  
Pharmacological analysis shows that this drug has significant 
Antidiabetic activity microbiological analysis shows that this drug was 
sensitive of Staphylococcus aureus and streptococcus pneumoniae.  
Scanning Electron Microscopic study reveals the presence of 
particles as nanoparticles and it shows trial drug has finished perfectly.  
 Fourier Transform infrared Spectroscopy study reveals the 
presence of functional group related to Vellallipoo Chooranam.  
 Clinical evaluation of this drug shows good response (77.5%) of 
patients, fair to response (17.5%) of patients and 5% showed poor 
response.  
Bio – stastical analysis also proved that this drug has got highly 
significant effect in treating madhumegam.  
No adverse reactions were noted during the treatment.  
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CONCLUSION 
 
It has been concluded that Vellallipoo Chooranam is effective in 
treating madhumegam without causing any adverse effects.  
 
 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Elangumani Age/Sex :   75/M   O.P.No. :  40566 From : 31/05/2012 To : 25/06/2012 No.of Days treated :   25 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
thirst,excessive 
urination and 
tiredness present 
since 2 years  
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 130 mgs% 
Post prandial – 280 mgs% 
Serum cholesterol - 120mgs% 
Blood Urea - 22 mgs% 
Hb A1 C - 8   
 
TC – 8100 cells/cumm 
DC -  P – 68%    
          L – 30% 
          E – 2% 
ESR ½ hr – 5 mm 
         1 hr  - 10 mm 
Hb – 79% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 82 mgs% 
Post prandial - 140 mg% 
Serum cholesterol - 120mgs% 
Blood Urea - 20 mgs% 
Hb A1C - 7 
 
TC - 8200 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr - 3 mm 
         1 hr  - 6 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - - - - - - 
 
Name : Pechimuthu Age/Sex :   54/M   O.P.No. :  42098 From : 06/05/2012 To : 19/07/2012 No.of Days treated :   78 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
urination, 
excessive thirst 
and tiredness 
present since 3 
years  
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 130 mgs% 
Post prandial – 223 mgs% 
Serum cholesterol - 202mgs% 
Blood Urea - 18 mgs% 
Hb A1 C - 7 
 
TC – 9200 cells/cumm 
DC -  P – 56%    
          L – 40% 
          E – 4% 
ESR ½ hr – 8 mm 
         1 hr  - 20 mm 
Hb – 72% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 120 mgs% 
Post prandial - 200 mg% 
Serum cholesterol - 190mgs% 
Blood Urea - 19 mgs% 
Hb A1C - 6 
 
TC - 9200 cells/cumm 
DC -  P – 60%    
          L – 36% 
          E – 4% 
ESR ½ hr - 6 mm 
         1 hr  - 12 mm 
Hb – 72% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - +++ 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : S. Swamy Age/Sex :   48/M   O.P.No. :  42143 From : 06/05/2012 To : 11/06/2012 No.of Days treated :   31 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
thirst,excessive 
urination and 
tiredness present 
since 4 years  
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 150 mgs% 
Post prandial – 220 mgs% 
Serum cholesterol - 233mgs% 
Blood Urea - 27 mgs% 
Hb A1 C - 8 
 
TC – 7800 cells/cumm 
DC -  P – 62%    
          L – 28% 
          E – 10% 
ESR ½ hr – 3 mm 
         1 hr  - 6 mm 
Hb – 76% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep – 1-2    
    puscells 
Blood : 
Blood sugar 
Fasting - 140 mgs% 
Post prandial - 170 mg% 
Serum cholesterol - 200mgs% 
Blood Urea - 25 mgs% 
Hb A1C - 6 
 
TC - 8000 cells/cumm 
DC -  P – 62%    
          L – 32% 
          E – 6% 
ESR ½ hr - 3mm 
         1 hr  - 4mm 
Hb –  80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Poor               
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - + - - - - 
 
Name : Subramanian Age/Sex :   55/M   O.P.No. :  44151 From : 13/06/2012 To : 21/07/2012 No.of Days treated :   38 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive Thirst, 
excessive 
urination and 
tiredness present 
since 1 year  
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 211 mgs% 
Serum cholesterol - 154mgs% 
Blood Urea - 18 mgs% 
Hb A1 C - 8 
 
TC -10000 cells/cumm 
DC -  P – 60%    
          L – 30% 
          E – 10% 
ESR ½ hr – 5 mm 
         1 hr  - 10 mm 
Hb – 76% 
Urine : 
Alb - Nil 
Sugar 
   F - - 
 PP – - 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 160 mg% 
Serum cholesterol - 160mgs% 
Blood Urea - 20 mgs% 
Hb A1C - 6 
 
TC - 9000 cells/cumm 
DC -  P – 60%    
          L – 34% 
          E – 6% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 78% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Madasamy Age/Sex :   56/M   O.P.No. :  45296 From : 18/06/2012 To : 25/07/2012 No.of Days treated :   37 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
urination, itching 
present in medial 
side of tibial 
region since 2 
years  
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 200 mgs% 
Serum cholesterol - 250mgs% 
Blood Urea - 24 mgs% 
 Hb A1 C - 8   
 
TC – 9000 cells/cumm 
DC -  P – 60%    
          L – 36% 
          E – 4% 
ESR ½ hr – 4 mm 
         1 hr  - 8 mm 
Hb – 72% 
Urine : 
Alb - Nil 
Sugar 
   F - + 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 90 mgs% 
Post prandial - 117 mg% 
Serum cholesterol - 220mgs% 
Blood Urea - 23 mgs% 
Hb A1C - 7 
 
TC - 9100 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr - 3 mm 
         1 hr  - 6 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - - - - - - 
 
Name : Vadivelmurugan Age/Sex :   46/M   O.P.No. :  45267 From : 18/06/2012 To : 25/07/2012 No.of Days treated :   37 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive thirst, 
excessive 
urination and 
tiredness present 
since 4 years  
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/70mmhg B.P. :  120/70mmhg 
Blood : 
Blood sugar 
Fasting – 150 mgs% 
Post prandial – 210mgs% 
Serum cholesterol - 116mgs% 
Blood Urea - 19 mgs% 
Hb A1 C - 7 
 
TC – 9700 cells/cumm 
DC -  P – 67%    
          L – 30% 
          E – 3% 
ESR ½ hr – 3 mm 
         1 hr  - 9 mm 
Hb – 74% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 78 mgs% 
Post prandial - 170 mg% 
Serum cholesterol - 115mgs% 
Blood Urea - 20 mgs% 
Hb A1C - 6 
 
TC - 9800 cells/cumm 
DC -  P – 70%    
          L – 25% 
          E – 5% 
ESR ½ hr - 3 mm 
         1 hr  - 5 mm 
Hb – 75% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Malaiappan Age/Sex :   60/M   O.P.No. :  48047 From : 27/06/2012 To : 01/08/2012 No.of Days treated :   35 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Polyphagia, 
polyuria, tiredness 
and numbness 
present in both 
feet since 5 
months.  
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/70mmhg B.P. :  130/70mmhg 
Blood : 
Blood sugar 
Fasting – 130 mgs% 
Post prandial – 210 mgs% 
Serum cholesterol - 130mgs% 
Blood Urea - 16 mgs% 
 Hb A1 C - 8   
 
TC – 7600 cells/cumm 
DC -  P – 64%    
          L – 32% 
          E – 4% 
ESR ½ hr – 4 mm 
         1 hr  - 8 mm 
Hb – 79% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 120 mgs% 
Post prandial - 190 mg% 
Serum cholesterol - 102mgs% 
Blood Urea - 20 mgs% 
Hb A1C - 7 
 
TC - 7600 cells/cumm 
DC -  P – 66%    
          L – 36% 
          E – 2% 
ESR ½ hr - 3 mm 
         1 hr  - 5 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Poor                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - - - - - - 
 
Name : Guruvammal Age/Sex :   56/F   O.P.No. :  50151 From : 04/07/2012 To : 08/08/2012 No.of Days treated :   34 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
ecessive urination 
and tiredness 
present since 1 
year.  
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 228mgs% 
Serum cholesterol - 126mgs% 
Blood Urea - 26 mgs% 
Hb A1 C - 7 
 
TC – 8700 cells/cumm 
DC -  P – 60%    
          L – 38% 
          E – 2% 
ESR ½ hr – 4 mm 
         1 hr  - 10 mm 
Hb – 65% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 118 mgs% 
Post prandial - 200 mg% 
Serum cholesterol - 190mgs% 
Blood Urea - 20 mgs% 
Hb A1C - 6 
 
TC - 9000 cells/cumm 
DC -  P – 62%    
          L – 36% 
          E – 2% 
ESR ½ hr - 4 mm 
         1 hr  - 8 mm 
Hb – 67% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Fair                     
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++  
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Murugan Age/Sex :   38/M   O.P.No. :  58486 From : 01/08/2012 To : 05/09/2012 No.of Days treated :   34 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
urination and 
tiredness present 
since 8 months.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 110 mgs% 
Post prandial – 201 mgs% 
Serum cholesterol - 190mgs% 
Blood Urea - 28 mgs% 
 Hb A1 C - 7   
 
TC – 8800 cells/cumm 
DC -  P – 60%    
          L – 39% 
          E – 1% 
ESR ½ hr – 4 mm 
         1 hr  - 8 mm 
Hb – 69% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 80 mgs% 
Post prandial - 180 mg% 
Serum cholesterol - 200mgs% 
Blood Urea - 25 mgs% 
Hb A1C - 7 
 
TC - 9000 cells/cumm 
DC -  P – 62%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 70% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Fair                      
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Thirumal Age/Sex :   67/M   O.P.No. :  60640 From : 08/07/2012 To : 12/08/2012 No.of Days treated :   34 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Polyphagia, 
polyuria and 
tiredness present 
since 1 year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/90mmhg B.P. :  130/90mmhg 
Blood : 
Blood sugar 
Fasting – 149 mgs% 
Post prandial – 180mgs% 
Serum cholesterol - 200mgs% 
Blood Urea - 23 mgs% 
Hb A1 C -   
 
TC – 9600 cells/cumm 
DC -  P – 54%    
          L – 43% 
          E – 4% 
ESR ½ hr – 12 mm 
         1 hr  - 78 mm 
Hb – 61% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 70 mgs% 
Post prandial - 110 mg% 
Serum cholesterol - 200mgs% 
Blood Urea - 22 mgs% 
Hb A1C - 6 
 
TC - 9500 cells/cumm 
DC -  P – 62%    
          L – 36% 
          E – 2% 
ESR ½ hr - 4 mm 
         1 hr  - 10 mm 
Hb – 65% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Manoharan Age/Sex :   50/M   O.P.No. :  60641 From : 08/07/2012 To : 12/09/2012 No.of Days treated :   64 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
apetite, excessive 
urination and 
tiredness present 
since 3 years   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 90 mgs% 
Post prandial – 180 mgs% 
Serum cholesterol - 250mgs% 
Blood Urea - 23 mgs% 
 Hb A1 C - 8   
 
TC – 7000 cells/cumm 
DC -  P – 60%    
          L – 38% 
          E – 2% 
ESR ½ hr – 7 mm 
         1 hr  - 15 mm 
Hb – 70% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 82 mgs% 
Post prandial - 140 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 20 mgs% 
Hb A1C - 7 
 
TC - 7200 cells/cumm 
DC -  P – 65%    
          L – 35% 
          E – 2% 
ESR ½ hr - 4 mm 
         1 hr  - 8 mm 
Hb – 71% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + + - - - - - - 
 
Name : Irudhayaraj Age/Sex :   61/M   O.P.No. :  68078 From : 03/07/2012 To : 10/10/2012 No.of Days treated :   36 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
urination and 
excessive thirst 
present since 5 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/90mmhg B.P. :  130/90mmhg 
Blood : 
Blood sugar 
Fasting – 120 mgs% 
Post prandial – 210mgs% 
Serum cholesterol - 191mgs% 
Blood Urea - 38 mgs% 
Hb A1 C - 8 
 
TC – 8500 cells/cumm 
DC -  P – 58%    
          L – 38% 
          E – 4% 
ESR ½ hr – 9 mm 
         1 hr  - 18 mm 
Hb – 68% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 70 mgs% 
Post prandial - 130 mg% 
Serum cholesterol - 180mgs% 
Blood Urea - 25 mgs% 
Hb A1C - 6 
 
TC - 8600 cells/cumm 
DC -  P – 60%    
          L – 38% 
          E – 2% 
ESR ½ hr - 4 mm 
         1 hr  - 8 mm 
Hb – 72% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + + - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Mallika Age/Sex :   45/F   O.P.No. :  68833 From : 05/09/2012 To : 10/10/2012 No.of Days treated :   35 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
apetite, excessive 
urination, 
excessive thirst 
present since 2 
years.  
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 120 mgs% 
Post prandial – 260 mgs% 
Serum cholesterol - 210mgs% 
Blood Urea - 24 mgs% 
 Hb A1 C -   
 
TC – 9200 cells/cumm 
DC -  P – 60%    
          L – 30% 
          E – 10% 
ESR ½ hr – 16 mm 
         1 hr  - 24 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 90 mgs% 
Post prandial - 150 mg% 
Serum cholesterol - 205mgs% 
Blood Urea - 22 mgs% 
Hb A1C -  
 
TC - 9200 cells/cumm 
DC -  P – 62%    
          L – 36% 
          E – 2% 
ESR ½ hr - 6 mm 
         1 hr  - 10 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - - - - - - 
 
Name : Shenbagam Age/Sex :   55/M   O.P.No. :  71247 From : 12/09/2012 To : 10/10/2012 No.of Days treated :   28 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 6 months.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 160 mgs% 
Post prandial – 240mgs% 
Serum cholesterol - 155mgs% 
Blood Urea - 30 mgs% 
Hb A1 C - 7 
 
TC – 9000 cells/cumm 
DC -  P – 60%    
          L – 32% 
          E – 8% 
ESR ½ hr – 6 mm 
         1 hr  - 8 mm 
Hb – 74% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 240 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 30 mgs% 
Hb A1C - 6 
 
TC - 9100 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 78% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Mohan Age/Sex :   54/M   O.P.No. :  78338 From : 03/10/2012 To : 31/10/2012 No.of Days treated :   27 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 6 months.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 97 mgs% 
Post prandial – 170 mgs% 
Serum cholesterol - 174mgs% 
Blood Urea - 18 mgs% 
 Hb A1 C -    
 
TC – 9400 cells/cumm 
DC -  P – 60%    
          L – 34% 
          E – 2% 
ESR ½ hr – 5 mm 
         1 hr  - 8 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 60 mgs% 
Post prandial - 110 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 9900 cells/cumm 
DC -  P – 60%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Gandhimathi Age/Sex :   50/M   O.P.No. :  78340 From : 03/10/2012 To : 31/10/2012 No.of Days treated :   27 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, 
Excessive 
urination at night 
time and tiredness 
present since 2 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/90mmhg B.P. :  130/90mmhg 
Blood : 
Blood sugar 
Fasting – 160 mgs% 
Post prandial – 232mgs% 
Serum cholesterol - 154mgs% 
Blood Urea - 20 mgs% 
Hb A1 C -  
 
TC – 9800 cells/cumm 
DC -  P – 56%    
          L – 34% 
          E – 4% 
ESR ½ hr – 2 mm 
         1 hr  - 4 mm 
Hb – 70% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 90 mgs% 
Post prandial - 200 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 9800 cells/cumm 
DC -  P – 64%    
          L – 32% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 72% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Fair                    
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Muthamal Age/Sex :   55/F   O.P.No. :  79011 From : 05/10/2012 To : 02/11/2012 No.of Days treated :   27 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
apetite, excessive 
urination, 
excessive thirst 
and tiredness 
present since 1 ½ 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 180 mgs% 
Serum cholesterol - 230mgs% 
Blood Urea - 18 mgs% 
 Hb A1 C -    
 
TC – 9600 cells/cumm 
DC -  P – 56%    
          L – 32% 
          E – 2% 
ESR ½ hr – 4 mm 
         1 hr  - 9 mm 
Hb – 75% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP - Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 140 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 9400 cells/cumm 
DC -  P – 58%    
          L – 32% 
          E – 2% 
ESR ½ hr - 3 mm 
         1 hr  - 6 mm 
Hb – 79% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Muthurajan Age/Sex :   50/M   O.P.No. :  81261 From : 12/10/2012 To : 09/11/2012 No.of Days treated :   26 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 8 months   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/90mmhg B.P. :  130/90mmhg 
Blood : 
Blood sugar 
Fasting – 158 mgs% 
Post prandial – 224mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 17 mgs% 
Hb A1 C -  
TC – 9300 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr – 2 mm 
         1 hr  - 5 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 168 mg% 
Serum cholesterol - 140mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 9200 cells/cumm 
DC -  P – 66%    
          L – 32% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Thilagavathy Age/Sex :   47/F O.P.No. :  81637 From : 13/10/2012 To : 12/11/2012 No.of Days treated :   29 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination, 
excessive thirst 
and tiredness 
present since 2 
years.  
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 157 mgs% 
Post prandial – 220 mgs% 
Serum cholesterol - 155mgs% 
Blood Urea - 16 mgs% 
 Hb A1 C - 8   
 
TC – 8100 cells/cumm 
DC -  P – 68%    
          L – 30% 
          E – 2% 
ESR ½ hr – 6 mm 
         1 hr  - 9 mm 
Hb – 76% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 132 mgs% 
Post prandial - 180 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 15 mgs% 
Hb A1C - 7 
 
TC - 9000 cells/cumm 
DC -  P – 69%    
          L – 32% 
          E – 2% 
ESR ½ hr - 5 mm 
         1 hr  - 7 mm 
Hb – 78% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Fair                      
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Name : Selvarangam Age/Sex :   47/F O.P.No. :  82360 From : 16/10/2012 To : 14/11/2012 No.of Days treated :   28 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 8 months   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 160 mgs% 
Post prandial – 230mgs% 
Serum cholesterol –250mgs% 
Blood Urea - 17 mgs% 
Hb A1 C - 7 
 
TC – 9600 cells/cumm 
DC -  P – 68%    
          L – 30% 
          E – 2% 
ESR ½ hr – 3 mm 
         1 hr  - 6 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 180 mg% 
Serum cholesterol - 200mgs% 
Blood Urea - 17 mgs% 
Hb A1C - 6 
 
TC - 9600 cells/cumm 
DC -  P – 68%    
          L – 30% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
 +- + + - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Kavitha Age/Sex :   62/F   O.P.No. :  82595 From : 17/10/2012 To : 12/11/2012 No.of Days treated :   25 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 1 year.   
INVESTIGATION 
Before treatment After treatment 
B.P. :                  mmhg B.P. :            mmhg 
Blood : 
Blood sugar 
Fasting – 156 mgs% 
Post prandial – 210 mgs% 
Serum cholesterol - 220mgs% 
Blood Urea - 19 mgs% 
 Hb A1 C - 8   
 
TC – 9400 cells/cumm 
DC -  P – 64%    
          L – 34% 
          E – 4% 
ESR ½ hr – 5 mm 
         1 hr  - 8 mm 
Hb – 72% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 180 mg% 
Serum cholesterol - 200mgs% 
Blood Urea - 19 mgs% 
Hb A1C - 7 
 
TC - 9400 cells/cumm 
DC -  P – 66%    
          L – 34% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 6 mm 
Hb – 74% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Joseph Age/Sex :   53/M   O.P.No. :  84285 From : 22/10/2012 To : 19/11/2012 No.of Days treated :   27 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 7 months.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 130 mgs% 
Post prandial – 184mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1 C - 7 
 
TC – 9800 cells/cumm 
DC -  P – 62%    
          L – 36% 
          E – 4% 
ESR ½ hr – 8 mm 
         1 hr  - 10 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 120 mgs% 
Post prandial - 160 mg% 
Serum cholesterol - 120mgs% 
Blood Urea - 16 mgs% 
Hb A1C - 6 
 
TC - 9800 cells/cumm 
DC -  P – 64%    
          L – 34% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Fair                     
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + + - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Sagunthala Age/Sex :   71/F   O.P.No. :  84276 From : 22/10/2012 To : 19/11/2012 No.of Days treated :   27 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 1 ½ 
year.  
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  130/80mmhg 
Blood : 
Blood sugar 
Fasting – 160 mgs% 
Post prandial – 232mgs% 
Serum cholesterol - 154mgs% 
Blood Urea - 18 mgs% 
 Hb A1 C - 8   
 
TC – 9900 cells/cumm 
DC -  P – 56%    
          L – 34% 
          E – 2% 
ESR ½ hr – 2 mm 
         1 hr  - 4 mm 
Hb – 73% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 90 mgs% 
Post prandial - 110 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C - 7 
 
TC - 9900 cells/cumm 
DC -  P – 64%    
          L – 32% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Name : Gandhimathi Age/Sex :   73/F   O.P.No. :  84555 From : 23/10/2012 To : 19/11/2012 No.of Days treated :   26 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 6 months.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 160 mgs% 
Post prandial – 240mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1 C -  
 
TC – 8100 cells/cumm 
DC -  P – 68%    
          L – 30% 
          E – 2% 
ESR ½ hr – 6 mm 
         1 hr  - 9 mm 
Hb – 76% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – - 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting – 102 mgs% 
Post prandial - 140 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1C -  
 
TC - 9800 cells/cumm 
DC -  P – 70%    
          L – 25% 
          E – 5% 
ESR ½ hr - 3 mm 
         1 hr  - 5 mm 
Hb – 75% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Ravichandran Age/Sex :   49/M   O.P.No. :  85206 From : 26/10/2012 To : 23/11/2012 No.of Days treated :   27 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 1 
year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 220 mgs% 
Serum cholesterol - 180mgs% 
Blood Urea - 16 mgs% 
 Hb A1 C -    
 
TC – 9500 cells/cumm 
DC -  P – 55%    
          L – 32% 
          E – 5% 
ESR ½ hr – 2 mm 
         1 hr  - 5 mm 
Hb – 79% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 100 mgs% 
Post prandial - 110 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 9500 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Mary Age/Sex :   50/F   O.P.No. :  88260 From : 05/11/2012 To : 25/12/2012 No.of Days treated :   45 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 10 months.  
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 196 mgs% 
Post prandial – 264mgs% 
Serum cholesterol - 210mgs% 
Blood Urea - 16 mgs% 
Hb A1 C -  
 
TC – 9600 cells/cumm 
DC -  P – 64%    
          L – 30% 
          E – 4% 
ESR ½ hr – 8 mm 
         1 hr  - 16 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 170mgs% 
Post prandial - 210 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
TC - 9800 cells/cumm 
DC -  P – 66%    
          L – 34% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + + - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Mohammed Ali Age/Sex :   51/M   O.P.No. :  89300 From : 07/11/2012 To : 05/12/2012 No.of Days treated :   28 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite and 
tiredness present 
since 7 months.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 160/80mmhg B.P. :  160/80mmhg 
Blood : 
Blood sugar 
Fasting – 100 mgs% 
Post prandial – 164 mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 17 mgs% 
 Hb A1 C -  
 
TC – 9300 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr – 2 mm 
         1 hr  - 5 mm 
Hb –  
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 80 mgs% 
Post prandial - 130 mg% 
Serum cholesterol - 140mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 9300 cells/cumm 
DC -  P – 66%    
          L – 32% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb –  
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Mayavan Age/Sex :   58/M   O.P.No. :  71248 From : 12/09/2012 To : 10/10/2012 No.of Days treated :   28 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
thrist, excessive 
urination and 
tiredness present 
since 1 year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 130 mgs% 
Post prandial – 250mgs% 
Serum cholesterol - 230mgs% 
Blood Urea - 16 mgs% 
Hb A1 C -  
 
TC – 6100 cells/cumm 
DC -  P – 60%    
          L – 33% 
          E – 7% 
ESR ½ hr – 3 mm 
         1 hr  - 6 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 190 mg% 
Serum cholesterol - 180mgs% 
Blood Urea - 18 mgs% 
Hb A1C -  
 
TC - 6400 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Gomathi Age/Sex :   52/F   O.P.No. :  1748 From : 30/05/2012 To : 23/06/2012 No.of Days treated :   23 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
urination, 
excessive thirst 
and tiredness 
present since 7 
moths years  
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 90 mgs% 
Post prandial – 180 mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
 Hb A1 C -  
 
TC – 9100 cells/cumm 
DC -  P – 68%    
          L – 36% 
          E – 4% 
ESR ½ hr – 8 mm 
         1 hr  - 10 mm 
Hb – 74% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 70 mgs% 
Post prandial - 110 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1C -  
 
TC - 9100 cells/cumm 
DC -  P – 68%    
          L – 38% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 76% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
- - - - - - - - - - 
 
Name : Rani Age/Sex :   64/F   O.P.No. :  4673 From : 29/11/2012 To : 31/12/2012 No.of Days treated :   32 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 1 
year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 220mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1 C -  
 
TC – 9600 cells/cumm 
DC -  P – 64%    
          L – 32% 
          E – 4% 
ESR ½ hr – 8 mm 
         1 hr  - 16 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 200 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1C -  
 
TC - 9600 cells/cumm 
DC -  P – 66%    
          L – 32% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 78% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Prakash Age/Sex :   71/M   O.P.No. :  75946 From : 26/09/2012 To : 24/10/2012 No.of Days treated :   28 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 2 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 120/80mmhg B.P. :  120/80mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 213 mgs% 
Serum cholesterol - 180mgs% 
Blood Urea - 16 mgs% 
 Hb A1 C -  
 
TC – 9500 cells/cumm 
DC -  P – 55%    
          L – 32% 
          E – 5% 
ESR ½ hr – 2 mm 
         1 hr  - 5 mm 
Hb – 79% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 120 mgs% 
Post prandial - 200 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C –  
 
 
TC - 9500 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Fair                    
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Name : Selvaraj Age/Sex :   73/M   O.P.No. :  64118 From : 12/10/2012 To : 12/11/2012 No.of Days treated :   30 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 2 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 150 mgs% 
Post prandial – 210mgs% 
Serum cholesterol - 116mgs% 
Blood Urea - 19 mgs% 
Hb A1 C - 7 
 
TC – 9700 cells/cumm 
DC -  P – 67%    
          L – 30% 
          E – 3% 
ESR ½ hr – 3 mm 
         1 hr  - 9 mm 
Hb – 74% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 90 mgs% 
Post prandial - 180 mg% 
Serum cholesterol - 180mgs% 
Blood Urea - 15 mgs% 
Hb A1C - 6 
 
TC - 9800 cells/cumm 
DC -  P – 70%    
          L – 25% 
          E – 5% 
ESR ½ hr - 3 mm 
         1 hr  - 5 mm 
Hb – 75% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN OUT PATIENTS 
Name : Meenakshi Age/Sex :   62/F   O.P.No. :  90346 From : 09/11/2012 To : 30/11/2012 No.of Days treated :   19 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 1 ½ 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 160 mgs% 
Post prandial – 220 mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
 Hb A1 C - 8   
 
TC – 9400 cells/cumm 
DC -  P – 64%    
          L – 32% 
          E – 4% 
ESR ½ hr – 4 mm 
         1 hr  - 8 mm 
Hb – 72% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – Nil 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 120 mgs% 
Post prandial - 190 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1C - 7 
 
TC - 9400 cells/cumm 
DC -  P – 66%    
          L – 30% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 79% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ ++ + - - - - - - - 
 
Name : Boothammal Age/Sex :   50/F   I.P.No. :  3545 From : 12/10/2012 To : 07/11/2012 No.of Days treated :   25 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 1 
year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 158 mgs% 
Post prandial – 224mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1 C -  
 
TC – 9300 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr – 2 mm 
         1 hr  - 5 mm 
Hb – 76% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 150 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 16 mgs% 
Hb A1C -  
 
TC - 9300 cells/cumm 
DC -  P – 66%    
          L – 32% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb –  
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + + - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN IN PATIENTS 
Name : Arumugam Age/Sex :   72/M   I.P.No. :  3191 From : 24/09/2012 To : 22/10/2012 No.of Days treated :   28 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination and 
tiredness present 
since 3 years.    
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/90mmhg B.P. :  140/90mmhg 
Blood : 
Blood sugar 
Fasting – 140 mgs% 
Post prandial – 220 mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
 Hb A1 C -   
 
TC – 8100 cells/cumm 
DC -  P – 68%    
          L – 30% 
          E – 2% 
ESR ½ hr – 6 mm 
         1 hr  - 9 mm 
Hb – 76% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – ++ 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 70 mgs% 
Post prandial - 118 mg% 
Serum cholesterol - 150mgs% 
Blood Urea - 18 mgs% 
Hb A1C - 7 
 
TC - 9000 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 5 mm 
         1 hr  - 7 mm 
Hb – 76% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
++ + + + - - - - - - 
 
Name : Chandra Age/Sex :   55/F   I.P.No. :  3172 From : 23/09/2012 To : 17/10/2012 No.of Days treated :   24 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination and 
tiredness present 
since 1 year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  120/70mmhg 
Blood : 
Blood sugar 
Fasting – 196 mgs% 
Post prandial – 250mgs% 
Serum cholesterol - 230mgs% 
Blood Urea - 16 mgs% 
Hb A1 C - 7 
 
TC – 9400 cells/cumm 
DC -  P – 60%    
          L – 30% 
          E – 3% 
ESR ½ hr – 3 mm 
         1 hr  - 9 mm 
Hb – 74% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 190 mg% 
Serum cholesterol - 180mgs% 
Blood Urea - 16 mgs% 
Hb A1C - 6 
 
TC - 9400 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 77% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + + - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN IN PATIENTS 
Name : Vedhamuthu Age/Sex :   71/M   I.P.No. :  2990 From : 10/09/2012 To : 11/10/2012 No.of Days treated :   30 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination and 
excessive thirst 
and tiredness 
present since 1 
year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 160/80mmhg B.P. :  160/80mmhg 
Blood : 
Blood sugar 
Fasting – 158 mgs% 
Post prandial – 210 mgs% 
Serum cholesterol - 150mgs% 
Blood Urea - 14 mgs% 
 Hb A1 C - 8   
 
TC – 9000 cells/cumm 
DC -  P – 60%    
          L – 36% 
          E – 4% 
ESR ½ hr – 4 mm 
         1 hr  - 8 mm 
Hb – 72% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 110 mgs% 
Post prandial - 164 mg% 
Serum cholesterol - 140mgs% 
Blood Urea - 14 mgs% 
Hb A1C - 7 
 
TC - 9100 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr - 3 mm 
         1 hr  - 6 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + + - - - - - - 
 
Name : Madathy Age/Sex :  71/F   I.P.No. :  2555 From : 04/08/2012 To : 08/09/2012 No.of Days treated :   34 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination and 
tiredness present 
since 1 year.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 160/90mmhg B.P. :  160/90mmhg 
Blood : 
Blood sugar 
Fasting – 180 mgs% 
Post prandial – 260mgs% 
Serum cholesterol - 220mgs% 
Blood Urea - 18 mgs% 
Hb A1 C - 7 
 
TC – 9500 cells/cumm 
DC -  P – 55%    
          L – 32% 
          E – 5% 
ESR ½ hr – 2 mm 
         1 hr  - 5 mm 
Hb – 78% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 120 mgs% 
Post prandial - 210 mg% 
Serum cholesterol - 200mgs% 
Blood Urea - 18 mgs% 
Hb A1C - 6 
 
TC - 9500 cells/cumm 
DC -  P – 64%    
          L – 36% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 80% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + + - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
 
REPORTS ON THE CLINICAL TRIALS OF VELLALLIPOO CHOORANAM IN IN PATIENTS 
Name : Mariyal Age/Sex :   60/F   I.P.No. :  1869 From : 11/06/2012 To : 18/07/2012 No.of Days treated :   37 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
intake of food, 
excessive 
urination, 
excessive thirst 
and tiredness 
present since 3 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 130/80mmhg B.P. :  120/70mmhg 
Blood : 
Blood sugar 
Fasting – 178 mgs% 
Post prandial – 240 mgs% 
Serum cholesterol - 250mgs% 
Blood Urea - 24 mgs% 
 Hb A1 C - 8   
 
TC – 9000 cells/cumm 
DC -  P – 60%    
          L – 36% 
          E – 4% 
ESR ½ hr – 4 mm 
         1 hr  - 8 mm 
Hb – 72% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 126 mgs% 
Post prandial - 200 mg% 
Serum cholesterol - 220mgs% 
Blood Urea - 23 mgs% 
Hb A1C - 7 
 
TC - 9100 cells/cumm 
DC -  P – 70%    
          L – 28% 
          E – 2% 
ESR ½ hr - 3 mm 
         1 hr  - 6 mm 
Hb – 82% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + + - - - - - - - 
 
Name : Anthony Age/Sex :  72/M   I.P.No. :  3545 From : 12/10/2012 To : 12/11/2012 No.of Days treated :   30 days 
Drug : Vellallipoo chooranam – 1gm bd with hot water                                                                                                     Diagnosis : Madhumegam 
Complaints of       
     Excessive 
appetite, excessive 
urination at night 
time and tiredness 
present since 2 
years.   
INVESTIGATION 
Before treatment After treatment 
B.P. : 140/80mmhg B.P. :  140/80mmhg 
Blood : 
Blood sugar 
Fasting – 150 mgs% 
Post prandial – 220mgs% 
Serum cholesterol - 210mgs% 
Blood Urea - 15 mgs% 
Hb A1 C - 7 
 
TC – 9200 cells/cumm 
DC -  P – 53%    
          L – 40% 
          E – 4% 
ESR ½ hr – 8 mm 
         1 hr  - 10 mm 
Hb – 69% 
Urine : 
Alb - Nil 
Sugar 
   F - Nil 
 PP – + 
 Dep -NAD 
Blood : 
Blood sugar 
Fasting - 90 mgs% 
Post prandial - 180 mg% 
Serum cholesterol - 180mgs% 
Blood Urea - 15 mgs% 
Hb A1C - 6 
 
TC - 9200 cells/cumm 
DC -  P – 55%    
          L – 40% 
          E – 2% 
ESR ½ hr - 2 mm 
         1 hr  - 4 mm 
Hb – 70% 
 
Urine : 
Alb - Nil 
Sugar 
  F - Nil 
 PP - Nil 
 Dep - NAD 
Response :                     Good                       
No. of weeks after Urine 
sugar - PP 
1
st
 2
nd
 3
rd
 4
th
 5
th
 6
th
 7
th
 8
th
 9
th
 10
th
 
+ + - - - - - - - - 
 
Good Response – Reduction of fasting and post prandial blood sugar and glycosuira     Mild  - + 
Fair Response - Significant reduction but not to normal level of fasting and post prandial blood sugar and glyosuria Moderate - ++ 
Poor Response - Insignificant reduction but no to normal level of fasting and post prandial blood sugar and glycosuia Severe  - +++ 
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INTRODUCTION 
 Siddha system of medicine is not a discovery but a gradual 
evolution during successive periods of History.  It owes it progress to 
great men ‘the siddhars’ who have not only enriched the science, but 
also society and civilization as a whole. 
 According to them the Universe is represented in everyone of its 
particles.  They realized that a good physical body free from disease is a 
great tool to attain the ‘Eternal bliss’.  The Pranan (Life force), Manam 
(mind), buddhi (intellect) and energy act in harmony that indeed in 
yogam.  In this process they evolved a system primarily for healthy and 
promitive living and also for elimination of disease. 
 According to siddha healthy living indicates not only Physical 
health but also Psychological, social and spiritual well being. 
 Anaemia is the most common disorder of the blood.  ‘Senneer’ is 
the second of the seven physical constituents and the ‘Ranjaka Pitham’ 
gets dearranged. 
 According to modern concept there are several kinds of Anaemia 
and main cause of Anaemia include deficient red blood cell Production 
due to nutritional deficiency of iron, excessive blood loss and 
excessive blood cell destruction. 
 Anaemia goes undetected in many people due to minor symptoms 
like weakness, fatigue, general malaise and poor concentration.  It is 
essential to emphasize the importance of preventing anaemia in the 
present day society. 
 The Materia Medica of Siddha Medicine is very vast, as they 
contain the usage of metals, minerals and biological products.  The use of 
inorganics is justified by the fact that they do not perish fast like herbal 
drugs and can also be used when the herbs are unavailable. 
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 Here I have brought out the efficacy of metal drug ‘Kaandha 
Chendhuram’ for the treatment of Anaemia, with promising result. 
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AIM AND OBJECTIVES 
A STUDY ON KAANDHA CHENDHURAM 
 The main aim and objective, of this dissertation is to do a Scientific 
review of the haematinic activity of kaandha chendhuram based on 
the reference of “Kannusamy Parambarai Vaithiyam (Page No: 317)” 
to be tested through pharmacological and clinical trials. 
 Anaemia is the most common disorder of blood.  In Siddha aspect, 
this can be correlated with Paandu Noi.  The clinical signs and 
symptoms of ‘Paandu’ are seen in Anaemia. 
 Anaemia goes undetermined in many people and symptoms can be 
minor or vague.  According to recent survey in India the percentage of 
people affected by anaemia according to age group are estimated below. 
47% of children younger than 5. 
56% of Adolescence girls. 
30% of Adolescence boys. 
55.3% of women of Reproductive age. 
40% of elder people. 
 It is essential to find out a drug which is very effective in smaller 
doses, easy to preserve, longer in self life.  So the author has selected 
Kaandha Chenduram for iron deficiency Anaemia drug for 
dissertation purpose. 
 In this dissertation the analyis of kaandha chendhuram is done in 
the following methods like,  
1) Gunapadam aspect 
2) Bio-Chemical Analysis 
3) Pharmacological Analysis 
4) Quantitaive & Qualitative Chemical Analysis 
5) Heavy Metal Analysis 
6) Bio Static Analysis 
7) Clinical assessment 
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REVIEW OF LITERATURE 
GEOLOGICAL ASPECTS 
MAGNET 
Category   : Mineral 
Chemical formula  : Iron (II, III) oxide, Fe3O4 
Colour   : Black, grayish 
Crystal habit  : Octahedral, fine granular to massive 
Fracture   : Uneven (or) subconchoidal 
Mohs scale hardness   : 5.5-6.5 
Luster   : Metallic 
Specific gravity  : 5.17-5.18 
Streak   : Black 
Refractive index  : Opaque 
Composition: 
Ferrous and ferric iron oxide (72.4% Fe, 27.6% O) also written 
FeO.Fe2O3.  Other elements Magnesium, Zinc and Manganese (rarely 
Nickel) can substitute in part for the first (the FeO, or ferrous) iron, while 
small amount of chromium, Aluminium, Manganic, Manganese and 
Vanadium can replace part of the second the (Fe2O3 or ferric) iron.  This 
permits a whole second spine series of related minerals to which different 
names have been given, but magnetite in by far the most important. 
Tests: 
 Naturally magnetic 
Distinguishing characteristics: 
 The magnetism (and frequent polarity) distinguishes it from most 
other similar minerals. 
 The streak is blacker than that of ilmenite. It is brittle and much 
lower in gravity than platinum mixed with iron or the native nickel – iron 
compounds. Zinc rich magnetite (franklinite) is less magnetic. 
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Occurrence: 
An important ore of iron Magnetic and other heavy minerals (dark) 
in a quartz beach and Chennai India. 
 Magnetite is sometimes found in large quantities in beachy sand.  
Such black sands (mineral sands or iron sands) are found in various 
places such as California and the west coast of New Zealand. 
 The Magnetite is carried to the beach via rivers from erosion and is 
concentrated via wave action and currents. 
 Huge deposits have been found in banded iron formations.  There 
sedimentary rocks have been used to inter changes in the oxygen content 
of the atmosphere of the earth. 
 Large deposits of magnetite are also found in the Atacama region 
of chile, kiruna, Sweden, the Pilbara, Midwest & Northern Gold fields 
regions in Western Australia & in the Adirondack region of  Newyork in 
the united states. 
 Deposits are found in Norway, Germany, Italy, South Africa, India, 
Mexico & Oregon, North Carolina, New Mexico, Colorado in the united 
states. 
 Recently in June 2005 an exploration company, Cardero resources 
discovered a vast deposit of magnetite, it bearing sand dunes in peru.  
 The sand contain 10%  magnetite. 
Biological occurrences: 
 Crystals of Magnetite have been found in some bacteria (eg. 
Magneto spirillum, Magneto tacticum) and in the brains of bees, of 
termites, fish, some birds (eg: the pigeon) and the humans. The chitons 
have teeth made of magnetite on their radula making them unique among 
animals. 
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GUNAPADAM ASPECTS 
1fhe;jk;;; ; (;;; Magnetic oxide of Iron) 
Njhw;wk;:; ;; ;; ;  
 ,Uk;Gf; FzKila XH cNyhfk; kw;w cNyhfq;fisg; 
NghyNt g+kpapdpd;W ntl;bnaLf;fg;gLfpwJ. 
NtWngaH: 
 rptNyhfr; Nrtfd; 
 juzpf;F ehjk; 
 #j mq;Frk; 
 etNyhfj; Jul;b 
 fharpj;jpf;F ghj;jputhd; 
 KUfd; Guhzk; 
nghJFzk;:;;;  
 ‘fhe;jj;jhw; Nrhig Fd;kq; fhkpyNk fk;ghz;L;;;   
  Nrhj;jjphp Njhlntl;il rPjq;fhy; Xa;e;jgrp 
  NgUjuq; fz;Nzha; gpukpaeP uhikAk; Nghk; 
  Xhpdpiw ahASWk; cd;.” 
fhe;jf;fy; tPf;fk;> Fd;kk;> fhkhiy> Nkfk;> ghz;L;;; > 
Kj;Njhlk;> nts;is tPoy;> rPjk;> thjNeha;> khe;jk;> kNfhjuk;> 
tpopNeha;> gpukpak;> ePuhikf;fl;b Kjypad ePq;Fk;.  g+uz MASk; 
cz;lhFk;. 
fhe;j rj;JU kpj;JU:; ; ;; ; ;; ; ;  
 ‘vz;zpa fhe;j kpay; ghdhYf;Fe; 
  jz;zpakpj; Jurj; juNfl;bU 
  ez;Z kpUk;Gf;F ehl;Lk; tifgij 
  cz;zpAiwe; Tz;ikaha;g; ghHj;jpNl 
  ghHj;jpL ehfk; gjwpa rj;JU 
  Nghj;Jq; fpspQ;rpg; nghUe;jpa mz;lKk; 
  fhj;J ntbAq;fs; neg;G tq;fKk;  
                                                           
1
 Gunapadam Thathu Vaguppu 
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  Mj;Jk;gb fkUshd rq;fNk 
  jq;fe; jpuhte; jdpnts;sp ntq;fyk; 
  nghq;F ez;NghL gf tPu rpq;Fld; 
  mq;fkpsF mtpd nts;is gh\hzk; 
  kq;Fk; tbiyts ud;d NgjpNa” 
fhe;j rj;JU:; ;; ;; ;  
NghfH epfz;bd; gb fhe;jj;jpw;Fs;s ,Of;Fk; rf;jpia 
nfLf;Fk; nghUl;fs; ethr;rhuk;> ntbAg;G> JUR. 
fhe;j kpj;JU:; ;; ;; ;  
,Uk;G 
fhe;jj;jpd; rpwg;G:; ; ; ;; ; ; ;; ; ; ;  
fhe;jj;jhy; nra;j ghj;jpuj;jpy; ghy; tpl;L fha;r;rpf; Fbj;J 
te;jhy; ,uj;j tpUj;jp cz;lhFk;.  JHg;gyk; ePq;Fk;. Njfk; Nkdp 
jUk;. fhe;jg; ghj;jpuj;jpy; ghy; tpl;L fha;r;rpdhy; nghq;fp 
cs;NsNa epw;Fk;. ghy; ntspapy; tuhJ. ,0J XH tpN\l Fzk;. 
 rpwe;j fhe;jj;jhy; Md ghj;jpuj;jpd; jz;zPhpy; xU Jsp 
vz;nza; tpl mJ jz;zPhpy; guthky; ,Uf;Fk;. 
 fhe;jj;jpd; Nky; Ntg;gpiyapd; fe;jfj;ij g+r Ntg;gpiyapd; 
frg;G ePq;Fk;. 
fhe;jj;jpd; tiffs;:; ; ; ;; ; ; ;; ; ; ;  
fhe;jk; 5 tifg;gLk;. mit  
 gpuhKfk; 
 fk;gfk; 
 fH\fk; 
 jpuhtfk; 
 Nuhkfk; 
,tw;wpd; KiwNa 
 fw;fhe;jk; 
 Crpfhe;jk; 
 gr;irf;fhe;jk; 
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 muf;Ff;fhe;jk; 
kapHf;fhe;jk; vd 5 tiffs; cs;sd. 
 gpuhKfk;  -  Nyhfj;ij gpukpf;fg; gz;Zk; 
 fk;gfk; - Nyhfj;ij ,Oj;Jf; nfhs;Sk; 
 fH\fk; - Nyhfj;ij J}u Xl;Lk; 
 jpuhtfk; - Nyhfj;ij jz;zPuhf;fp tpLk; 
 Nuhkfk;  - Nyhfj;jpy; kapH Nghy Njhw;Wtpf;Fk; 
Nyhfj;ij kpLf;fha; ,Of;fpd;w ,lj;jpw;F Kfk; vd;W 
ngaH.  fhe;jj;jpw;F Ie;J Kfq;fSk; mjw;F Nkw;gl;l Kfq;fSk; 
,Ug;gJz;L.  5 Kfq;fSf;F Nkw;gl;l rHtKfq;fSs;s fhe;jNk 
rpwe;jJ. 
Rit (Taste) :  JtHg;G (Astringent)> rpWghd;ik Gspg;G (Slightly  
Sour)> ifg;Gr; Rit (Bitter)  
tPhpakPPP ; ( ;;; Bio Transformation) :  ntg;g tPhpak; (Hot) 
nra;if:;;;  
 grpAz;lhf;fp (Stomachic) 
 cly; cukhf;fp (Nutritive) 
 FUjpg;ngUf;fp (Cordial) 
 clw;Njw;wp  (Alterative) 
fhe;j Rj;jp Kiw:; ;; ;; ;  
 ‘Jitj; jpUtha; VOtpir vUf;fk; ghypy; 
  nrhy;YfpNwd; ey;nyz;nza; Nfhkaj;jpy; 
  Ritj;jpahk; jhk;guj;ijr; #l;L rhl;L 
  #l;rkhk; jhk;gpu Rj;jpahr;R 
  eptHj;jahk; Nyhfq;fs; nghd;dkhFk; 
  NeHikaq; fhe;j Rj;jp rhl;l epNfs; 
  Jfg;gw;Wq; fhe;jj;ij Jz;lha; Ngl;Nl” 
fhe;jj;ij nfhy;yd; ciyapy; tpl;L fha;r;rp VO (m) 21 
Kiw nfhs;Sf; FbePhpy; Njha;j;Jf; fOtp vLf;f Rj;jpahFk;. 
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Rj;jp Kiw NtW:;;;  
fhe;jj;ij nghbj;J Kbfl;b fhbapYk; nfhs;Sf;FbePhpYk; 
KiwNa mtpj;J vLj;J fOtp cyHj;jp vLf;f Rj;jpahk;. 
Rj;jp Kiw NtW:;;;  
 vYkpr;rk; gor;rhW> Gspj;j fhb> Gspj;j NkhH ,itfspy; 
KiwNa Kk;%d;W ehs; fhe;jj;ij Cwitj;J ntapypy; itj;J 
vLf;f Rj;jpahk;. 
2fhe;jr;nre;J}uk;; ; ; ;; ; ; ;; ; ; ; 
fhe;jj;ij nfhy;yd; ciyapypl;L fha;r;rp gRePupy; 
rha;f;fTk;.  ,t;thW    7 Kiw nra;a fhe;jk; Rj;jpahFk;. 
 fhe;jj;ij fuprhiy rhw;wpy; 12kzp Neuk; miuj;J tpy;iy 
nra;J rpy;ypl;L rpiy nra;J GlkplTk;.  gpd; Glkpl;l fhe;jj;ij 
Nkw;gb rhW tpl;L 9kzp Neuk; miuj;J tpy;iy nra;J rpy;ypl;L 
rPiy nra;J GlkplTk;.  ,t;thNw Nrhw;Wfw;whio> ehty;gl;il> 
murk;gl;il> murk;gl;il rhw;wpy; Glkpl;L miuj;J vLj;Jf; 
nfhs;sTk;. 
msT :  100 kp.fp. 
mDghdk; :  Njd; 
jPUk; Neha; :  kJNkfk;> ghz;L> Nrhif> fhkhiy 
fhe;jk; ; ;; ;; ; NrUk; ghz;Lf;fhd kUe;Jfs;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1) 3ghz;LkNjg rpk;k#jk;; ; ;; ; ;; ; ; 
msT   :  Fd;wp vil khj;jpiu 
mDghdk; ;;;   :  mDghdq;fspd; tpN~q;fspy;  
nfhLf;f 
jPUk; Neha; P ; ;P ; ;P ; ;  :  ghz;L> Ruk;> jhfk;> ,uj;j gpj;jk;> Fd;kk;>  
~ak;> fhrk;> RuNgjk;> mf;fpdp khe;jk;> 
%Hr;ir> cgjq;fs;> gpj;j tpahjp 
,itfis ehrg;gLj;Jk; 
                                                           
2
 fz;Zrhkp guk;giu itj;jpak;   g.v.37 
3
 Mjhuk; : mDgt itj;jpa Njt ufrpak; gf;f vz; 369 
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2) 4fhe;j nre;J}uk;.; ; ;; ; ;; ; ;  
msT  :  Fd;wp vil jpdk; 2 Ntis. 
Njd; my;yJ jf;f mDghdk;. 
jPUk; Neha; P ; ;P ; ;P ; ;  : ghz;L> Nrhif> fhkhiy> ntg;G> 
gpj;jRuk;> ntz;Nkfk;. 
3)5,ujhjp #uzk;;;; 
msT   :  3 gzntil tPjk; 
mDghdk; ;;;   :  Njd; 
jPUk; NehaP ;P ;P ; ;  :  FspH> Fiog;G> ghz;L> fhkhiy> Nrhif>  
Kiw  
4. 6,ujhjpf; Fkhp gw;gk;; ; ;; ; ;; ; ; 
msT   :  4 gzntil J}s; (13 Fd;wpkzp) 
mDghdk; ;;;   :  Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  ePuhik> kNfhjuk;> ghz;L> tpl clk;G  
tPf;fk;> nrhpkhdk; ,y;yhik> Gspj;j Vg;gk;> 
mjpf fopr;ry;> thj  gpj;jq;fspdhy; 
Vw;gLk; 108 tpahjpfSk; jPUk;. 
5) 
7kz;^ ur; nre;J}uk; ; ;; ; ;; ; ; ; 
NrUk; ruf;Ffs; ; ; ;; ; ;; ; ;   :   kz;^ ur; rpe;J}uk; - 3 1/3 Fd;wp 
fhe;j rpe;J}uk; - 6 2/3 Fd;wp 
mDghdk; ;;;    :  Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;   :  rhif> gpj;j ghz;L> gpj;jk;> fhkhiy>  
<is> kNfhjuk;> ,Uky;> ngUtapW> 
6) 
8fhe;jhjp kz;^ ur; rpe;J}uk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
NrUk; ruf;Ffs;; ; ;; ; ;; ; ;   :  kz;^ ur;rpe;J}uk; - 2gzntil  
fhe;j. nre;J}uk; - 1 gzntil 
                                                           
4
 mDgt itj;jpa Njt ufrpak; gf;f vz; 381. 
5
 ru.itj;jpa Kiwfs; ghz;L> fhkhiy> rpfpr;ir gf;f vz; 15 
6
 ru.it.Kiwfs; ghz;L> fhkhiy – gf;f vz; 24 rpfpr;ir 
7
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 30 
8
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 30 
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mDghdk; ;;;    :  nea; 
jPUk; Neha; P ; ;P ; ;P ; ;   :  kNfhjuk;> Nrhif> gpj;j ghz;L>  
fhkhiy> ngUtapW> gPypif> jpkpuk;> 
CJfhkhiy> ,Uky;. 
7)  
9vYkpr;rk;go Nyfpak;; ; ;; ; ;; ; ; 
msT    :  fow;rpf;fha; msT 
jPUk; Neha; P ; ;P ; ;P ; ;   :  ghz;L> fhkhiy> the;jp ,isg;Gj;  
jPUk;.  
vYk;ig gw;wpa Ruk;> if>fhy; mrjp> mjprhuk;>  ke;jhf;fpdp> 
11 tif tpg;GUjp> Mfhu ntWg;G. Ruk;> uj;jkpd;ik> cly;tPf;fk;> 
fug;ghd;. 
8) 10fhpg;ghdhjp Nyfpak;; ;; ;; ; 
msT   :  nfhl;ilg;ghf;fsT 
mDghdk; ;;;   :  Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  gpj;jghz;L> fhkhiy> Fd;kk;> gpj;jk;  
                    tp~ghz;L. 
9) 11mug;nghbahjp tlfk;; ;; ;; ; 
msT   :  Gspaq;nfhl;il msT 
mDghdk; ;;;   :  ifahe;jfiur; rhW 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Nrhif> gpj;jghz;L 
10) 12Nyfpak; ;;; - ghz;L KjypaitfSf;F; ;; ;; ;  
msT   :  1 ghf;fsT 
jPUk; Neha; P ; ;P ; ;P ; ;  :  tp~ghz;L> gpjj ghz;L> fhkhiy>  
jPUk;> jhJG\;b cz;lhFk;. 
  
                                                           
9
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 40 
10
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 52 
11
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 56 
12
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 62 
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11.13fpl;lhjpr; #uzk;; ; ;; ; ;; ; ; 
msT   :  %tpuy; nfhs;SksT 
mDghdk; ;;;   :  nte;ePUld; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  tPf;fk;> ghz;L> fhkhiy 
12) 14fhe;j gw;gk;; ; ;; ; ;; ; ; 
msT   :  1-2 Fd;wp   
mDghdk; ;;;   :  g+z;L ijyk;> kpsF ijyk;> JsrprhW 
jPUk; Neha; P ; ;P ; ;P ; ;  : gpj;j ghz;L> kQ;rs; Neha;> Fotp  
ngUq;fopr;ry; ntg;Ggpzp> ,uj;jfhr Neha;> 
khh;GNeha;> gf;fNeha;> tpaHit> vhpFd;kk;> 
ghz;L. 
13) 
15fhe;j nre;J}uk;; ; ;; ; ;; ; ; 
msT   : 3-4 Fd;wp vil 
jPUk; Neha; P ; ;P ; ;P ; ;  :  kQ;rs; Neha;> ghz;L> Nrhif 
14) 16fhe;j nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  3-4 Fd;wp vil 
mDghdk; ;;;   :  Vy;rrp> frfrh> ew;rPufk;> kpsF ,tw;iw  
           rkkhf ,bj;J Jzpapy; tbfl;b itj;Jf;  
nfhs;sTk;. ,e;j fyit J}s; ¼ vil> nea; 
my;yJ ntz;nza; 1 tpuyfd msT 
,t;tpuz;ilAk; fye;J Nkw;gb 
nre;J}uj;ij mDghdpj;J cl;nfhs;s 
Ntz;Lk;. 
jPUk; Neha; P ; ;P ; ;P ; ;  :  gpj;j ghz;L> Nrhif> kQ;rs; Neha;>  
fpuhzp> %ythA> MrpfthA jPUk;. 
  
                                                           
13
 ru.it.Kiw  ghz;L fhkhiy rpfpr;ir gf;f vz; 80 
14
 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 59 
15
 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 61 
16
 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 62 
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15) 17Nyhfkhuz fhe;j nre;J}uk;; ; ;; ; ;; ; ; 
mDghdk; ;;;   :  Njd;> nea;> thJik my;th> ntz;nza;  
jPUk; Neha;fs; P ; ; ;P ; ; ;P ; ; ;  :  thA rk;ke;jkhd ghz;L Neha;fs;>  
Nrhif> kQ;rs; Neha;> Fd;kk;> nrhpahik> 
Kiw Neha;fs; 
16) 
18maf;fhe;jg; gw;gk; (NtW); ; ; ; ;; ; ; ; ;; ; ; ; ;  
msT   :  2-4 Fd;wp 
mDghdk; ;;;   :  Njd;> nea;> rkNahrpj ,sfk; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  thj#iy> Fd;k #iy> fLg;G.  
              ,isg;G> vy;yhtpj tapw;W Neha;fs;> Cjy;>     
vz;tif ghz;L> kQ;rs; Neha;> Nrhif 
Kjypad jPUk;. 
17) 19RtHzNahf fhe;jr; nre;J}uk;; ; ; ;; ; ; ;; ; ; ; 
msT   :  1-2 Fd;wp 
mDghdk; ;;;   :  nea;> Njd;-me;je;j Neha;f;F Vw;w FbePH>  
,sfk;> nea;fs;> kzg;ghFfs; 
MfpaitfSld; fye;J nfhLf;f 
Ntz;Lk;. 
jPUkPPP ; Neha; ; ;; ;; ;  :  rak;> ,Uky;> ,uj;j ryk;> FUjp ,Uky;>  
ePhpopT> kJNkfk;> ghz;L Nrhif. 
jhJel;lk;> tpe;J el;lk; 
  
                                                           
17
 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 64 
18
 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 75 
 
19
 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 76 
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18) 20v‡F fhe;jr; nre;J}uk;; ; ; ;; ; ; ;; ; ; ; 
msT   :  1-2 Fd;wp vil 
mDghdk; ;;;   :  Njd;> nea;> Neha;f;F Vw;w kUe;Jfs; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  ghz;L> Nrhif> ngUtapW> Fd;kk;>  
nrhpahik> ngUq;fopr;ry; jPUk;. 
jhJtpUj;jp> cly; typik> kdtypik> 
Kaw;rp> JzpT cz;lhFk;> rak;> jPUk;. 
19) 21jphpahf;fpdp nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  2-3 Fd;wp vil 
mDghdk; ;;;   :  nea;> Njd;> rPdpr;rHf;fiu 
jPUk; Neha; P ; ;P ; ;P ; ;  :  ePH Nkfk;> ePnuhpr;ry;> ePuilg;G> ePuhik>  
ePuhikfl;b> Nkf#iy> ghz;L> Nrhif 
kype;j thA> khuilg;G> 6tif 
ngUq;fopr;ry; 
20) 22MWKf tlfk;;;; 
msT   :  1 – 1 ½ khj;jpiu 
mDghdk; ;;;   :  rHf;fiu> gidnty;yk;> tpy;thjp ,sfk;> 
jPUk; Neha; P ; ;P ; ;P ; ;  :  ghz;L> Nrhif> gpj;j ntl;il  
Ritapd;ik> ff;fy;> Ml;Lke;jk;>  
21) 
23fhkhiy> Nrhif> gpjj ghz;LfSf;F gw;gk;; ; ; ;; ; ; ;; ; ; ; 
msT   :  gzntil 
mDghdk; ;;;   :  goNkhhpy; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  fhkhiy> Nrhif> ghz;L> tPf;fk;>  
nghUky;> ePHfl;L 
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 mDgt itj;jpa etePjk; ghfk; -1 gf;f vz; 76 
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22) gpj;j ghz;Lf;F (NtW); ; ;; ; ;; ; ;  
msT   :  Njitahd msT 
jPUk; Neha; P ; ;P ; ;P ; ;  :  fhkhiy> Nrhif> ghz;L> tapw;nwLg;G  
gapj;jpak;> 
mDgt itj;jpa Kiw ghfk; ; ;; ;; ; -1 gf;f vz; 44; ;; ;; ;  
 
fhe;jk; NrUk; gpw Neha;f;fhd kUe;Jfs;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
1) 24jhk;gpu fhe;jr; nre;J}uk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
jf;f mDghdk;; ;; ;; ; 
jPUk; Neha; : P ; ;P ; ;P ; ;  thjj;jhy; cz;lhd jPuhj typfs;> nghy;yhj 
Fd;k Nuhfq;fs;> Nkftha;T> mz;l tPf;fk;> 
Fly;thjk;. 
2) 25mar;nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  ½ fhR 
mDghdk; ;;;   :  Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  m~;lFd;kk;> kfhNuhfk;> thjgpj;j fgk;  
xbNghFk;> Njfk; rpWfp tYtilAk;. 
3) 26gr;ir ntl;L fhe;j nre;J}uk;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
jPUk; Neha; : P ; ;P ; ;P ; ;  
thj #iy Neha;fs;> tapw;W Neha;> 8tif Fd;k Neha;fs;> 
Fly;thjk;> mz;lthjk; 
4)  
27gQ;rNyhf khj;jpiu; ;; ;; ;  
 rfy Nuhfk;> Nkf thA 
5) 
28jphptq;f khj;jpiu (ePhpopTf;F); ; P ;; ; P ;; ; P ;  
msT :  ,ye;ij nfhlil msT 
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jf;f mDghdk;; ;; ;; ; 
jPUk; Neha; P ; ;P ; ;P ; ;  : 21 tif Nkfq;fSk;> fphpr;ruq;fSk; NghFk;. 
6)  
29mafhe;j nre;J}uk;; ; ;; ; ;; ; ; 
vy;yh Neha;fisAk; mbj;J Juj;Jk; GypahFk;. 
7) 
30tp~;Z rf;fu khj;jpiu; ; ;; ; ;; ; ;  
msT   :  ½ -1 khj;jpiu 
mDghdk; ;;;   :  Njd;> jha;ghy; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  vy;yhtpj rsp> mz;lthjk;> jpkpHthjk;>  
,sk;gps;is thjk;> ghhprthjk;> 
jDHthjk;> nrtpNeha;> gPdprk;> typg;G 
Neha;fs;> Ruk;> ,Uky;> vhpFd;kk;> Fl;lk; 
8) 31rQ;rPtp khj;jpiu; P ;; P ;; P ;  
msT   :  1 khj;jpiu 
mDghdk; ;;;   :  ,Q;rprhW> Njd;> rPuf frhak; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Ruk;> rd;dp> khe;jk; 
9)  
32Nkfuh[hq;f urfQ;rp nkOF; ;; ;; ;  
msT   :  ½ - 1 fpuhk; 
mDghdk; ;;;   :  ghy; my;yJ ePH 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Fl;lk;> jpkpH> fz;lkhiy> Nkf#iy>  
fpue;jp> miuahg;G> Gw;W fUk;Gs;sp> Nkf 
Cwy;> glHjhkiu> njhilthio> gTj;jpuk;> 
Foptpuzk;>  
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10)  
33Fkl;b nkOF;;;  
msT  :  200kp.ypfp – 500 kp.yp fpuhk; 
fhiy 1Ntis 
mDghdk; ;;;  :  gidnty;yj;Jld; 
jPUk; Neha; :P ; ;P ; ;P ; ;   #jf tha;T. #jf jpul;rp> Fd;kk;> kNfhjuk;> 
fy;yPuy;> kz;zPuy; ngUj;jy;> gPypfk;> 
11)  
34thd; nkOF;;;  
msT   :  100-200kp.fp 
mDghdk; ;;;   :  gidnty;yk; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  fgthjrd;dp> fhrk;> Fl;lk;> Fd;kk;> #jf  
#iy> kNfhjuk;> fz;lkhiy> #iy> ghhpr 
thjk;> ePhpopT> fpue;jp> khuilg;G> 5tif 
thj Neha;fs;:  
12) 35,uhkghd ,bkUe;J;;;  
msT   :  rpWRz;ilf;fha; msT 
mDghdk; ;;;   :  ghy; (m) ePH 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Nahdpg;Gw;W> ypq;fGw;W> ntbg;Gw;W>  
Fiyg;Gw;W> <uy;Gw;W> tp\ePH Gw;W> 
fz;lGw;W> GiuNghFk; Gz;fs;> 
%f;nfhOFjy;> #iy> F~;lk;> 
FiwNuhfk;> ntz;F\;lk;> Klf;F #iy. 
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34
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13)  
36rlh~u mf;fpdp Fkhu nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  100 – 200kp.fp. 
mDghdk; ;;;   :  jphpfLF MH> Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  thjk;80> tha;T. #iy> 8tif Fd;kk;>  
rd;dp> Kfthjk;> Fkufz;l typ> 
neQ;rilg;G. nkhspr;#iy> fpue;jp> 
miuahg;G. 
14)  
37fhe;j nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  100-200kp.fp. 
mDghdk; ;;;   :  nea;> Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  : fpuhzp rk;ke;jkhd gytif Ngjpfis  
epWj;Jk;.  
15)  
38gQ;r gh~hz nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  50-100kp.fp 
mDghdk; ;;;   :  nea;> Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Ruk;> rd;dp> #iy 18> Nkfk; 20> F~;lk;  
18> thjk;80> ntz;F~;lk;> fpuhzp> 
Fd;kk;> gpsit> fz;lkhiy> ePHxOFk; 
gTj;jpuk;> fpue;jp> Gw;WNeha;fs;> fug;ghd;> 
ahidj; Njhiy Nghd;w rHkNuhfk;> 
GOntl;L 
16) 
39rlFz nre;J}uk;; ;; ;; ;  
msT   :  100 kp.fp 
mDghdk; ;;;   :  Njd;> nea;> ntz;nza; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Ngjp> fpuhzp> ntl;il> %yk; fpue;jp> Nkf  
tpuzk;> ngUk;ghL> gTj;jpuk; 
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17)  
40Nkf rpe;jhkzp nre;J}uk;; ; ;; ; ;; ; ; 
msT   :  50-100kp.fp 
mDghdk; ;;;   :  nea;> ntz;iz> guq;fpg;gl;il #uzk;>  
jPUk; Neha; P ; ;P ; ;P ; ;  :  ,uj;jj;jpy; cs;s rHf;fiu rj;J FiwAk;>  
Nkf moiy> jhfk;> ntF%j;jpuk;> ePhpopT> 
rf;jp FiwT> %Hr;ir> 
18) 
41gl;Lf;fUg;G; ; ;; ; ;; ; ;  
msT   :  50-100kp.fp 
mDghdk; ;;;   :  Njd; 
jPUk; Neha; P ; ;P ; ;P ; ;  :  Ruk;> #jfRuk;> #jf#iy ,Uja  
gytPdk; 
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About the jucies used in the preparation of trial drug (Kaandha 
Chenduram) 
nghw;wpiyf;fahd;; ; ;; ; ;; ; ; 
1. 42NtW ngah;fs;:; ;; ;; ;  
 fhprdhq;fd;dp 
 fhprhiy 
 fhparhiy  
 ifNfrp 
 iftPrp ,iy 
 ifahe;jfiu 
 gpUq;fuh[k; 
 fhpg;ghd; 
 Njfuh[k; 
2. 43Taxonomy position according Bentham – Hooker. 
Class  - Dicotyledons 
Sub class - Gamopetalae 
Series  - Inferae 
Order  - Asterales 
Family - Asteraceae 
Genus - wedelia 
Species - Chinensis 
3. 44Vernacular names : 
Hindi  - Pilambhamgara 
Kan  - Kalsaiji 
Mat  - Manmakannunni 
Sans  - Pitabhringa 
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 Fzghlk; %ypif tFg;G. gf;fk; vz;. 229   
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Tam  - Manjal karisalai 
Guj  - Bhangaru. 
4. 45tshpay;G :;;;  
 ePyk;> kQ;rs;> rpfg;G> nts;is vd Nkw;$wpa ehY ,dkhf 
tsUk; xU G+z;bdk;. Kjy; %d;W tif mNefkhf mfg;glhJ. 
Ehd;fhtjhff; $wpa nts;isf; fhpryhq;fz;zp vq;Fk; 
mfg;glf; $baJ. 
5. 46Rit (Taste)    -  ifg;G (Astringent)  
jd;ik (Potency)    -  ntg;gk; (Hot) 
gphpT (Bio-transformation)  -  fhh;g;G (Pungent) 
6. 47nra;if :;;;  
 gpj;j ePh; ngUf;fp 
 cukhf;fp 
 clw;Nww;wp 
 the;jpAz;lhf;fp 
 ePh;kyk; Nghf;fp 
 tPf;fKUf;fp 
 <uy; Njw;wp 
7. Phytochemicals : 
 Glycosides 
 Tannins 
 Saponins 
 Phytosterol  
 Benzoforan 
 Norwedelic acid 
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 Norwedelolactone 
 Triterpenoids 
 Major   
(Mixture of  wedelolactone and dimetyl wedelolactone). Nor- wedelic acid 
The expressed Juice of herb contained. 
Soluble Black Dye - 11.2 
Tannins   - 1.14 
Carotene    - 1.14 
Saponin    -  3.75 
Phytosterol    -  3.75 
Waxy compound   - 297 
Resins    - 44 
Gum     - 80 
Total sugar   - 1040g/100g Juice. 
8. Uses: 
Plant  is astringent, bitter, acid, anti-inflammatory, vulnerary, 
cardiotonic, anthelmentics, diuretics, aphrodisiac, febrifuge. 
The plant is useful in vitiated conditions of kabha, elepahantiasis, 
otalgia, cephalgia, wounds, ulcers, hepato spleenomegaly, coliec 
dyspepsia, heminthiasis, strangury, Anaemia, greyness of hair.  
The plant is useful  in indigestion and root used in abscess. 
Plant is very specific for viral hepatitis. 
Leaves are regarded as tonic, alterative, useful in cough, cephalgia, 
disease of the skin and also it is used in dying grey hair and to promote its 
growth. 
Leaves used in treatment of digestive system disorder. 
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9. 48gad; :;;;  
1. fhprhiy r%yk;> clk;Gf;F MNuhf;fpaj;ijAk;> gyj;ijAk; 
jUtJkd;wp> gpj;jj;ij Ngjp %ykhf ntspg;gLj;Jk; 
jd;ikiaAk;> %j;jpug; Nghf;ifAz;lhf;Fk; FzKk; 
tha;e;jJ. 
2. ,jd; rhw;iw \ar;Ruk;> fhkhiy > ghz;L> F\;lk;> Kjypa 
Neha;fSf;F nfhLg;gJz;L. 
3. fhprhiy rhw;iw NkYf;Fg; G+rr; nrhwp rpuq;Ffspd; 
jpditg; Nghf;Fk;.  
4. fhprhiy rhw;iwf; nfhz;L ik nra;J fz;Nzha;f;Fg; 
Nghlyhk;. 
5. fhprhiy rhw;iw cz;zhf;fpy; jlt Nfhio ntspg;gLk;. 
6. fhprhiy rhw;iw jiyapy; Nja;j;J KOfj; jiytyp> gPdprk; 
> fghy Neha;> fz; vhpr;ry; jPUk;. 
10. 49magpUq;fuh[ fw;gk; :; ; ;; ; ;; ; ;  
msT   :  500 kp.fp> 2 Ntis> 40 ehl;fs; 
mDghdk;   :  Njd;> nea;> gor;rhW> japh; 
jPUk; Neha;  :  eiu> mrjp> ,uj;jf;FiwT. 
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Nrhw;Wf;fw;whio; ; ;; ; ;; ; ;  
1. 50NtW ngah; ;;;  
fd;dp 
Fkhp 
2. 51Taxonomy position according Bentham – Hooker Classification 
Class  - Monocotyledons 
Series  - Coronarieae 
Family - Liliaceae 
Genus - Aloe 
Species - Vera 
3. 52Vernacular Names : 
 Bengali - Ghrita kumari 
 English - Indian aloe 
 Gujarat - Kadvi kumari 
 Hindi  - Ghee – Banwar, Gwarpatha 
 Kannada - Komarka 
 Malayalam - Kattavazha 
 Sans  - Kumari 
 Tamil  - Sottru – Katrazhae. 
4. 53gad;gLk; cWg;G :; ; ;; ; ;; ; ;  
ghy;> klw;NrhW> rhW> Nth; 
5. 54Rit (Taste)   - rpWifg;G  (Slightly bitter) 
jd;ik (Potency)  - jl;gk; (Coolant) 
gphpT (Bio-Transformation) - ,dpg;G (Sweet) 
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6. 55nra;if;;;  : 
 cukhf;fp 
 clw;Nww;wp 
 ePh;kyk; Nghf;fp 
 UJ cz;lhf;fp 
7. Phytochemicals : 
The mucilaginous jelly (gel) isolated from the fresh leaves contains 
 Amino acids 
 Arginine   
 Histidine 
 Phenyalanine 
 Leucine 
 Valine 
 Isoleucine 
 Polysaccharides 
8. 56Uses : 
1. Extract of leaves is used for treating obstruction of Lymphatic 
system, arthritis and myopathies. 
2. Juice of leaves is reported to be used for treating gonorrhoea and 
the pulp in menstrual suppression. 
3. The pulp is also used as vermicide. 
4. The phenolic and non – phenolic fractions of the leaf extract 
showed antimicrobial activity comparable to standard antibiotics 
such as neomycin, tetracycline, and co – trimazole. 
5. The pulp is mixed with misri and taken for stomach disorders. 
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6. In uttar pradesh, crushed leaves are applied on forehead for relief 
in headache. 
7. Experiments have revealed that zine acetate and lyophilized aloe at 
conc of 75% and 10% can be used as effective and safe vaginal 
contraceptive by humans.  
9. 57gad; :;;;  
1) fw;whio ,sklYld; rPufk;> fw;fz;L Nrh;j;jiuj;J 
FUjpAk; rPjKk; fye;j fopr;rYf;Ff; nfhLf;fyhk;. 
2) fw;whioapd; Nrhw;iw vLj;Jg; gyKiw fOtp> ,jpy;rpwpJ 
gbfhuk; my;yJ rPdhfw;fz;L Nrh;j;J> rpW Jz;by; Kbe;J 
njhq;ftpl ePh;tbAk;. ,ijf; fz;fspy; tpl fz;Nzha;> 
fz; rpfg;G> fz;zUfy; Kjypad jPUk;. 
3) fw;whio rhW ntg;gj;ijj; jdpg;gjw;fhFk;. gw;gr; 
nre;J}uq;fSf;F Jiz nfhs;syhk;. 
4) fw;whio rhw;iw ntJg;gp khe;j Neha;fSf;Fk;> Copahy; 
fhZk; ePh; Ntl;iff;Fk; nfhLf;fyhk;. 
5) fw;whio rhw;iw jhgpjq;fSf;Fk; tPf;fq;fSf;Fk; G+ryhk;. 
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muR 
1. 58NtW ngah;fs; :; ;; ;; ;  
 m];tj;jk; 
 mr;Rtj;jk; 
 jpUkuk; 
 ftiy 
 Ngjp  
 giz  
 fztk; 
 ruhrdk; 
 gpg;gpyk; 
2. 59Taxonomy position according Bentham – Hooker 
Classification 
Class  - Dicotyledons 
Series  - Unisexuales  
Family - Moraceae 
Genus - Ficus 
Species - Religiosa 
3. Vernacular Name : 
Bengali - Ashathwa 
 English - Peepul tree 
 Kannada - Pinpala 
 Malayalam - Arasu 
 Sans  - Aswdtha 
 Tamil  - Arasu 
 Telgu  -  Ravichettu 
 Uru  - Peepul Paras 
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Duk  - Anipeepul 
4. g.c.   - ,iy> tpj;J> gl;il> Nth; 
5.  Rit  (Taste)   - Jth;g;Gk; ifg;GKs;sJ  
(Astringent bitter) 
jd;ik (Potency)   - jl;gk; (Coolant) 
gphpT (Bio-Transformation) - ,dpg;G (Sweet) 
6. 60nra;if;;; : 
 ,iy> Nth;> gl;il - Jth;g;gp 
7. 61Bark – Phytochemical 
  Tannin  
8. Uses : 
1) The decoction of the stem bark with molasses is given in 
haematuria. 
2) Infusion of bark is taken internally for scabies and its powder is 
applied over severe body burns after application of coconut oil. 
3) The benzene extract of stem bark exhibited anti- bacterial 
activity against staphylococcus areus and Escherichia coli and 
anti fungal activity against pencilium glacum due to presence of 
furanocoumarins, bergapten and bergaptol.  
4) The tree is suitable for planting a near petrochemical and 
thermal power station to purify air by absorbing gaseous 
pollutants.  
9. 62gad; :;;;  
1. gl;ilia ,bj;Jg; nghbahf;fp fUf;fpa rhk;gypy; nfhQ;rk; 
vLj;J ePhpy; Cw itj;J tbfl;b nfhLf;f tpf;fy; NghFk;. 
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2. gl;ilj;J}spy; fhy; Kjy; miu gyk; vLj;J FbePh; nra;J 
nfhLf;f nrhwp> rpuq;Ffs; FzkhFk;. ntg;gk; mfYk;. 
3. gl;ilapd; Ez;zpa J}s;fis Gz;zpd; kPJ J}tp tu Gz; 
Mwp tUk;.  
4. Ie;J Jth;g;G nghUl;fspy; muRk; xd;W. Mifahy;> 
,t;ite;J gl;ilfspd; FbePiu> tha;g;Gz;Zf;F 
nfhg;gspf;Fk; ePuhfTk;> nts;isapd; ePh;j;jhiu topahf 
nrYj;jp fOTk; ePuhfTk; gad;gLj;jyhk;.  
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vYkpr;ir;;;  
1. 63NtW ngah; :;;;  
 Njrp ePh; 
 $jo;r; rhW  
 rpWfpsp gor; rhW 
 epk;gtsr; rhW 
 Nehthyp khjurp 
 cgNdhuQ;rfk; 
 gpj;j Kwpkhjh;  
 NgRk;fdpkhjh; 
2. Vernacular Name : 
 Sans  - Jambha  
 Eng  - Acid lime 
 Hindi  - Ninbu Limu 
 Punj & Guj - Limbu 
 Mah  - Kagdi Limbu 
 Tel   - Nimma 
 Tam  - Elumichai 
 Mal  - Cheru- Naranga 
3. 64gad;gLk; cWg;G:; ; ;; ; ;; ; ;  
 ,iy> fha;> gok;> gourk;> vz;nza;.  
4. fha;> gok;; ;; ;; ; : 
 Rit (Taste)    - Gspg;G (Sour) 
 jd;ik  (Potency)  - ntg;gk; (Hot) 
 gphpT (Bio-transformation) - fhh;g;G  (Pungent) 
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 gQ;r fhtpa epfz;L> ghly; 493 gf;fk; 202 
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 (3>4>5>6) T.V.rhk;grptk; gps;is mfuhjp ghfk; - 1 gf;fk; vz;.1446 
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5. nra;if :;;;  
 Fsph;r;rpAz;lhf;fp 
6. tof;F :;;;  
 gpj;jj;ij rhe;jp gz;ZtJld; the;jpia epWj;Jk;. 
md;wpAk;> vd;GUf;fp fzNuhfk;> tp\Ruk; Kjypad Nghk;. 
 ekJ ehl;L itj;jpah;fs; kUe;Jfs; miug;gjw;F 
mDghdkhfTk; ruf;Ffis Rj;jp nra;tjw;Fk;> rpy 
Gz;fis fOtTk; ,ij cgNahfg;gLj;Jthh;fs;. 
 clk;gpy; gytpj fpUkpfis mopj;J clk;gpw;F tYitf; 
nfhLf;Fk;.  
 Neh;thsk;> Mkzf;F Kjypaitfspd; tp\q;fis ,J 
Kwpf;Fk;. 
 ,jd; rhw;Wld; Njd; fye;J nfhLf;f jhJTf;F tYit 
jUk;. 
 efr;Rw;Wf;F  ,jd; goj;ij itj;J fl;l my;yJ nrhUfp 
itj;J fl;l Fzk; cz;lhFk;. 
7. 65Phytochemicals : 
 Lemon juice contains citric acid 7-10pc, phosphoric acid, malic 
acid, also citrate of potassium and other bases. 
8. Uses : 
 A few drops of fresh lemon juice put  early morning into the eye 
when cataract is forming in the eyes of old men nearing 70 years, 
is said to gradually dissolve the cataract and make the eye light 
cleared day by day. 
 Juice of the fruit in doses of four to six drachms is employed as a 
very useful refrigerant drink in small pox, measles, scarlating and 
other forms of fever. 
 It is also useful in the rheumatism. 
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BOTANICAL ASPECT 
SYZYGIUM CUMINI (Linn)  
TAXONOMY CLASSIFICATION: 
 Kingdom  : Plant Kingdom 
 Division : Angiosperms 
 Class  : Dicotyledonae 
 Sub Class : Polypetalae 
 Series  : Calyciflorae 
 Order  : Myrtales 
 Family : Myrtaceae 
 Genus : Syzygium 
 Species : Cumini 
66Distribution: 
 Throughout India, in forests upto 1800m usually along river banks 
and moists localities; also cultivated as shade trees along roadsides. 
67Botanical Description: 
 A large or Medium sized evergreen tree. 
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CHEMICAL ASPECT 
CHEMICAL CONSTITUENTS: 
Stem bark: 
 Betulinic acid, friedelin, friedelinol, kaempferol and its 3-0 
glucoside, quercetin, sitosterol and its glucoside and sucrose, tannins, 
gallic acid,ellagic acid. 
GUNAPADAM ASPECT 
NtWngaH: 
 et;ty;> ek;G> rk;G> rhjtk;> MUfjk;> NeNuL> NeNulk;> 
rhl;Ltyk;> rhk;gy;> Rugpgj;jpiu. 
VERNACULAR NAMES: 
 Eng - Jaman, Jambolan, Black plum 
 Hindi - Jamun, Jambhal, Jaman, Bada Jamun, Jam. 
 Beng - Jam, Kalajam 
 Guj - Jambu, Jamli 
 Kan - Neralu, Jambuva 
 Mal - Naval, Perinnaral 
tshplk;;;;: 
 ,k;kuk;> ek; ehL KOikAk; tsUfpd;wJ. 
gad;gLk; cWg;G:; ; ;; ; ;; ; ;  
 midj;J cWg;GfSk;. 
ORGANOLEPTIC CHARACTERS: 
 Rit (Taste)     : JtHg;G 
 jd;ik (Potence)   : jl;gk; 
 gphpT (Therapeutic Actions) : fhHg;G 
nra;if:;;;  
 JtHg;gp (Astringent) 
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68gl;il Fzk;:; ;; ;; ;  
 ‘MrpaNeha; fhrk; mrpHf;fuQ;R thrtpid 
 NfrKW ghy fpufNeha; - Ngrhpa  
 khtpaq;f yhQ;rdkpt; td;gpzpna yhNkFk; 
 ehtYW gl;ilaj dhy;” 
gl;ilapdhy; thapw;gpwf;Fk; Neha;fs;> ,Uky;> ngUk;ghL> 
<is> Foe;ijfSf;Fz;lhFk; Gs; Kjypa Fw;wk; (Njhlk;). 
kUj;Jtg; gad;fs;:; ; ; ;; ; ; ;; ; ; ;  
 69‘gl;ilapdp Y}l;bg; gbfhu kpe;Jg;G 
 vl;bul;b ahftiuj; Jz;il nra;J - nul;ilg; 
 gpukpure; Njidg; ngUk;ghL NghFk;  
 tUilajp uj;ijeh ty;” 
nghUs;:;;;  
ehtw; gl;ilf;Ff; ; ;; ; ;; ; ; ; FWk;ghl;bd; FUjpia tpl;L Cw itj;J 
vl;Lg;gq;F nfhz;L> mj;Jld; gbfhuk;> ,e;Jg;G ,uz;L gq;F 
$l;b miuj;J> cUz;il nra;J> ,ul;ilg; gpukpr;rhWk; NjDk; 
NrHj;Jj;jhpd; ngUk;ghL vd;Dk; Neha; Nghk;. 
 70,ij Kiwg;gb FbePH nra;J cl;nfhs;s ePhpopT> fopr;ry; 
tif Nghk;. tha;g; Gz;Zf;Fk;> ,ijf; nfhz;L tha; nfhg;Gspf;f 
cyUk;. 
 ,ij miuj;J> mbgl;l tPf;fk;> fl;b Kjypatw;wpd; 
Nkw;Nghl mit mKq;Fk;. 
,jd; rhw;iwg; ngUk;ghl;Lf;F toq;fyhk;. 
,JNt vl;b eQ;Rf;F khw;whFk;. 
 ,jd; gl;ilr; rhw;wpdhy; ,Uk;G nre;J}ukhFk;. 
 ,jdhy; fLtd;> fug;ghd;> khe;jk; ,it cz;lhk;. ePhpopT> 
ntg;gk;> thA> fLg;G> ePHNtl;if ,itfs; ePq;Fk;.  
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 Njud; ntz;gh 
70
 Fzghlk; %ypif tFg;G> gf;f vz; - 572 
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 71gl;ilia #uzpj;jhtJ> FbePhpl;lhtJ mUe;jptu rPjNgjp> 
,uj;jNgjp> ngUk;ghL Kjypa FzkhFk;. 
Uses: 
1. 72The bark dried in the shade and powdered and mixed in goat’s 
milk is prescribed for diarrhoea, chronic dysentery, hemorrhoid etc. 
2. The powder when dusted over bleeding wounds arrests the 
bleeding and heals the wound. 
73The bark is astringent, sweet, sour acrid, refrigerant, carminative, 
diuretic, digestive, anthelmintic, febrifuge, constipating, stomachic and 
antibacterial.  It is useful in diabetes, leucorrhoea, stomachalgia, fever, 
gastropathy, strangury and dermatopathy. 
74The bark is astringent and is used in the preparation of gargles 
and mouth washes. 
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 mDgt itj;jpa Njt ufrpak;> gf;f vz; - 59 
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 b.tp. rhk;grptk; gps;is jkpo;> Mq;fpy mfuhjp> gf;f vz; - 2960 
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 Indian Medicinal Plants – a compendium of 500 species, Volume – V, Page No: 225 
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 Wealth of India, Volume – X, Page No: 100 
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75ntSg;G Neha;; ;; ;; ; 
NtWngah; :;;;  ntz;ik Neha;> ghz;L. 
,ay;G : ;;;  
,aw;if epwkhwp> cly; ntSj;J> fz;izAk; eff; 
fz;izAk; ePf;fpg; ghh;f;fpd; FUjpapd;wp ntSj;jpUf;Fk;.  
Neha; Njhd;Wk; top :; ; ;; ; ;; ; ;  
 FUjpapd; td;ikiaf; Fiwf;ff; $ba cg;G> Gspg;Gs;s 
nghUs;fis kpFjpahff; nfhs;tjhYk; Ruk;> Ngj> the;jp> fPy;thA 
Kjypa Neha;fSf;Fl;gLjyhYk; FUjpia msT fle;J 
ntspahf;Fk; ngUk;ghL> FUjpaoy; Neha;> FUjpf;fopr;ry;> 
KisNeha; (%yk;)> FUjpthe;jp Kjypait  Vw;gLjyhYk;, 
ntl;Lg;gl;L kpFjpahff; FUjp ntspg;gLjyhYk; ,e;Neha; 
cz;lhk;.  md;wpAk;> er;Rj;jd;ikAila kUe;Jfis ehssTf;F 
kpQ;rp cz;gjhYk;> cliy ,isf;fr;nra;Ak; tapw;Wg;GO Neha;> 
,isg;G  Neha;> epzf; fopr;ry; KjypaitfshYk;> FUjpg; 
ngUf;iff; nfLf;ff;$ba <uy; Neha;fshYk;> Gifapiy> 
ntw;wpiyg; ghf;F> kz;> rhk;gy;> jpUePW> fw;G+uk; Kjypaitfis 
mbf;fb nfhs;tjhYk; ,e;Neha; tUk;.  
Kw;Fwpfs; :; ;; ;; ;  
 czT Kjypa NtWghLfshy;> jPf;Fw;w kpFe;J> FUjpapd; 
epwj;ijAk; viliaAk; nfLj;J> clw;F Ntz;ba Cl;lj;ijAk; 
nfhlhky;> cliy ntSf;fr; nra;Ak;. gpd;G> rpwpJ njhiyT 
elf;fpDk; fhy; Xa;e;J Nghjy;> ngU%r;R thq;fy;> cztpy; 
tpUg;gkpd;ik> tha;Fkl;ly;> jiyRw;wy;> fz; ,Usy;> mbf;fb 
kaf;fkhjy;> khh;G Jbj;jy;> cly; ,isj;jy; Mfpa FwpfisAk; 
fhl;Lk;.  
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Neha; vz; :; ;; ;; ;  
 Fw;wj;jhy; tUtd ehd;Fk;> eQ;rhy;tUtd xd;Wk; $b 
Ie;jhFk;. 1. tsp (thjg;) ghz;L> 2. jP (gpj;jg;) ghz;L> 3. Ia (fgg;) 
ghz;L> 4. Kf;Fw;wg; (jphpNjh\) ghz;L> 5. eQ;R (tpl)g; ghz;L 
vd Ie;njd tFj;Js;shh;. ,d;Dk;> kz;Zz; ntSg;G (ghz;L) 
Neha; xd;WsJ vd;Wk; rpyh; $Wth;. md;wpAk;> FUjpf; Fiwthy;> 
clw;fl;Lfs; nkype;J> cly; tPq;fp> epwkhwp kQ;rs; my;yJ 
ePyepwk; ngw;W> kpFe;j ePh;Ntl;if> mbf;fb kaf;fk; tUjy;> 
kdr;Nrhh;tiljy;> mwpT jLkhwy;> Mz;ik Fiwjy; vd;Dk; 
FwpfisAk; fhl;Lk;. ,e;Nehapid> ePyg;ghz;L> myrg;ghz;L> 
mypKfg; ghz;L vd %tifahf toq;FthuhapDk;> ,it 
ntSg;G (ghz;L) Nehapy; fhZk; FwpFzq;fisNa ngWkhjypd; 
,tw;iwj; jdpj;J $wNtz;Ltjpy;iy.  
jPUk; jPuhjit :P ; PP ; PP ; P  
 ,e;Nehapy;> ,iltplhj the;jp my;yJ fopr;ry; 
cz;lhapDk;> cly; kpFjpahf tPq;fy; (Nrhfk;).  ePh; Ntl;if> 
tpf;fy;> ,Uky; vd;Dk; Fwpfs; Vw;gbDk; ,‡J vspjpy; 
jPuhjjhFk;> md;wpAk; eQ;rhy; gpwe;j ntSg;G NehAk; vspjpy; 
jPuhjhk;.  
nghJf; Fwp Fzq;fs; :; ; ;; ; ;; ; ;  
 ,e;Nehapy;> cly; td;ik ehSf;F ehs; Fiwe;J elf;f 
,ayhik> jiyNehjy;> khh;G Jbj;jy;> fz; mbf;fb ,Usy;> 
jiyRw;wy;> kaf;fKz;lhjy;> %r;Rj; jLkhwy;> grpj;jPf; nfly;> 
czT Ntz;lhik> cz;l rpW czTk; the;jpahjy; Mfpa 
Fwpfs; Njhd;Wk;> ,d;Dk; kpfTk; ntSj;Jj; Njhy; RUq;fy;> 
cly; nkype;J gsgsj;J ntSg;ghjy;> eff; fz;fs; jbj;J 
ntSj;jy;> ehntbj;Jg; Gz;zhjy; my;yJ ehtpd; Nky; Njhiyr; 
rPtpnaLj;jJ Nghd;W rpte;J fhZjy;> my;yJ ehf;Fg; 
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gl;Lj;JzpNghy; tOtOj;J ntSj;Jf; fhzy;> njhz;il fl;ly; 
vd;Dq; FwpfSk; fhZk;.  
 ,e;Neha;> ngz;fSf;Fz;lhapd;> #jfj;jpy; ntspahFk; 
FUjp> jd;dpwk;> vil> msT Kjypad Fiwe;J ntspahFk;> 
rpyUf;F msT fle;J ntspahFk;. Foe;ijfSf;Fk; 
nghpath;fSf;F Kz;lhFk; tapw;Wg;GO Neha;> FUjpaoy; Neha; 
Mfpatw;wpw;Fk; ,e;Neha; JizNehahf mikAk;. moy; 
clNyhh;f;F ,e;Neha; gpwf;Fkhapd;> Kjypy; grpj;jPiaf; nfLj;J> 
cz;l czT nrhpahik> cly; vhpr;ry;> Ruk; cs;sJ Nghd;W 
ntg;Gj; Njhd;wy;> ehntSj;Jr; rptj;jy;> my;yJ gl;Lj; Jzp 
Nghy; tOtOj;jy;> czit nky;yTk; tpOq;fTk; Kbahik rpwpJ 
gpj;j ePh; fye;J mbf;fb the;jpahjy;> tha;f;ifg;G> tapw;W Neha;> 
tapW fLj;J EiuEiuahff; fopjy; vd;Dq; Fwpfs; cz;lhFk;.  
 ,it ehSf;Fehs; kpFe;J nfhz;Nl tUkhapd; clypd; 
FUjpapd; msT> vil> epwk; ahTk; Fiwe;J> cly; kQ;rs; G+j;jJ 
Nghd;whfp kQ;rs; (fhkhiy) Nehapidg; Nghyf;fhzg;gLk;.  Neha; 
ngUfpa epiyapy;> Mahrk;> ,isg;G> ngU%r;R> ngUq;fopr;ry;> 
czit ntWj;jy;> td;ik ,oj;jy;> cly; Cjy; vd;Dq; 
nfhbajhd FwpFzq;fSk; njhlUk;. 
Fw;wk; Kjypa NtWghLfs; :; ; ;; ; ;; ; ;  
 Kd;G Neha; tUtopapy; $wpathW> cly; td;ik Fiwe;J 
grpj;jP Nflile;J> cz;l czT rhpahfr; nrhpahkw; NghFk;. 
cztpd; Nfl;lhy; ,ur FUjpfSf;F Cl;lk; ngwh. mjdhy; 
mitfSf;F NjhYf;F epwj;ijf; nfhLf;Fk; moy; (,uQ;rpj 
gpj;jKk;) nkype;J> epwj;jpYk; vilapYk; Fiwe;J> jPf;Fw;wj;ijg; 
ngUf;fk;.  mjdsthf kw;iwa Fw;wq;fSk; jd;dpiyapy; jphpe;J> 
guTfhypd; td;ikiaf; nfLj;J Nehia cz;lhf;Fk;.  Nehapd; 
td;ik ngUfg; ngUf> IaKk; ngUfp tPf;fk; KjypaitfisAk; 
Jiznfhs;sr; nra;Ak;. 
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MODER ASPECT OF DISEASE 
ANAEMIA 
Other names:  
 Iron poor blood  
 Low blood  
 Tired blood.  
Definition:  
Ancient Greek meaning “without blood”.Anaemia refers to a state 
in which the level of hemoglobin in the blood is below the normal range 
appropriate for age and sex .It is also defined as a qualitative or 
quantitative deficiency of hemoglobin, a molecule found inside red blood 
cells.  
Since hemoglobin normally carries oxygen from the lungs to the 
tissues, Anaemia leads to hypoxia (lack of oxygen) in organs. Since all 
human cells depend on oxygen for survival, varying Anaemia is also 
caused by a lack of iron in the body.  
The clinical features of Anaemia reflect diminished oxygen supply 
to the tissues and depend upon the degree of anaemia, the rapidity of its 
development and the presence of cardio respiratory disease.  
Anemic ranges of hemoglobin:  
 Adult men: < 13.0  
 Non pregnant women: < 12.0  
 Pregnant women: < 11.0  
Grading of Anaemia: 
WHO grades Anaemia according to hemoglobin level as follows, 
 Hb between 10 gm and cut off point for age -Mild  
 Hb between 7 to 10 gm -Moderate  
 Hb under 7 gm -Severe  
 Hb under 5 gm -Very severe. 
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Classification of anaemia:  
1. Morphological classification  
 Normocytic Anaemia  
 Microcytic Anaemia  
 Macrocytic Anaemia  
2. Pathological classification  
 Anaemia due to blood loss  
 Anaemia due to impaired red cell production  
 Anaemia due to increased cell destruction  
Causes of Anaemia:  
• Lack of iron, it B12 and folate  
• Hypoplasia  
• Invasion by malignant cells  
• Blood loss  
• Hemoglobin  
• Hypersplenism  
• The three main causes are  
• Heavy blood loss  
• Lack of RBC production  
• High rates of RBC destruction.  
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IRON DEFICIENCY ANAEMIA 
 Iron deficiency Anaemia is the most common and widespread 
nutritional disorder in the world. The numbers are staggering; 2 billion 
people over 30% of the world’s population are anaemic, many due to iron 
deficiency.  
Structure of the red corpuscles in IDA:  
 In Iron deficiency anaemia, the red blood corpuscles are decreased 
or normal in the number and hemoglobin content of the red blood 
corpuscles is reduced. In the blood smear, the red cells appear pale with a 
large central pale area and many of the RBC appears to be smaller than 
the normal. This type of Anaemia is called “Hypo chromic and 
Microcytic Anaemia”.  
Etiological factors:  
1. Increased physiological requirements  
2. Decreased iron stores  
3. Decreased iron assimilation  
4. Blood loss  
5. Increased demands.  
Pathogenesis:  
IDA develops when the supply of iron to the bone marrow is 
insufficient for the requirements of hemoglobin synthesis. It has been 
pointed out that the body is normally in a state of positive iron balance. 
When a negative balance occurs due to blood loss, increased 
requirements or impaired absorption, the deficit is made good by iron 
mobilized from the tissue stores and an adequate supply of iron for 
hemoglobin formation is maintained. It is only when the tissue stores are 
exhausted and the supply of iron to the marrow for hemoglobin synthesis 
becomes inadequate, hypochromic Anaemia develops.  
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Stage of iron deficiency Anaemia:  
1. Storage iron depletion  
 Iron reserve is small or absent and is characterized by reduced 
serum ferritin or reduced iron concentration in marrow and liver tissue 
.Hemoglobin serum iron, transferritin concentration and saturation are 
within normal limits.  
2. Iron limited erythropoiesis  
 Hb may still be normal but serum iron is low and TIBC increased 
with a low serum ferritin and raised free erythrocyte protoporphyrin 
(FEP). 
3. Iron deficiency Anaemia  
 The flow of iron to erythroid marrow is impaired to cause 
reduction in hemoglobin concentration with a progressive microcytic 
hypo chromic Anaemia associated with the reduced serum iron, 
transferrin saturation and serum ferritin level.  
Symptoms and Signs  
• Pallor of the skin, mucous membrane, palms, nails and conjunctiva.  
• Weakness, Dizziness  
• Headache, Giddiness  
• Breathlessness, Tachycardia  
• Loss of appetite, Constipation  
• Angular stomatitis, Glossitis  
• Pica.  
Complications:  
 Iron deficiency Anaemia may be the present finding in 
gastrointestinal cancer.  
 In patients with heart disease severe Anaemia may precipitate 
angina pectoris or congestive heart failure.  
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 Infections are common in IDA, especially those of the respiratory, 
gastrointestinal and urinary tracts.  
Investigation:  
Hemoglobin level  
Heamatocrit values (PCV, MCV, and MCHC)  
Blood smear study  
Iron binding capacity  
Serum ferritin  
Serum iron  
Fecal occult blood test if present any gastro intestinal disorders.  
Prevention:  
• Cow’s milk consumption  
• Iron fortified cereal and formulas  
• Well balanced diet.  
• Good choices include iron fortified grains and cereals, red meat, 
egg yolk, leafy green vegetables, yellow vegetables and fruits. 
IRON Metabolism: 
 Absorption of iron takes place from almost all parts of the small 
intestine by the following mechanism. A substance called apotransferrin 
secreted by the liver flows in the duodenum. There it binds with free iron 
and iron compound haemoslobin and myoglobin to from transferrin. 
Transferrin binds with receptors of intestinal epithelial cells. Now 
transferring molecule carrying iron is absorbed into the epithelial cells 
and released in the form of plasma transferrin. Ascorbic acid, citric acid, 
amino acids, and sugars in the diet enhance absorption of iron. 
 Storage of excessive iron in the blood is deposited in all cells 
especially in the liver Hepatocytes. A smaller amount being stored in 
reticuoendothelial cells of the bone marrow. In the cell cytoplasm it 
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combines with apoferritin to form ferritin. This iron stored as ferretin is 
called storage iron some iron is stored in as soluble form haemosiderin. 
 The subsequent stages of Fe(iron) absorption are outlined below. 
 Ferrous iron Oxidised Ferric Hydroxide (enter mucosa) 
 Ferric Hydroxide combines with protein (Apoferritin – unstable) 
Ferritin (Stable) 
 Normally, the total body iron is divided into functional and storage 
comportments approximately 80% of the functional from is found in 
Haemoglobin. 
Liver, spleen 
kidneys  
(Storage Fe) 
RBC (Hb Fe) 
Liver, spleen 
kidneys 
(Storage Fe) 
Cellos 
(parenchymal Fe) 
Ferritin and 
Hemosiderin 
from break 
down, of RBC 
Transport iron in 
plasma attached 
to protein 
siderophilin 
level reflects 
storage Fe 
 
 
7% 
Essential Fe for all 
cells not available 
for the Hb 
combination 
20% 58%  15% 
 
IRON STORAGE: 
Tissue stores provide a buffer for events that upset the balance of 
iron turnover between the erythron and macrophages when the rate of red 
cells production exceeds the rate of destruction (Such as occurs following 
acute blood loss) iron is mobilized from stores to satisfy the needs of an 
expanded erythroid effort. When red cell destruction exceeds production 
surplus iron is diverted to stores for later use. Tissue stores of iron exist in 
two related forms. The soluble, readily available storage fraction is 
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known as ferritin, the insoluable more stable fraction is known as 
hemosiderin. 
The lost of Iron from the Body 
 Mainly iron is lost from the body by Desquamation 
 Excessive sweating. 
 About 1 mg of iron is excreted through faeces each day. 
 Whenever bleeding occurs additional quantity of iron is lost. 
 In women, about 20 mg iron per period is lost during menstrual 
cycle. 
Table : Spectrum of Body Iron Content 
State of iron Stored iron Transport iron Functional 
Iron-Deficiency Anaemia Low Low Low 
Iron-Deficient Erythro poiests Low Low Low 
Iron depletion Low Low Low 
Normal Normal Normal Normal 
Iron overload High High Normal 
 
Pharmacological Aspect: 
1) Prophylatic in pregnancy, infancy and childhood, in menstruation 
women in professional blood donars and following gastrectomy. 
2) Therapeutic, in cases of iron deficient intake or decrese absorption. 
(a) Nutritional deticiency due to defiency intake (or) decrease 
absorption 
(b) Anaemia of pregnancy and infancy 
(c) Anaemia due to acute (or) chronic blood loss. 
During pregnancy, women should receive oral iron supplement 
(equivalent to 100mgm of elemental iron daily), prophylactically from the 
four month onwards and this should be continued during the lactation 
period. 
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Prophylactic iron theraphy is also advocated for infants and 
children more so in those with low birth weights. The average dily dose 
ferrous sulphate in the form of syrup (or) paediatric drop varies from 100 
to 200mg. 
Professional blood donors should receive routinely 300mg. ferrous 
sulphate daily to one months after each donation of 500mg. 
Following oral iron, normal, hemoglobin level is usually attained 
within 1-3 months depending mainly on the initial hemoglobin level. It is 
important however to continue with the therapy for 12-20 weeks after the 
hemoglobin level has returned to normal in order to replenish the 
depleted iron stores. 
The response of patient with iron deficiency anaemia to iron 
therapy is quite predictable. The response to oral iron considered 
satisfactory when the hemoglobin level increases by about 1 percent 
(Sahli’s method) per day with rise of atleast 10 percent (1.5g/100 mg of 
blood) with three weeks mos patients respond to oral therapy 
satisfactorily if iron is taken regularly and it is absorbed. Failure of a 
patient to respond to adequate oral iron therapy may be due to. 
1. Incorrect diagnosis 
2. Uncooperative patient who does not take the medication regularly 
3. Continued blood loss at a rate greater than that of regeneration. 
4. Super imposed infection, malignancy, inflammation (or) Uraemia 
which reduced from utilization. 
5. Defective absorption of iron from the gastro intestional treat. 
The pharamacopoeial preparation of iron salts, which are largely 
used in medicine are mostly prepared from sulphate, carbonate and 
perchloride of iron. When these salts are administered in large doses they 
produce poisonous symptoms and may even cause exogenous 
haemosiderosis as a manifestation of chronic poisoining. 
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1) Iron Sulphate (Ferrous Sulphate) – FeSo4 7H2O 
Iron Sulphate is commercially known as green vitriol of copper. It 
forms green monosymmetric crystals efflorescing on exposure  to the 
atmosphere. It is freely soluble in water. It is used in making blue black 
ink and dyes. 
2) Perchloride or iron (Ferric Chloride) – FeCl6  12H2O 
 Perchloride of iron is an extremely deliquescent salt, rapidly 
soluble in water. Locally, it is a powerful irritant, when its watery 
solution is slowly evaporated, below crystals are formed. When dissolved 
in alcohol, it forms a non-official preparation called tinctora ferri per 
chloride (tincture of iron) 
Evaluation of Toxic History: 
 Dose of element iron ingested product name (or) preparation type 
helpful it’s not the total mg of iron salt but rather the amount of elemental 
iron ingested that determines toxicity, predicted toxicity of calculated iron 
load by history. Time since ingestion, history of emesis and if so how 
many times.  
This is a key element of the history. 
Mg/kg toxicity 
 < 20 mg/kg  - non-toxic 
 20 – 60 mg/kg - mild to moderate toxicity 
 >6mg/kg  - severe toxicity 
Iron Toxic Effects: 
1) Direct mucosal cell necrosis 
2) Impairs capillary permeability 
3) Binds/alters lipid membrane of mitochondria 
4) Inhibits kreb’s cycle, anaerobic metabolism 
5) Acts as an electorn sink 
6) Un couples oxidative phosphorylation 
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7) Direct vaso dilator 
8) Free ferric irons are cellular toxic. 
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MATERIALS AND METHODS 
 In this dissertation the Kaandha Chenduram was taken as a 
compound during study.  This drug was prepared as per the specification 
given in Kannusamy Parambarai Vaithiyam Page No.:316 
Collection of the test drug 
Kaantham was bought from a raw drug store at Tirunelveli.  
Karisalai and Lemon was bought from Palayamkottai market.  
Arasampattai and Sottru Katrazhai was collected from Goverment Siddha 
Medical College campur.  Naaval Pattai was collected around the 
Vannarpettai area, Palayamkottai.  The above drugs were identified by 
Gunapadam and Medicinal Botany Department Staff. 
Purification of the Drug: 
 Kaandham pieces was heated with the help of blower.  After 
heating kaandham pieces was soaked in cow’s urine.  This process of 
purification was repeated for 7 times.  Then purified kaandham was made 
into fine mortor by using stone mortar. 
Process: 
Ingredients: 
Kaandham (purified magnetic oxide of Iron). 
Manjal Karisalai Juice (Juice of Eclipta Prostrata). 
Sottru Katrazhai Juice (Juice of Aloe vera). 
Naval Pattai Juice (Juice of Syzygirm cumini bark). 
Arasam Pattai Juice (Juice of Ficus religiosa). 
Elumicham Pazham Juice (Juice of citrus medica). 
 Purified kaandham was ground by using Manjal Karisalai juice for 
4 Saamam (12 hrs). Made into villais and dried.  The villais was placed 
in a mud Pan, covered by using another mud Pan and scaled with day and 
then allowed to dry in sunlight and subjected to putam.  The seal was 
removed on next day and the subjected kaandham was again ground 
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using the same Manjal Karisalai Juice but the grinding tune is only for 
about  3 saamam (9 hrs.). 
 The above said process was repeated using the following saaru 
respectively. 
1) Sottru Katrazhai Saaru 
2) Naaval Pattai Saaru 
3) Arasam Pattai Saaru 
4) Elumicham Pazham Saaru 
After all the above process was completed by using all Juices.  The 
seal was removed and the villai was powdered pressured in an airtight 
container. 
Dose: 
 100 mg. along with honey twice a day after food. 
Rate of administration: 
 Enteral dose 
Indication: 
Paandu 
Thus prepared Kaandha chendhuram was used for the treatment of 
Paandu and analysed by the following methods: 
• Biochemical analysis 
• Pharmacological analysis 
• Heavy metal analysis 
• Qualitative and Quantitative chemical analysis 
• Microbiological analysis 
• Clinical assesments 
• Bio stastical analysis 
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PHYSICO-CHEMICAL STANDARDIZATION 
The standardization parameters of  Kaandha Chenduram  was done 
at Sastra universityThanjavur. 
The tests done are as follows. 
pH at 10% of aqueous solution: 
Five grams of Kaandha Chenduram is weighed accurately and 
placed in clear 100 ml beaker. Then 50 ml of distilled water is added to it 
and dissolved well. Wait for 30 minutes and then apply in to pH meter at 
standard buffer solution of  4.0, 7.0 and 9.2 
Loss on drying@ 1050 C: 
Five gram of Kaandha Chenduram is heated in a hot oven at 1000 
C to constant weight. The percentage of loss of weight was calculated as 
10.35 %. 
Determination of ash value: 
Weighed accurately 2 grams of Kaandha Chenduram in tarred 
platinum or silica dish and incinerate at a temperature not exceeding 
4500C until free from carbon, cooled, and weighed. Calculate the 
percentage of ash as 3.975 with reference to the air dried drug. 
Water soluble ash: 
To the gooch crucible containing to the total ash, added 25 ml of 
water and boiled for 5 minutes. Collected the insoluble matter in a 
sintered glass crucible or on ash less filter paper. Wash with hot water 
and ignite in a crucible for 15 minutes at a temperature not exceeding 450 
0
 C substract the weight of the insoluble matter from the weight of the ash 
the difference of the weight represents the water soluble ash. Calculate 
the percentage of water soluble ash as 305 with reference to the air dried 
drug. 
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Alkalinity as CaCO3 in water soluble ash: 
Five grams of Kaandha Chenduram converted to ash, boiled with 
water filtered. Filtered was tilt rated against 0.1 N of HCl using 
phenophthalin as an indicator. 
Alkalinity of water soluble ash         = X x of acid/ 0.1 x W 
X –Titre value 
W - Weight of material taken 
Alkalinity is given as 1.14 % of 0.1 N of HCl equated to 1 gm. 
Acid in soluble ash; 
Boiled the ash 5 minutes with 25 ml of dilHCl. Collect the 
insoluble matter in gooch crucible on an ash less filter paper wash with 
hot water and ignite. Cooled in a dessicator and weighed. Calculated the 
percentage of acid insoluble ash as 1.96% with reference to the air dried 
drug. 
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BIO – CHEMICAL ANALYSIS OF  
KAANDHA CHENDURAM 
PREPARATION OF THE EXTRACT 
 100 mgs of chenduram is weighed accurately and placed into a 
clean beaker and added a few drops of conc.  Hydrochloric acid and 
evaporated it well.  After evaporation cooled the content and added a few 
drops of conc.  Nitric acid and evaporated it well.  After cooling the 
content add 20 ml of distilled water and dissolved it well.  Then it is 
transferred to 100 ml volumetric flask and made up 100 ml with distilled 
water.  Mix well.  Filter it.  Then it is taken for analysis.  
QUALITATIVE ANALYSIS 
S. NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared extract is 
taken in a clean test tube.  To this 
add 2ml of 4 % ammonium oxalate 
solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
calcium  
2.  TEST FOR SULPHATE: 
2ml of the extract is added to 5% 
barium chloride solution. 
No white 
precipitate is 
formed  
Absence of 
Sulphate 
3.  TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
A white 
precipitate is 
formed  
Indicates the 
presence of 
chloride 
4.  TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl 
No brisk 
effervescence is 
formed 
Absence of 
Carbonate 
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5.  TEST FOR STARCH 
The extract is added with weak 
iodine solution. 
No blue colour is 
formed 
Absence of  
Starch. 
6.  TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and Potassium ferro 
cyanide. 
No blue colour is 
formed  
Indicates the 
absence of 
ferric Iron. 
7.  TEST FOR FERROUS IRON 
The extract is treated with 
concentrated Nitric acid and 
ammonium thiocyanate solution. 
Blood red colour 
is formed 
Indicates the 
presence of 
Ferrous Iron. 
8.  TEST FOR PHOSPHATE 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed 
Absence of 
Phosphate. 
9.  TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed. 
 
Absence of 
Albumin 
10. 
 
TEST FOR TANNIC ACID 
The extract is treated with ferric 
chloride. 
No blue black 
precipitate is 
formed 
Absence of 
Tannic acid. 
11. TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets 
decolourised 
Indicates the 
presence of 
Unsaturated 
compound. 
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12. TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and added 
8-10 drops of the extract and again 
boil it for 2 mts. 
No colour change 
occurs. 
Absence of 
Reducing 
Sugar. 
13. TEST FOR AMINO ACID 
One or two drops of the extract is 
placed on a filter paper and dried it 
well.  After drying, 1% Ninhydrin is 
sprayed over the same and dried it 
well. 
No violet colour is 
formed 
Absence of 
Amino acid 
 
14. TEST FOR ZINC: 
The extract is treated with potassium 
ferro cyanide 
A white 
precipitate is 
formed 
Indicates the 
presence of 
Zinc 
 
Inference: 
 The given sample “Kaandha Chenduram” indicates the presence 
of calcium, Chloride, Ferrous Iron, Unsaturated compound  and 
Zinc. 
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PHARMACOLOGICAL  ANALYSIS 
Pharmacological Analysis of trial medicine: 
Study on the haematinic effect of Kaandha Chenduram on 
Albino rats. To prove its haematinic effect of Kaandha Chenduram an 
attempt was made to study its effect using “Albino rats”. For this 
purpose rats are made anemic by the following procedure. 
Artificially induced iron deficiency: 
 The albino rats taken for this experiment were kept in aluminum 
cages and provided with drinking water and milk, free from iron. The 
administration of the iron preparation under investigation was started 
when the hemoglobin level fall to 5.28 gms /100ml at the beginning of 
the experiments   Hb mg% were determined. 
Study on rats: 
 The albino rats were first divided into 2 equal groups with five rats 
in each group. The first group received Kaandha Chenduram 
20mg/100gm body weight with hot water. The second group received 
normal diet. All the procedures were continued for five weeks in once a 
day the hemoglobin levels of rats were measured for I, II, III, IV, V 
weeks. The result is observed are tabulated in the following chart. 
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STUDY OF HAEMATINIC ACTION 
Sl. 
No. 
 
Drugs 
 
Dose 
Before drug 
Administration 
After Drug 
Administration 
 
Remarks 
Initial 
Reading 
I 
week 
II 
week 
III 
week 
IV 
week 
V 
week 
 
 
1. 
 
 
Control 
(Water) 
 
 
20ml 
5.8 
6.2 
6.0 
6.4 
6.2 
6.5 
5.8 
6.2 
6.0 
6.4 
6.2 
6.5 
5.6 
6.0 
5.7 
6.1 
6.0 
6.2 
5.5 
6.0 
5.6 
6.0 
5.9 
6.1 
5.3 
5.7 
5.3 
5.7 
5.6 
5.8 
5.2 
5.5 
5.1 
5.5 
5.5 
5.6 
 
 
5.8 
 
 
2. 
 
 
Kaandha 
Chenduram 
 
 
20mg 
6 
6.3 
6.7 
6.4 
6.6 
6.9 
6.4 
6.9 
7.0 
6.8 
6.9 
7.1 
7.1 
7.5 
7.9 
7.4 
7.4 
7.9 
7.5 
7.9 
8.1 
7.6 
7.6 
8.2 
8.1 
8.4 
8.6 
8.3 
8.7 
8.9 
9.2 
9.5 
9.7 
9.1 
9.6 
9.8 
 
 
9.6 
 
Result: 
 The trail drug Kaandha Chenduram has significant Haematinic 
action. 
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Anti Microbial Activity of Kaandha Chenduram By Kirby 
Bauer Method 
Aim : 
 To derermine the Antimicrobial activity at Kaandha Chenduram 
Components of Medium: 
 Beef extract  : 300 gms /Lit. 
 Agar    ; 17 gms / Lit. 
 Starch   : 1.5 gms / Lit. 
 Caesin Hydroxlate : 17.5 gms / Lit. 
 pH   : 7.6 
Procedure : 
 The method of anti microbial activity study is ups diffusion 
method. The principle of  antibiotic sensitivity test is simple. Antibiotic 
discs are prepared with known concentration of antibiotic and placed on 
agar plates that has been inoculated with the known micro – organisms. 
The antibiotic diffuses through the agar producing an antibiotic 
concentration, gradient antimicrobial of suspectibility is proportional to 
the diameter of the inhibitory zone around the disc. If the micro – 
organism which grows up to the edge of the disc are resistant to the 
antimicrobial agent. 
 The recommended medium in this method is Muller Hinton Agar. 
Its pH should be between 7.2 – 7.6 and should be poured to uniform 
thickness at 4mm in the petri plate (25ml). 
Methodology  
 Muller Hinton Agar plates are prepared and pseudomonas, vibro 
cholera, E –coli, Bacillus, Klebsiella, Streptococcus is inoculated 
separately. 
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 The prepared discs of antibiotics  Kaandha chenduram are placed 
over the incubated plate using steile forceps and incubated for 24 
hours at 370 celsius. 
 The plates after 24 hours incubation are observed for the zone of 
inhibition. 
Kirby Bauer Antimicrobial Suspectibility Methods 
S.No. Test Drug 
Organisms 
(Cultures) Susceptibility 
Zone 
size 
(mm) 
1  
 
 
Kaandha 
Chenduram 
Escherichia coli Resistant - 
2 Klebsiella Resistant - 
3 Proteus Resistant - 
4 Staphylococcus Sensitive 12mm 
5 Streptococcus Resistant - 
6 Pseudomonas Resistant - 
7 Candida Resistant - 
 
Results : 
 The drug Kaandha Chenduram is sensitive against 
Staphylococcus. 
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Scanning Electron Microscopy (SEM) 
 
A typical SEM instrument, showing the electron column, sample 
chamber, EDS detector, electronics console, and visual display monitors. 
The scanning electron microscope (SEM) uses a focused beam of 
high-energy electrons to generate a variety of signals at the surface of 
solid specimens. The signals that derive fromelectron-sample 
interactions reveal information about the sample including external 
morphology (texture), chemical composition, and crystalline structure 
and orientation of materials making up the sample. In most applications, 
data are collected over a selected area of the surface of the sample, and a 
2-dimensional image is generated that displays spatial variations in these 
properties. Areas ranging from approximately 1 cm to 5 microns in width 
can be imaged in a scanning mode using conventional SEM techniques 
(magnification ranging from 20X to approximately 30,000X, spatial 
resolution of 50 to 100 nm). The SEM is also capable of performing 
analyses of selected point locations on the sample; this approach is 
especially useful in qualitatively or semi-quantitatively determining 
chemical compositions (using EDS), crystalline structure, and crystal 
orientations (using EBSD). The design and function of the SEM is very 
similar to the EPMA and considerable overlap in capabilities exists 
between the two instruments. 
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Fundamental Principles of Scanning Electron Microscopy (SEM) 
Accelerated electrons in an SEM carry significant amounts of 
kinetic energy, and this energy is dissipated as a variety of signals 
produced byelectron-sample interactions when the incident electrons are 
decelerated in the solid sample. These signals include secondary electrons 
(that produce SEM images), backscattered electrons (BSE), diffracted 
backscattered electrons (EBSD that are used to determine crystal 
structures and orientations of minerals), photons (characteristic X-
rays that are used for elemental analysis and continuum X-rays), visible 
light (cathodoluminescence--CL), and heat. Secondary electrons and 
backscattered electrons are commonly used for imaging samples: 
secondary electrons are most valuable for showing morphology and 
topography on samples and backscattered electrons are most valuable for 
illustrating contrasts in composition in multiphase samples (i.e. for rapid 
phase discrimination). X-ray generation is produced by inelastic 
collisions of the incident electrons with electrons in discrete ortitals 
(shells) of atoms in the sample. As the excited electrons return to lower 
energy states, they yield X-rays that are of a fixed wavelength (that is 
related to the difference in energy levels of electrons in different shells 
for a given element). Thus, characteristic X-rays are produced for each 
element in a mineral that is "excited" by the electron beam. SEM analysis 
is considered to be "non-destructive"; that is, x-rays generated by electron 
interactions do not lead to volume loss of the sample, so it is possible to 
analyze the same materials repeatedly. 
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SEM IMAGE OF KAANDHA CHENDURAM IN 
DIFFERENT MAGNIFICATION 
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FOURIER TRANSFORM INFRARED SPECTROSCOPY 
Fourier transform infrared spectroscopy (FTIR)[1] is a 
technique which is used to obtain an infrared spectrum of absorption, 
emission, photoconductivity or Raman scattering of a solid, liquid or gas. 
An FTIR spectrometer simultaneously collects spectral data in a wide 
spectral range. This confers a significant advantage over a dispersive 
spectrometer which measures intensity over a narrow range of 
wavelengths at a time. FTIR has made dispersive infrared spectrometers 
all but obsolete (except sometimes in the near infrared), opening up new 
applications of infrared spectroscopy. 
The term Fourier transform infrared spectroscopy originates from 
the fact that a Fourier transform (a mathematical process) is required to 
convert the raw data into the actual spectrum. For other uses of this kind 
of technique, see Fourier transform spectroscopy. 
Conceptual introduction 
An FTIR interferogram. The central peak is at the ZPD position 
("Zero Path Difference" or zero retardation) where the maximum amount 
of light passes through the interferometer to the detector. 
The goal of any absorption spectroscopy (FTIR, ultraviolet-visible 
("UV-Vis") spectroscopy, etc.) is to measure how well a sample absorbs 
light at each wavelength. The most straightforward way to do this, the 
"dispersive spectroscopy" technique, is to shine a monochromatic light 
beam at a sample, measure how much of the light is absorbed, and repeat 
for each different wavelength. (This is how UV-Vis spectrometers work, 
for example.) 
Fourier transform spectroscopy is a less intuitive way to obtain the 
same information. Rather than shining a monochromatic beam of light at 
the sample, this technique shines a beam containing many frequencies of 
light at once, and measures how much of that beam is absorbed by the 
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sample. Next, the beam is modified to contain a different combination of 
frequencies, giving a second data point. This process is repeated many 
times. Afterwards, a computer takes all these data and works backwards 
to infer what the absorption is at each wavelength. 
The beam described above is generated by starting with a 
broadband light source—one containing the full spectrum of wavelengths 
to be measured. The light shines into a Michelson interferometer—a 
certain configuration of mirrors, one of which is moved by a motor. As 
this mirror moves, each wavelength of light in the beam is periodically 
blocked, transmitted, blocked, transmitted, by the interferometer, due to 
wave interference. Different wavelengths are modulated at different rates, 
so that at each moment, the beam coming out of the interferometer has a 
different spectrum. 
As mentioned, computer processing is required to turn the raw data 
(light absorption for each mirror position) into the desired result (light 
absorption for each wavelength). The processing required turns out to be 
a common algorithm called the Fourier transform (hence the name, 
"Fourier transform spectroscopy"). The raw data is sometimes called an 
"interferogram". 
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FTIR Analysis of Kaandha Chenduram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
~2.SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 100.0 2000 96.9 600 
3916.8  80.6   3820.3  80.4   3470.1  55.7   2930.1  79.2   2363.7  65.6    
2344.0  68.9   1870.1  92.2   1625.0  94.2   1072.1  3.1    794.5   31.2    
691.6   83.4   563.1   42.9    
END 12 PEAK(S) FOUND 
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 Infrared Absorption 
Frequencies 
Stretching Vibrations 
(Functional Class) 
Bending Vibrations 
(Functional Class) 
563.1 C–Cl stretch  (alkyl 
halides) 
Or 
C-Br stretch  (alkyl 
halides) 
 
691.6  NH2 & N-H wagging 
(shifts on H-bonding) 
(Amines) 
794.5 C-Cl stretch  (alkyl 
halides) 
(out-of-plane bending) 
(Alkenes) 
Or 
Aromatic C-H Bending  
1072.1 C-N (Amines)  
1625  NH2 scissoring (1°-
amines) (Amines) 
1870.1 3-membered cyclic – 
1850 (Ketone) 
 
2344 2280-2440 cm-1 (med 
& shp) (Phosphorous 
Functions) 
 
2363.7 Si-H silane strong 
(Silicon Functions) 
 
2930.1 CH3, CH2 & CH 
2 or 3 bands (Alkanes) 
 
3470.1 O-H (H-bonded), 
usually broad 
(Alcohols & Phenols) 
 
3820.3 Amide N-H Stretch. 
(As with amines, an 
amide produces zero to 
two N-H absorptions 
depending on its type.) 
 
3916.8 Amide N-H Stretch  
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GEO CHEMICAL ANALYSIS 
ICP - OPTICAL EMISSION SPECTROMETRY PRINCIPLE 
ICP, abbreviation for Inductively Coupled Plasma, is one method 
of optical emission spectrometry. When plasma energy is given to an 
analysis sample from outside, the component elements (atoms) are 
excited. When the excited atoms return to low energy position, emission 
rays (spectrum rays) are released and the emission rays that correspond to 
the photon wavelength are measured. The element type is determined 
based on the position of the photon rays, and the content of each element 
is determined based on the rays' intensity 
Analytical Chemical Features of ICP-OES 
The following features of ICP-OES distinguish it from atomic 
absorption spectrometer used for similar purposes.  
1. Simultaneous, sequential analysis of multiple elements possible 
2. Wide linear region of analytical curve 
3. Few chemical interference or ionization interference, making analysis 
of high-matrix samples possible 
4. High sensitivity (low limit of detection for majority of elements is 
10ppb or lower) 
5. High number of measurable elements - elements that are difficult to 
analyze in atomic absorption spectrometry such as Zr, Ta, rare earth, P 
and B can be easily analyzed 
6. Stable 
Equipment 
Equipment for ICP optical emission spectrometry consists of a 
light source unit, a spectrometer, a detector and a data processing unit. 
There are several types of equipment based on differences in the 
spectrometer and the detector. The most common type is shown in 
Figure1.  
 
130 
 
1) Sequential type 
A spectrometer with a Czerny-Turner monochrometor, and a 
detector with a photomultiplier is most common for this type. With this 
equipment, programmed wavelength of the spectrometer is consecutively 
varied to measure multiple elements. This causes rather long measuring 
time, however, with its high resolution spectrometer, it is favorable for 
measurement of high-matrix samples. 
 
Figure 1: Sequential Type ICP-OES 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM,CHENNAI-36 
PERKIN ELMER OPTIMA 5300DV ICP-OES 
Analyte   Mean 
As193.696   BDL 
Bi 306.772   05.172 mg/L 
Cd 226.502                       BDL 
Cu 324.754   03.415 mg/L 
Co 228.616   07.181 mg/L 
Fe 238.204   878.125 mg/L 
Hg253.652                       BDL 
Ni 58.693   BDL 
Pb 230.204                      BDL 
Sb 206.833   26.372 mg/L 
Zn213.856   32.154 mg/L 
     BDL=Below  detection limit 
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TOXICOLOGICALANALYSIS 
ACUTE TOXICITY STUDY OF KAADHA CHENDURAM 
ANIMAL USED FOR THE STUDY: 
Wister albino rats breed in the animal house attached to the Post 
Graduate Pharmacology Department, Govt. Siddha Medical College, 
Palayamkottai were used. 
Sex: 
 Animals of both sex were used. 
Weight: 
Animals weighing 100-120gms were selected. 
Food and water: 
 The animals were maintained with standard laboratory pellet food 
and water ad-Libitum. 
Preparation of Animals: 
 The animals were randomly selected and were marked with picric 
acid on for and kept in their cages for five days prior to dosing, to allow 
acclimatization to the laboratory conditions. 
Separation of Animals in Groups: 
 10 rats were divided into 5 groups each consisting of 2 rats, one 
group is kept as control group by giving water alone. 
Dose Levels: 
 The following dose levels were arbitrarily fixed by persuming 
range of least toxic to high toxic doses. 
 I Group - 40 mg/kg body weight of animal 
 II Group - 80 mg/kg body weight of animal 
 III Group - 160 mg/kg body weight of animal 
 IV Group - 320 mg/kg body weight of animal 
 V Group - 640 mg/kg body weight of animal 
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Route of Administration: 
 The drug was administered orally. 
Test Dose Preparation: 
 The preparation was done in such a way as 1ml of the suspension 
contained 40mg of kaandha chenduram and administered as given above 
in each group. The drug was administered once on the day of the 
experiment and there after other 24 hour parameters were used. 
Experimental set up: 
 All the five groups were fasted for over night prior to dosing. 
Following the period of fasting the animals were weighed and test 
substance was administered through “Rat oral intubation tube”. 
After the administration of the test drug, food was withheld for 1 to 
2hrs. 
OBSERVATION: 
 The following parameters were noted. 
Central effects: 
I. Stimulation  
 Hyper activity  
 Piloerection 
 Twitching 
 Rigidity 
 Irritability 
 Jumping 
 Colonic convulsion 
 Tonic convulsion 
II. Depression 
 Ptosis 
 Sedation 
 Sleep 
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 Loss of traction 
 Loss of Pinna reflex 
 Ataxia 
 Catatonia 
 Loss of muscle tone 
 Analgesia 
Autonomic Effect: 
 Straub’s   tail flicking 
 Laboured respiration 
 Cyanosis 
 Blanching 
 Reddening 
 Abnormal secretions 
At the end of 24 hrs, the number of animals dead in each group was 
noted and the approximate LD50 was determined. The animals were 
morphologically examined for any toxic symptoms. 
Result: 
During the acute toxicity study none of the albino rat was found 
dead. During morphological examination of the rats no toxic symptoms 
were found. This proves the safety of the Kaandha Chenduram. 
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CLINICAL ASSESMENT 
Design of  Study : 
Open Clinical trial phase II - B 
An open clinical trial on Paandu Noi was carried out at the siddha 
medical college Hospital Palayamkottai in order to assess the efficaccy of 
kaandha chendhuram.  
 40 cases with clinical signs and symptoms of Paandu Noi of both 
sexes with clinical signs sexes with age ranging from 20 to 70 years were 
selected and treated.  
Case Selection : 
 The patients were selected paandu Noi according to the following 
criteria.  
Including criteria : 
• 7 to 10 gms of haemoglobin 
• Loss of appetite  
• Palpitation  
• Dyspnoea on exertion  
• Pallor of conjunctiva and nail beds.  
• Emasciation  
• Fatigue  
Excluding criteria : 
• Chronic liver disease. 
• Chronic renal disease. 
• Thalassemia. 
• Myxedema.  
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Clinical pathological Examinations : 
Blood Test 
• Total count  
• Differential count.  
Poymorphs 
Lymphocytes  
Eosinophils  
• Haemoglobin  
• Erythrocyte sedimentation Rate.  
• PCV 
• MCV 
• Blood sugar  
• Blood urea. 
• Serum cholesterol.  
Urine Examination :    Motion Examinations : 
 Albumin      Ova 
 Sugar       Cyst  
 Deposit      Occult blood.  
Line of Treatment : 
 The trial drug kaandha chenduram was administered orally in a 
dose of 100 mg two times a day with honey after meals.  
Diet and medical advice to consume  
• Iron rich diet.  
• Green leafy vegetables. 
• Meat 
• Fruits. 
• Egg. 
• Cereals. 
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• Fresh vegetables and fruits.  
• Increased dietary fibre  
• Food high in vitamin C like fruits like tomatoes helps the body 
absorbing iron from food.  
Observations: 
 The haematinic action of Kaandha chenduram was observed on the 
basis of the relief of signs and symptoms which was further confirmed by 
routine lab investigation.  
 Among the complaints of Paandu Noi, dyspnoea on exertion were 
reduced significantly within 15 days and other symptoms gradually 
subsided during the remaining course of treatment.  
 The clinical improvements were recorded every seven days in 
outpatients department and daily in the inpatient department.  The 
opinion and guidance of the gunapadam department. Staff were sought 
periodically The laboratory investigations were done for the Patients 
before and after treatment.  For all the patient prognosis was noted and 
recorded. 
Result : 
 Among the 40 cases< 34 cases (85%) showed good response, 5 
cases (12.5%) showed fair response and 1 case (2.5%) showed poor 
response.  
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Gender wise age distribution of the subjects : 
Age group 
(years) 
Males Females Total 
No % No % No % 
20 – 29 2 28.6 2 6.1 4 10.0 
30 – 39 2 28.6 11 33.3 13 32.5 
40 – 49 1 14.3 6 18.2 7 17.5 
50 – 59 1 14.3 8 24.2 9 22.5 
60 – 69 1 14.3 6 18.2 7 17.5 
Total 7 100.0 33 100.0 40 100.0 
 
Response of the drug to the Patient  
S.No Response grade No of persons percentage 
1 Good 34 85.0 
2 Fair 5 12.5 
3 Poor 1 2.5 
 Total 40 100.0 
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BIO-STATISTICAL ANALYSIS 
Description of the study subjects 
The clinical trials of the study were described according to their 
sex and age. The gender of the clinical trials were compared in respect of 
their age as follows.  
Table 1 Gender wise age distribution of the subjects 
Age group  
(years) 
Males Females Total 
No % No % No % 
20-29 2 28.6 2 6.1 4 10.0 
30-39 2 28.6 11 33.3 13 32.5 
40-49 1 14.3 6 18.2 7 17.5 
50-59 1 14.3 8 24.2 9 22.5 
60-69 1 14.3 6 18.2 7 17.5 
Total 7 100.0 33 100.0 40 100.0 
 
 The above table 1 states the gender wise age distribution of the 
clinical trials. The participation of the males was 17.5% and the same of 
the female was 82.5%. 
Table 2: Comparison of age between the gender 
Gender 
 
Age (years) Differences of 
means 
't' 
 
d.f 
 
Significance 
 
Mean S.D 
Males 40.0 15.1 5.3 years 
 
1.047 
 
38 
 
P>0.05 
 
Females 45.3 11.6 
 
The above table 2 compares the ages of males and females. The 
mean age of male was 40.0 ±15.1 and the female was 45.3 ± 11.6. The 
difference of age was 5.3 years and the same was not statistically 
significant (P> 0.05). 
Gender wise the ages of the study subjects was not statically 
significant (P>0.05). 
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Assessment of the Anaemia before and after treatment 
The anaemia was assessed on the Heamoglobin level before and 
after treatment. 
Table 3 Heamoglobin level before and after treatment 
Level of HB 
(gm) 
Before After 
 No % No % 
5,0-7.5 1 2.5 - - 
7.5-10.0 30 75.0 7 17.5 
10.0-12.5 9 22.5 32 80.0 
12.5-15.0 - - 1 2.5 
Total 40 100.0 40 100.0 
 
The above table 3 states that 75% of the clinical trials of paandu 
cases haemoglobin level was 7.5 - 10 gms. Among the remaining 22.5% 
were in between 10 - 22.5 and the 2.5% women had their heamoglobin 
levels were 10.0 -12.5 and 5 - 7.5 gms respectively. After the treatment 
80 % of the patients Hb level was in between 10 - 12.5 gms. The 
remaining 17.5 % and 2.5% of the patients Hb level were in between 7.5 
- 10 gms and 12.5 - 15 gms respectively. 
Effectiveness of the drug in the improvement of Hb 
The effectiveness of the drug was assessed by calculating the 
mean Hb level before and after treatment.  
Table 4: Hb level before and after treatment 
Variable 
Before After Differences 
't' d.f Significance 
Mean S.D Mean S.D Mean S.D 
Hb 9.13 0.9 10.8 0.9 1.7 0.8 13.740 39 PO.001 
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The mean Hb level before and after treatment of the paandu 
patients was given in the above table 4. The mean Hb levels before and 
after the treatment were 9.13 ± 0.9 and 10.8 ± 0.9 respectively. After 
treatment the Hb level was improved from before treatment as 1.7 ± 0.8 
in an average. The improvement was statistically very highly significant 
(P<0.001). 
Response of the drug 
The response of the drugs was assessed by considering other 
factors related to the improvement of Hb level and graded as good, fair 
and poor. 
Table 5: Response of the drug to the Patient 
S.No Response grade No. of persons Percentage 
1 Good 34 85.0 
2 Fair 5 12.5 
3 Poor 1 2.5 
 Total 40 100.0 
 
The above table 5 shows the response of the drug. The response 
of the drug in the improvement of haemoglobin level was outstanding 
(85%). The fair and poor responses were 12.5% and 2.5% respectively. 
The drug was significantly improved the level of Hb after the 
administration of the drug to the paandu patients. 
Discussions 
The participants of the clinical study were not significantly differed 
in respect of their age between the gender (P>0.05). 
The drug Kaandha chenduram was very high significantly 
improved the haemoglobin level of the patients from 9.1 ± 0.9 gms to 
10.8 ± 0.9 after treatment. The above improvement was attributed to 
effectiveness of drug in controlling paandu. 
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The outstanding (85%) good response to the patients was also 
attributed to the effective of the drugs. 
  
KAANDHA CHENDURAM
Response of The Drug in Percentage
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
Good
85
Pe
rc
en
ta
ge
 
 
 
 
 
 
Fair Poor
12.5
2.5
 
 
VELLALLIPOO CHOORANAM
Response of The Drug in Percentage
0
10
20
30
40
50
60
70
80
Good
77.5
Pe
rc
en
ta
ge
 
 
 
 
 
Fair Poor
17.5
5
 
143 
 
RESULTS AND DISCUSSION 
 The drug “Kaandha Chendhuram was selected in this 
dissertation to study its therapeutic efficacy in the management of 
Paandu Noi.  
 According to siddha texts the disease Paandu Noi (anaemia) is 
caused by the increase of azhal kutram.  It leads to nutritional deficiency 
in body, dyspnoea on exertion, anorexia, giddiness, fatigue, palpitation.  
 ‘MNk jhd; mj;jpRuk; ghz;L Nrhif 
  Mokhd tplRuKk; gpuNkfe;jhd; 
  NghNkjhd; fhkhiy  
  ehNkjhd; nrhd;NdhNk gpj;jf;$W” 
mfj;jpah; ghly;> Neha; ehly; Neha; ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  
Kjy; ehly; jpul;L g.vz; : 177; ; ; ;; ; ; ;; ; ; ;  
 From the review of literatures it is inferred that the constituents of 
the drug “Kaandha Chendhuram” ie kaandham selected for this study 
process possess astringent, sour, bitter taste and hot property.  
 According to Panchapoodham theory astringent sour and bitter 
taste are made up of  
 Astringent - Earth + air 
 Sour  - Earth + Fire 
 Bitter  - Air + Space  
Bitter and astringent tastes neutralize the pitha humour.  
  ‘FUjp Rj;jpahf;Fk;  
   nfhba gpj;jk; Nghf;Fk; 
   .................. 
  Fsph;e;j Jth;g;gpd; Ntiy.” 
rpj;j kUj;Jthq;fr; RUf;fk; gf;fk; vz; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; - 40 
All these factors seem to neutralize the vitiated pitha humour.  
All the patients were given kaandha chendhuram 100mg bd with 
honey as vehicle (Anupanam)  This honey acts on pitha humour, thereby 
144 
 
assist in reducing the increased thosam and improving the efficacy of the 
drug.  This has been stated in siddha literature as  
 ‘murd; Kjy;Nth iuAkhl;L tpj;jhNy  
  gpurj; jpdhw;Nghk; gpzp” 
- Fzghlk; rPt tFg;G; P ;; P ;; P ;  
 This explanation is arrived on the basis of the analysis of the 
gunapadam aspects of the drug which correlates with the pharmacological 
analysis and clinical assessments.  
 According to the physio-chemical analysis it is indicated that the 
nature of the drug is amorphous quality due to the high acid insoluble 
ash value and the moisture content is low.  
 The Biochemical analysis shows the presence of Calcium, 
Chloride and ferrous iron.  The presence of ferrous form of iron is 
essential for synthesis of Haemoglobin. Odema will be present in 
advanced stage of anemia calcium and chloride is necessary for 
maintenance of acid base balance and water balance  
 The Pharmacological studies show that the drug has got 
significant haematinic activity. 
 Microbiological analysis of Kaandha chendhuram shows 
sensitivity for stephylococcus. 
 According to scanning  Electron microscopic result in the picture 
of Kaandha chendhuram particle size is noted in nanometer. The average 
value of particle size is 69.6 nm. 
 It is appeared to contain nano sized particles of Oxidised elements 
ranging from 124nm to 61.0nm indicating the action of drug at cellular 
and sub- cellular levels. Our medicine particles are in Oxygen deficient 
state and clearly identifiable function of particles in nanometer size range. 
These properties might impact the therapeutic property (Journal of Nano 
Particle Research Vol – II Pg. No. 655-664). 
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 According to the Fourier Transform Infra red spectroscopy, it 
showed the functional  groups related to Kaandha chendharam is present. 
 Geo chemical analysis using Inductively coupled plasma – optical 
emission spectroscopy shows that biologically important transition 
elements or the elements like  copper, iron, cobalt, zinc are present in 
mg/l.  
The presence of iron is essential for synthesis of Hb. 
Zinc enhances the absorbtion of iron. 
Administration of stimulates the production of the hormone. 
Erythropoietin which promotes erythropoiesis. 
Copper is necessary for transportation of iron.  
The other toxic metal ions like  Mercury, Cadmium, Lead and  
Arsenic are absent or not detective inthe drug. 
Acute toxicological study exhibit the drug upto 640 mg/ kg body 
weight of albino rats  produce no adverse or toxic effects. 
 In the clinical assessments, 40 Patients were selected. Out of these 
34(85%) of cases showed  good response, 4(12.5%) cases showed fair  
response and 2(2.5%) of the cases showed poor  response. The 
improvement was proved by the alleviation of signs and symptoms 
present after treatment. 
 Bio – stastical  analysis shows that the drug is efficient in 
controlling Paandu Noi. 
 During clinical trial the Patients tolerated the drug well and showed 
no adverse  reaction. 
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SUMMARY 
 The tested drug “Kaandha Chendhuram” was selected for this 
dissertation work from the text “ Kannusamy Parambarai Vaithiyam” 
page No. 317. 
 The drug Kaandha Chendhuram has been selected for the study to 
establish its efficacy in treating Paandu Noi. 
 Bio chemical analysis revealed the presence of Iron, Calcium and 
Chloride and their biological significance has been discussed.  
 In anti – microbial studies, the drug was sensitive against 
staphylococcus. 
 In scanning electron microscopic studies, the drug is appeared to 
contain nano sized paricles  of oxidised elements. 
 In  Fourier Transform Infrared Spectroscopy study, it is showed 
that the functional  group related  to Kaandha Chendhuram present. 
 Geo chemical analysis  shows that the presence of biologically 
important  transition elements  mainly Iron necessary for  haematinic 
action  and other toxic elements in  below detection  limit.  
 Acute Toxicological study shows  no adverse  or toxic effects.  
 Clinical evaluation was carried out on 40 patients suffering from 
Paandu Noi in Govt Siddha Medical College, Palayamkottai, revealed 
that the patient treated with Kaandha Chendhuram had obtained excellent  
improvement. 
 Bio – stastical analysis also proved that this drug has got  
Significant effect  in treating Paandu Noi. 
 No adverse  reaction were noted during the treatment.  
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CONCLUSION  
 The above said studies reveal that “Kaandha Chendhuram”  had 
showed  Excellent result in relieving the signs and symptoms of the 
Patients suffering from Paandu Noi. 
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DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 1 OP.NO: 50790 NAME: Faritha AGE/SEX: 45/F OCCUPATION: Coolie 
FROM: 06/07/2012 TO: 10/08/2012 NO. OF DAYS TREATED: 35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea with Palpitation loss of appclite 
and tiredness present since 1 year. 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm     Albumin: Nil TC: 8400 cells/cumm     Albumin: Nil 
DC: P-63%   L-35%   E-2% Sugar: Nil DC:  P-60%   L-37%   E-3% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: 1-2 epithelial 
cells 
ESR:  ½ hr: 5mm Deposits: NAD 
          1 hr: 15mm MOTION           1 hr: 10mm MOTION 
Hb: 60% (9gms%) Ova: - Nil Hb: 67% (10gms%) Ova:  - Nil 
MCV: 82cumm Cyst: - Nil MCV:  - 90cumm Cyst:  - Nil 
PCV: 32% Occult Blood: -Nil PCV:   - 44% Occult Blood: Nil 
Sugar(R): 101mgs%  Sugar(R): 96mgs%  
Urea: - 18 mgs %  Urea: - 22mgs %  
Cholesterol: 221mgs%  Cholesterol: 210mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 2 OP.NO: 51702 NAME: Selvi AGE/SEX: 38/F OCCUPATION: Coolie 
FROM: 09/07/2012 TO: 15/08/2012 NO. OF DAYS TREATED: 37 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea with palpitation, tiredness, 
loss of appetite present since 8 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9500 cells/cumm Albumin: Nil TC: 10200 cells /cumm Albumin: Nil 
DC:  P-60%    L-33%   E-7% Sugar: Nil DC:  P-56%   L-57%  E-7% Sugar: Nil 
ESR:  ½ hr: 5mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 10mm MOTION           1 hr: 8mm MOTION 
Hb: 61%  (9.7gms%) Ova:   - Nil Hb: 69% (10.3gms%) Ova:   - Nil 
MCV:  - 84 cumm Cyst:   - Nil MCV:  -  88 cumm Cyst:   - Nil 
PCV:  - 34% Occult Blood: -Nil PCV:   -  40% Occult Blood: Nil 
Sugar(R): 82mgs%  Sugar(R): 94mgs%  
Urea:  22 mgs%  Urea: 20 mgs%  
Cholesterol: 168mgs%  Cholesterol: 176mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 3 OP.NO: 51701 NAME: Sugirtha AGE/SEX: 28/F OCCUPATION: Coolie 
FROM: 09/07/2012 TO: 14/08/2012 NO. OF DAYS TREATED: 36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea with Palpitation loss of appclite 
and tiredness present since 7 months. 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells/cumm     Albumin: Nil TC: 10200 cells/cumm     Albumin: Nil 
DC: P-70%   L-28%   E-2% Sugar: Nil DC:  P-71%   L-28%   E-1% Sugar: Nil 
ESR:  ½ hr: 30mm Deposits: 2-3 pus cells ESR:  ½ hr: 10mm Deposits: NAD 
          1 hr: 65mm MOTION           1 hr: 20mm MOTION 
Hb: 51% (7.5gms%) Ova: - Nil Hb: 72% (10.8gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -  Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -  Occult Blood: Nil 
Sugar(R): 75mgs%  Sugar(R): 70mgs%  
Urea: - 45 mgs %  Urea: - 40mgs %  
Cholesterol: 169 mgs%  Cholesterol: 160mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 4 OP.NO: 55788 NAME: Gandhimathi AGE/SEX: 41/F OCCUPATION: Coolie 
FROM: 23/07/2012 TO: 27/08/2012 NO. OF DAYS TREATED:  34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea with palpitation, hair fall and 
tiredness present since 3 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7800 cells/cumm Albumin: Nil TC: 7900 cells /cumm Albumin: Nil 
DC:  P-64%    L-34%   E-2% Sugar: Nil DC:  P-64%   L-35%  E-1% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 16mm MOTION           1 hr: 4mm MOTION 
Hb: 67%  (10gms%) Ova:   - Nil Hb: 72% (10.8gms%) Ova:   - Nil 
MCV:  - Cyst:   - Nil MCV:  -   Cyst:   - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 68mgs%  Sugar(R): 69mgs%  
Urea:  26 mgs%  Urea: 20 mgs%  
Cholesterol: 159mgs%  Cholesterol: 156mgs%  
   Response:                                  Fair 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 5 OP.NO: 56458 NAME: Subbulakshmi AGE/SEX: 48/F OCCUPATION: Coolie 
FROM: 25/07/2012 TO: 31/08/2012 NO. OF DAYS TREATED:  36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
and tiredness present since 5 months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9000 cells/cumm     Albumin: Nil TC: 9200 cells/cumm     Albumin: Nil 
DC: P-61%   L-36%   E-3% Sugar: Nil DC:  P-61%   L-36%   E-3% Sugar: Nil 
ESR:  ½ hr: 5mm Deposits: NAD ESR:  ½ hr: 10mm Deposits: NAD 
          1 hr: 10mm MOTION           1 hr: 20mm MOTION 
Hb: 62% (9.3gms%) Ova: - Nil Hb: 71% (10.6gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 140mgs%  Sugar(R): 130mgs%  
Urea: - 24mgs %  Urea: - 22mgs %  
Cholesterol: 201mgs%  Cholesterol: 200mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 6 OP.NO: 57684 NAME: Selvi AGE/SEX: 25/F OCCUPATION: Coolie 
FROM: 30/07/2012 TO: 03/09/2012 NO. OF DAYS TREATED:   34days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 5 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 10500 cells/cumm Albumin: Nil TC: 10200 cells /cumm Albumin: Nil 
DC:  P-57%    L-35%   E-8% Sugar: Nil DC:  P-61%   L-35%  E-4% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: NAD ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 20mm MOTION           1 hr: 16mm MOTION 
Hb: 61%  (9.1gms%) Ova:   - Nil Hb: 78% (11.7gms%) Ova:   - Nil 
MCV:  - Cyst:   - Nil MCV:  -   Cyst:   - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 89mgs%  Sugar(R): 102mgs%  
Urea:  12 mgs%  Urea: 24 mgs%  
Cholesterol: 163mgs%  Cholesterol: 182mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 7 OP.NO: 57685 NAME: Sundari AGE/SEX: 35/F OCCUPATION: Coolie 
FROM: 30/07/2012 TO: 04/09/2012 NO. OF DAYS TREATED:     35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 7 
months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells/cumm     Albumin: Nil TC: 10100 cells/cumm     Albumin: Nil 
DC: P-68%   L-28%   E-4% Sugar: Nil DC:  P-70%   L-28%   E-2% Sugar: Nil 
ESR:  ½ hr: 25mm Deposits: NAD ESR:  ½ hr: 10mm Deposits: NAD 
          1 hr: 50mm MOTION           1 hr: 20mm MOTION 
Hb: 58% (8.7gms%) Ova: - Nil Hb: 78% (11.5gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 102mgs%  Sugar(R): 100mgs%  
Urea: - 29mgs %  Urea: - 20mgs %  
Cholesterol: 209mgs%  Cholesterol: 204mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 8 OP.NO: 58744 NAME: Mrs. Sofia  AGE/SEX: 41/F OCCUPATION: Coolie 
FROM: 02/08/2012 TO: 06/09/2012 NO. OF DAYS TREATED:   35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 7 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9700 cells/cumm Albumin: Nil TC: 10200 cells /cumm Albumin: Nil 
DC:  P-51%    L-38%   E-5% Sugar: Nil DC:  P-55%   L-40%  E-5% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 4mm MOTION           1 hr: 8mm MOTION 
Hb: 61%  (9.1gms%) Ova:   - Nil Hb: 80% (12gms%) Ova:   - Nil 
MCV:  90 cumm Cyst:   - Nil MCV:  98 cumm   Cyst:   - Nil 
PCV:  28%  Occult Blood: -Nil PCV:   42%  Occult Blood: Nil 
Sugar(R): 87mgs%  Sugar(R): 92mgs%  
Urea:  25 mgs%  Urea: 24 mgs%  
Cholesterol: 165mgs%  Cholesterol: 182mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 9 OP.NO: 60801 NAME: Kamalam AGE/SEX: 45/F OCCUPATION: Coolie 
FROM: 09/08/2012 TO: 13/09/2012 NO. OF DAYS TREATED:   34  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm     Albumin: Nil TC: 8400 cells/cumm     Albumin: Nil 
DC: P-63%   L-35%   E-2% Sugar: Nil DC:  P-60%   L-37%   E-3% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: NAD ESR:  ½ hr: 5mm Deposits: NAD 
          1 hr: 15mm MOTION           1 hr: 10mm MOTION 
Hb: 60% (9gms%) Ova: - Nil Hb: 64% (9.5gms%) Ova:  - Nil 
MCV:  83 cumm Cyst: - Nil MCV:  90 cumm Cyst:  - Nil 
PCV:  32% Occult Blood: -Nil PCV:   38% Occult Blood: NAD 
Sugar(R): 101mgs%  Sugar(R): 96mgs%  
Urea: - 24mgs %  Urea: - 21mgs %  
Cholesterol: 221mgs%  Cholesterol: 210mgs%  
   Response:                                    Fair 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 10 OP.NO: 64118 NAME: Janani AGE/SEX: 33/F OCCUPATION: Coolie 
FROM: 21/08/2012 TO: 25/09/2012 NO. OF DAYS TREATED:       35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 5 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9500 cells/cumm Albumin: Nil TC: 10200 cells /cumm Albumin: Nil 
DC:  P-60%    L-33%   E-7% Sugar: Nil DC:  P-56%   L-37%  E-7% Sugar: Nil 
ESR:  ½ hr: 5mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 10mm MOTION           1 hr:   8mm MOTION 
Hb: 67%  (10gms%) Ova:   - Nil Hb: 74% (11.1gms%) Ova:   - Nil 
MCV:  - Cyst:   - Nil MCV:  -   Cyst:   - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 82mgs%  Sugar(R): 94mgs%  
Urea:  22 mgs%  Urea: 20 mgs%  
Cholesterol: 168mgs%  Cholesterol: 176mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 11 OP.NO: 65202 NAME: Vasantha AGE/SEX: 42/F OCCUPATION: Coolie 
FROM: 24/08/2012 TO: 28/09/2012 NO. OF DAYS TREATED:     34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9500 cells/cumm     Albumin: Nil TC: 10500 cells/cumm     Albumin: Nil 
DC: P-62%   L-35%   E-3% Sugar: Nil DC:  P-64%   L-34%   E-2% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: NAD ESR:  ½ hr: 10mm Deposits: NAD 
          1 hr: 16mm MOTION           1 hr: 20mm MOTION 
Hb: 58% (8.7 gms%) Ova: - Nil Hb: 70% (10gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 109mgs%  Sugar(R): 110mgs%  
Urea: - 18mgs %  Urea: - 21mgs %  
Cholesterol: 171mgs%  Cholesterol: 175mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 12 OP.NO: 65952 NAME: Mrs. Rathna AGE/SEX: 42/F OCCUPATION: Coolie 
FROM: 27/08/2012 TO: 02/10/2012 NO. OF DAYS TREATED:      35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 9 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 11,400 cells/cumm Albumin: Nil TC: 9900 cells /cumm Albumin: Nil 
DC:  P-54%    L-44%   E-2% Sugar: Nil DC:  P-50%   L-44%  E-6% Sugar: Nil 
ESR:  ½ hr: 5mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 10mm MOTION           1 hr: 8mm MOTION 
Hb: 64%  (9.5gms%) Ova:   - Nil Hb: 80% (12 gms%) Ova:   - Nil 
MCV:  - Cyst:   - Nil MCV:  -   Cyst:   - Nil 
PCV:  - Occult Blood: -Nil PCV:   - Occult Blood: Nil 
Sugar(R): 160mgs%  Sugar(R): 150mgs%  
Urea:  45 mgs%  Urea: 40 mgs%  
Cholesterol: 190 mgs%  Cholesterol: 124mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 13 OP.NO: 67203 NAME: Santhanam AGE/SEX: 44/F OCCUPATION: Coolie 
FROM: 31/08/2012 TO: 05/10/2012 NO. OF DAYS TREATED:     36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
and tiredness present since 8 months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8600 cells/cumm     Albumin: Nil TC: 7600 cells/cumm     Albumin: Nil 
DC: P-50%   L-41%   E-9% Sugar: Nil DC:  P-54%   L-41%   E-5% Sugar: Nil 
ESR:  ½ hr: 9mm Deposits: NAD ESR:  ½ hr: 7mm Deposits: NAD 
          1 hr: 18mm MOTION           1 hr: 14mm MOTION 
Hb: 64% (10.2gms%) Ova: - Nil Hb: 80% (12.8gms%) Ova:  - Nil 
MCV:  82 cumm Cyst: - Nil MCV:  94 cumm Cyst:  - Nil 
PCV:  31% Occult Blood: -Nil PCV:   40% Occult Blood: Nil 
Sugar(R): 108mgs%  Sugar(R): 104mgs%  
Urea: - 28mgs %  Urea: - 26mgs %  
Cholesterol: 226mgs%  Cholesterol: 212mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 14 OP.NO: 69610 NAME: Mrs. Sumathi AGE/SEX: 35/F OCCUPATION: Coolie 
FROM: 07/09/2012 TO: 05/10/2012 NO. OF DAYS TREATED:     28 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 7 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 10300 cells/cumm Albumin: Nil TC: 9800 cells /cumm Albumin: Nil 
DC:  P-57%    L-41%   E-2% Sugar: Nil DC:  P-56%   L-38%  E-6% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: NAD ESR:  ½ hr: 7mm Deposits: NAD 
          1 hr: 16mm MOTION           1 hr: 14mm MOTION 
Hb: 68%  (10.4gms%) Ova:   - Nil Hb: 80% (12 gms%) Ova:   - Nil 
MCV:   Cyst:   - Nil MCV:  -   Cyst:   - Nil 
PCV:    Occult Blood: -Nil PCV:   -  Occult Blood: Nil 
Sugar(R): 116mgs%  Sugar(R): 110mgs%  
Urea:  39 mgs%  Urea: 38 mgs%  
Cholesterol: 224mgs%  Cholesterol: 220mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 15 OP.NO: 75079 NAME: Selvam AGE/SEX: 45/Male OCCUPATION: Coolie 
FROM: 14/09/2012 TO: 12/10/2012 NO. OF DAYS TREATED:     28 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation  
and tiredness present since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7900 cells/cumm     Albumin: Nil TC: 8100 cells/cumm     Albumin: Nil 
DC: P-67%   L-30%   E-3% Sugar: Nil DC:  P-67%   L-30%   E-3% Sugar: Nil 
ESR:  ½ hr: 25mm Deposits: NAD ESR:  ½ hr: 25mm Deposits: NAD 
          1 hr: 50mm MOTION           1 hr: 50mm MOTION 
Hb: 68% (10 gms%) Ova: - Nil Hb: 72% (10.8gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 117mgs%  Sugar(R): 110mgs%  
Urea: - 30 mgs %  Urea: - 20mgs %  
Cholesterol: 150mgs%  Cholesterol: 140mgs%  
   Response:                                   Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 16 OP.NO: 75567 NAME: Ravanan AGE/SEX: 38/Male OCCUPATION: Coolie 
FROM: 25/09/2012 TO: 24/10/2012 NO. OF DAYS TREATED:     29 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with palpitation 
and tiredness present since 7 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8000 cells/cumm Albumin: Nil TC: 9900 cells /cumm Albumin: Nil 
DC:  P-58%    L-38%   E-4% Sugar: Nil DC:  P-61%   L-34%  E-5% Sugar: Nil 
ESR:  ½ hr: 3mm Deposits: NAD ESR:  ½ hr: 3mm Deposits: NAD 
          1 hr: 6mm MOTION           1 hr: 6mm MOTION 
Hb: 54%  (8.1gms%) Ova:   - Nil Hb: 64% (9.6 gms%) Ova:   - Nil 
MCV:  82 cumm Cyst:   - Nil MCV:  96 cumm   Cyst:   - Nil 
PCV:  30%  Occult Blood: -Nil PCV:   40%  Occult Blood: Nil 
Sugar(R): 80mgs%  Sugar(R): 85mgs%  
Urea:  18 mgs%  Urea: 18 mgs%  
Cholesterol: 150 mgs%  Cholesterol: 160mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 17 OP.NO:  1558 NAME: Raja AGE/SEX: 35 Male OCCUPATION: Coolie 
FROM:  20/09/2012 TO:  22/10/2012 NO. OF DAYS TREATED:   33   days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea present during Exertion, loss of 
appetite, tiredness, pain in extremities are 
present since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7500 cells/cumm     Albumin: Nil TC: 10200 cells/cumm     Albumin: Nil 
DC: P-57%   L-35%   E-8% Sugar: Nil DC:  P-61%   L-35%   E-5% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 20mm MOTION           1 hr: 8mm MOTION 
Hb: 35% (5.6 gms%) Ova: - Nil Hb: 61% (9.1gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 87mgs%  Sugar(R): 80mgs%  
Urea: - 20mgs %  Urea: - 20mgs %  
Cholesterol: 160 mgs%  Cholesterol: 158mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 18 OP.NO: 1562 NAME: Madhavan AGE/SEX: 38/F OCCUPATION: Coolie 
FROM:  24/09/2012 TO:  24/10/2012 NO. OF DAYS TREATED:  31 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea present during Exertion, loss of 
appetite, tiredness, pain in extremities are 
present since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9100 cells/cumm Albumin: Nil TC: 9200 cells /cumm Albumin: Nil 
DC:  P-68%    L-30%   E-2% Sugar: Nil DC:  P-70%   L-28%  E-2% Sugar: Nil 
ESR:  ½ hr: 7mm Deposits: Occ.epi.cells ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 18mm MOTION           1 hr: 10mm MOTION 
Hb: 60%  (8.6gms%) Ova:   - Nil Hb: 73.3% (10.9 gms%) Ova:   - Nil 
MCV:  80 cumm Cyst:   - Nil MCV:  90 cumm   Cyst:   - Nil 
PCV:  32%  Occult Blood: -Nil PCV:   36%  Occult Blood: Nil 
Sugar(R): 70mgs%  Sugar(R): 72mgs%  
Urea:  37 mgs%  Urea: 35 mgs%  
Cholesterol: 158mgs%  Cholesterol: 160mgs%  
   Response:                                  Good 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 19 OP.NO: 76762 NAME: Amaravathi AGE/SEX: 35/F OCCUPATION: Coolie 
FROM: 28/09/2012 TO: 26/10/2012 NO. OF DAYS TREATED:     29 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
and tiredness present since 1 year 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8500 cells/cumm     Albumin: Nil TC: 8900 cells/cumm     Albumin: Nil 
DC: P-64%   L-30%   E-6% Sugar: Nil DC:  P-66%   L-33%   E-1% Sugar: Nil 
ESR:  ½ hr: 3mm Deposits: few pus cells ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 7mm MOTION           1 hr: 4mm MOTION 
Hb: 61% (9.1 gms%) Ova: - Nil Hb: 68% (10.2gms%) Ova:  - Nil 
MCV:  86 cumm Cyst: - Nil MCV:  98 cumm Cyst:  - Nil 
PCV:  30% Occult Blood: -NAD PCV:   38% Occult Blood: Nil 
Sugar(R): 78 mgs%  Sugar(R): 77 mgs%  
Urea: - 22 mgs %  Urea: - 20 mgs %  
Cholesterol: 171 mgs%  Cholesterol: 170 mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 20 OP.NO: 77536 NAME: Mrs. Megala AGE/SEX: 52/F OCCUPATION: Coolie 
FROM: 02/08/2012 TO: 06/09/2012 NO. OF DAYS TREATED:      31days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with palpitation 
and tiredness present since 1 year  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8500 cells/cumm Albumin: Nil TC: 8800 cells /cumm Albumin: Nil 
DC:  P-57%    L-38%   E-5% Sugar: Nil DC:  P-60%   L-38%  E-2% Sugar: Nil 
ESR:  ½ hr: 6mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 11mm MOTION           1 hr: 8mm MOTION 
Hb: 60%  (9 gms%) Ova:   - Nil Hb: 74% (11.1 gms%) Ova:   - Nil 
MCV:  - 84 cumm Cyst:   - Nil MCV:  - 92 cumm Cyst:   - Nil 
PCV:  -30%  Occult Blood: -Nil PCV:   - 40% Occult Blood: Nil 
Sugar(R): 60mgs%  Sugar(R): 64mgs%  
Urea:  23 mgs%  Urea: 20 mgs%  
Cholesterol: 169 mgs%  Cholesterol: 170 mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 21 OP.NO: 78066 NAME: Chandraleka AGE/SEX: 53/F OCCUPATION: Coolie 
FROM: 02/10/2012 TO: 31/10/2012 NO. OF DAYS TREATED:     29 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 8 
months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7200 cells/cumm     Albumin: Nil TC: 7800 cells/cumm     Albumin: Nil 
DC: P-79%   L-18%   E-3% Sugar: Nil DC:  P-80%   L-19%   E-1% Sugar: Nil 
ESR:  ½ hr: 4mm Deposits: 1-2 pus cells ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 8mm MOTION           1 hr: 4mm MOTION 
Hb: 58% (8.7gms%) Ova: - Nil Hb: 61% (9.0gms%) Ova:  - Nil 
MCV: 88 cumm Cyst: - Nil MCV:  92 cumm Cyst:  - Nil 
PCV:  31% Occult Blood: -Nil PCV:   33% Occult Blood: Nil 
Sugar(R): 99 mgs%  Sugar(R): 95mgs%  
Urea: - 19 mgs %  Urea: - 17mgs %  
Cholesterol: 174 mgs%  Cholesterol: 170 mgs%  
   Response:                                    Poor 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 22 OP.NO: 78766 NAME: Mrs. Vijaya AGE/SEX: 55/F OCCUPATION: Coolie 
FROM: 04/10/2012 TO: 02/11/2012 NO. OF DAYS TREATED:      28days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 9 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9200 cells/cumm Albumin: Nil TC: 9200 cells /cumm Albumin: Nil 
DC:  P-66%    L-30%   E-4% Sugar: Nil DC:  P-60%   L-38%  E-2% Sugar: Nil 
ESR:  ½ hr: 7mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 18mm MOTION           1 hr: 4mm MOTION 
Hb: 63.3%  (9.4gms%) Ova:   - Nil Hb: 80% (12 gms%) Ova:   - Nil 
MCV:   Cyst:   - Nil MCV:   -  Cyst:   - Nil 
PCV:    Occult Blood: -Nil PCV:   -  Occult Blood: Nil 
Sugar(R): 87mgs%  Sugar(R): 88mgs%  
Urea:  -  Urea: 24 mgs%  
Cholesterol: 167 mgs%  Cholesterol: 160mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 23 OP.NO: 79012 NAME: Devarajan AGE/SEX: 50/M OCCUPATION: Coolie 
FROM: 05/10/2012 TO: 02/11/2012 NO. OF DAYS TREATED:      days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation  
and tiredness present since 8 months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8900 cells/cumm     Albumin: Nil TC: 9700 cells/cumm     Albumin: Nil 
DC: P-68%   L-29%   E-3% Sugar: Nil DC:  P-69%   L-30%   E-1% Sugar: Nil 
ESR:  ½ hr: 11mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 18 mm MOTION           1 hr: 8mm MOTION 
Hb: 60% (9 gms%) Ova: - Nil Hb: 71% (10.6gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 102mgs%  Sugar(R): 100mgs%  
Urea: - 20mgs %  Urea: - 18mgs %  
Cholesterol: 172 mgs%  Cholesterol: 170 mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 24 OP.NO: 80912 NAME: Mrs. Shanmugathai AGE/SEX: 50/F OCCUPATION: Coolie 
FROM: 11/10/2012 TO: 09/11/2012 NO. OF DAYS TREATED:      28days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 7 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9900 cells/cumm Albumin: Nil TC: 11200 cells /cumm Albumin: Nil 
DC:  P-67%    L-30%   E-3% Sugar: Nil DC:  P-58%   L-30%  E-2% Sugar: Nil 
ESR:  ½ hr: 6mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 12mm MOTION           1 hr: 8mm MOTION 
Hb: 54%  (8.1gms) Ova:   - Nil Hb: 64% (9.6 gms%) Ova:   - Nil 
MCV:  88 cumm Cyst:   - Nil MCV:  98 cumm   Cyst:   - Nil 
PCV:  31%  Occult Blood: -Nil PCV:   42%  Occult Blood: Nil 
Sugar(R): 76mgs%  Sugar(R): 95mgs%  
Urea:  25 mgs%  Urea: 20 mgs%  
Cholesterol: 219mgs%  Cholesterol: 201mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 25 OP.NO:   NAME: Mrs. Devaki AGE/SEX: 41/F OCCUPATION: Coolie 
FROM: 12/10/2012 TO: 09/11/2012 NO. OF DAYS TREATED:     27 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 5 
months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7100 cells/cumm     Albumin: Nil TC: 7100 cells/cumm     Albumin: Nil 
DC: P-48%   L-49%   E-3% Sugar: Nil DC:  P-49%   L-50%   E-1% Sugar: Nil 
ESR:  ½ hr: 7mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 16mm MOTION           1 hr: 8mm MOTION 
Hb: 51% (7.5 gms%) Ova: - Nil Hb: 54% (8gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 81 mgs%  Sugar(R): 80mgs%  
Urea: -   Urea: - 19mgs %  
Cholesterol: 100 mgs%  Cholesterol: 99mgs%  
   Response:                                    Fair 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 26 OP.NO:  NAME: Mrs. Rani AGE/SEX: 54/F OCCUPATION: Coolie 
FROM: 16/10/2012 TO: 14/11/2012 NO. OF DAYS TREATED:      28days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with palpitation 
during walking and tiredness present 
since 7 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7900 cells/cumm Albumin: Nil TC: 8000 cells /cumm Albumin: Nil 
DC:  P-67%    L-30%   E-3% Sugar: Nil DC:  P-69%   L-30%  E-1% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: 1-2 pus cells ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 17mm MOTION           1 hr: 8mm MOTION 
Hb: 65%  (9.7gms%) Ova:   - Nil Hb: 80% (12 gms%) Ova:   - Nil 
MCV:  89 cumm Cyst:   - Nil MCV:  96 cumm   Cyst:   - Nil 
PCV:  34%  Occult Blood: -Nil PCV:   42%  Occult Blood: Nil 
Sugar(R): 105mgs%  Sugar(R): 100mgs%  
Urea:  45 mgs%  Urea: 25 mgs%  
Cholesterol: 225mgs%  Cholesterol: 210 mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 27 OP.NO: 82385 NAME: Mrs. Shyamala AGE/SEX: 50/F OCCUPATION: Coolie 
FROM: 16/10/2012 TO: 14/11/2012 NO. OF DAYS TREATED:    28  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
during walking tiredness and hair fall 
present since 5 months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 6400 cells/cumm     Albumin: Nil TC: 7100 cells/cumm     Albumin: Nil 
DC: P-58%   L-40%   E-2% Sugar: Nil DC:  P-60%   L-38%   E-2% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 20mm MOTION           1 hr: 4mm MOTION 
Hb: 51% (7.5gms%) Ova: - Nil Hb: 72% (10.8gms%) Ova:  - Nil 
MCV:  - Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:  - Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 89mgs%  Sugar(R): 85 mgs%  
Urea: - 17mgs %  Urea: - 16 mgs %  
Cholesterol: 127mgs%  Cholesterol: 126 mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 28 OP.NO: 84554 NAME: Poongothai AGE/SEX: 62/F OCCUPATION: Coolie 
FROM: 23/10/2012 TO: 23/11/2012 NO. OF DAYS TREATED:     30 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 8 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8500 cells/cumm Albumin: Nil TC: 8300 cells /cumm Albumin: Nil 
DC:  P-68%    L-28%   E-4% Sugar: Nil DC:  P-70%   L-29%  E-1% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits: 1-2 pus cells ESR:  ½ hr: 7mm Deposits: NAD 
          1 hr: 5mm MOTION           1 hr: 15mm MOTION 
Hb: 61%  (9.1gms%) Ova:   - Nil Hb: 80% (12 gms%) Ova:   - Nil 
MCV:  80 cumm Cyst:   - Nil MCV:    90 cumm Cyst:   - Nil 
PCV:  30%  Occult Blood: -Nil PCV:    38% Occult Blood: Nil 
Sugar(R): 103 mgs%  Sugar(R): 99mgs%  
Urea:  22 mgs%  Urea: 20 mgs%  
Cholesterol: 120 mgs%  Cholesterol: 115 mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 29 OP.NO: 85205 NAME: Mrs. Rekha AGE/SEX: 35/F OCCUPATION: Coolie 
FROM: 26/10/2012 TO: 23/11/2012 NO. OF DAYS TREATED:     27 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
and tiredness present since 7 months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 6500 cells/cumm     Albumin: Nil TC: 7000 cells/cumm     Albumin: Nil 
DC: P-63%   L-30%   E-7% Sugar: Nil DC:  P-65%   L-33%   E-2% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits:1-2 pus cells ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 5mm MOTION           1 hr: 8mm MOTION 
Hb: 56% (8.4gms%) Ova: - Nil Hb: 66% (9.9 gms%) Ova:  - Nil 
MCV:   Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:   Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 79mgs%  Sugar(R): 70mgs%  
Urea: - 20mgs %  Urea: - 20mgs %  
Cholesterol: 89mgs%  Cholesterol: 80mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 30 OP.NO: 85204 NAME: Mahalakshmi AGE/SEX: 38/F OCCUPATION: Coolie 
FROM: 26/10/2012 TO: 23/11/2012 NO. OF DAYS TREATED:      27days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 9 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7300 cells/cumm Albumin: Nil TC: 7500 cells /cumm Albumin: Nil 
DC:  P-65%    L-31%   E-4% Sugar: Nil DC:  P-67%   L-31%  E-2% Sugar: Nil 
ESR:  ½ hr: 7mm Deposits: 2-3 pus cells ESR:  ½ hr: 7mm Deposits: NAD 
          1 hr: 10mm MOTION           1 hr: 10mm MOTION 
Hb: 54%  (8.1gms%) Ova:   - Nil Hb: 60% (9 gms%) Ova:   - Nil 
MCV:  86 cumm Cyst:   - Nil MCV:  96 cumm   Cyst:   - Nil 
PCV:  30%  Occult Blood: -Nil PCV:   40%  Occult Blood: Nil 
Sugar(R): 71mgs%  Sugar(R): 75mgs%  
Urea:  41mgs%  Urea: 40 mgs%  
Cholesterol: 199 mgs%  Cholesterol: 180 mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 31  OP.NO: 1794 NAME: Mrs.Mari AGE/SEX: 38/F OCCUPATION: Coolie 
FROM: 20/06/2012 TO: 26/07/2012 NO. OF DAYS TREATED:     36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Dyspnoea during walking pallor, 
Palpitation, loss of appetite present since 1 
year. 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8900 cells/cumm     Albumin: Nil TC: 9100 cells/cumm     Albumin: Nil 
DC: P-58%   L-40%   E-2% Sugar: Nil DC:  P-60%   L-39%   E-1% Sugar: Nil 
ESR:  ½ hr: 20mm Deposits: few epi cells ESR:  ½ hr: 5mm Deposits: NAD 
          1 hr: 35mm MOTION           1 hr: 10mm MOTION 
Hb: 64.7% (10 gms%) Ova: - Nil Hb: 80% (12 gms%) Ova:  - Nil 
MCV: 90 cumm Cyst: - Nil MCV:  95 cumm Cyst:  - Nil 
PCV:  36% Occult Blood: -Nil PCV:   42% Occult Blood: Nil 
Sugar(R): 138 mgs%  Sugar(R): 128 mgs%  
Urea: - 26 mgs %  Urea: - 25 mgs %  
Cholesterol: 122 mgs%  Cholesterol: 120 mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 32 OP.NO: 1996 NAME: Nachiyar AGE/SEX: 63/F OCCUPATION: Coolie 
FROM: 20/06/2012 TO: 26/07/2012 NO. OF DAYS TREATED:      35days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with palpitation 
loss of appetite and tiredness present 
since 9 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7800 cells/cumm Albumin: Nil TC: 8000 cells /cumm Albumin: Nil 
DC:  P-48%    L-40%   E-12% Sugar: Nil DC:  P-60%   L-38%  E-2% Sugar: Nil 
ESR:  ½ hr: 3mm Deposits: 2-3 pus cells ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 5mm MOTION           1 hr: 8mm MOTION 
Hb: 60%  (9 gms%) Ova:   - Nil Hb: 75% (11.2 gms%) Ova:   - Nil 
MCV:  89 cumm Cyst:   - Nil MCV:  102 cumm   Cyst:   - Nil 
PCV:  29%  Occult Blood: -Nil PCV:   38%  Occult Blood: Nil 
Sugar(R): 106mgs%  Sugar(R): 102mgs%  
Urea:  38 mgs%  Urea: 25 mgs%  
Cholesterol: 140 mgs%  Cholesterol: 142mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 33 IP.NO: 210 NAME: Chellammal AGE/SEX: 61/F OCCUPATION: Coolie 
FROM: 21/06/2012 TO: 25/07/2012 NO. OF DAYS TREATED:      days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
loss of appetite and tiredness present since 8 
months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8000 cells/cumm     Albumin: Nil TC: 8100 cells/cumm     Albumin: Nil 
DC: P-68%   L-29%   E-3% Sugar: Nil DC:  P-68%   L-30%   E-2% Sugar: Nil 
ESR:  ½ hr: 9mm Deposits: 1-2 pus cells ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 18mm MOTION           1 hr: 4mm MOTION 
Hb: 64% (9.5gms%) Ova: - Nil Hb: 76% (12.1gms%) Ova:  - Nil 
MCV:  86 cumm Cyst: - Nil MCV:  -  96 cumm Cyst:  - Nil 
PCV:  30% Occult Blood: -Nil PCV:   -  40% Occult Blood: Nil 
Sugar(R): 133 mgs%  Sugar(R): 130mgs%  
Urea: - 20 mgs %  Urea: - 20mgs %  
Cholesterol: 143 mgs%  Cholesterol: 140mgs%  
   Response:                                   Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 34 IP.NO: 2068 NAME: Bakiam AGE/SEX: 60/F OCCUPATION: Coolie 
FROM: 26/06/2012 TO: 30/07/2012 NO. OF DAYS TREATED:     34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness loss of appetite 
present since 1 year  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 11200 cells/cumm Albumin: Nil TC: 11300 cells /cumm Albumin: Nil 
DC:  P-70%    L-25%   E-5% Sugar: Nil DC:  P-73%   L-27%  E-5% Sugar: Nil 
ESR:  ½ hr: 22mm Deposits: NAD ESR:  ½ hr: 20mm Deposits: NAD 
          1 hr: 50mm MOTION           1 hr: 48mm MOTION 
Hb: 58%  (8.7gms%) Ova:   - Nil Hb: 70% (10.5 gms%) Ova:   - Nil 
MCV:   Cyst:   - Nil MCV:    Cyst:   - Nil 
PCV:    Occult Blood: -Nil PCV:     Occult Blood: Nil 
Sugar(R): 78mgs%  Sugar(R): 76mgs%  
Urea:  23 mgs%  Urea: 20 mgs%  
Cholesterol: 210 mgs%  Cholesterol: 200mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 35 IP.NO: 3546 NAME:  Anandham AGE/SEX: 61/F OCCUPATION: Coolie 
FROM: 28/07/2012 TO: 23/08/2012 NO. OF DAYS TREATED:    26  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and loss of appetite hair fall 
present since 7 months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8600 cells/cumm     Albumin: Nil TC: 8800 cells/cumm     Albumin: Nil 
DC: P-55%   L-40%   E-5% Sugar: Nil DC:  P-54%   L-41%   E-5% Sugar: Nil 
ESR:  ½ hr: 4mm Deposits: 1-2 pus cells ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 8mm MOTION           1 hr: 4mm MOTION 
Hb: 64% (9.1gms%) Ova: - Nil Hb: 68% (10gms%) Ova:  - Nil 
MCV:  89 cumm Cyst: - Nil MCV:  96 cumm Cyst:  - Nil 
PCV:  29% Occult Blood: -Nil PCV:   40% Occult Blood: Nil 
Sugar(R): 91mgs%  Sugar(R): 90mgs%  
Urea: - 23mgs %  Urea: - 20mgs %  
Cholesterol: 259mgs%  Cholesterol: 220mgs%  
   Response:                                    Fair 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 36 IP.NO: 2554 NAME: Lakshmi AGE/SEX: 54/F OCCUPATION: Coolie 
FROM: 04/08/2012 TO: 01/09/2012 NO. OF DAYS TREATED:  27days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation, tiredness and hair fall 
present since 9 months  
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8800 cells/cumm Albumin: Nil TC: 8800 cells /cumm Albumin: Nil 
DC:  P-55%    L-40%   E-5% Sugar: Nil DC:  P-54%   L-41%  E-5% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits: 1-2 pus cells  ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 4mm MOTION           1 hr: 4mm MOTION 
Hb: 64%  (9.1gms%) Ova:   - Nil Hb: 75% (10.7 gms%) Ova:   - Nil 
MCV:  89 cumm Cyst:   - Nil MCV:  96 cumm   Cyst:   - Nil 
PCV:  29%  Occult Blood: -Nil PCV:   40%  Occult Blood: Nil 
Sugar(R): 91 mgs%  Sugar(R): 90mgs%  
Urea:  23 mgs%  Urea: 20 mgs%  
Cholesterol: 259 mgs%  Cholesterol: 220mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 37 IP.NO: 2879 NAME: Arunachala Vadivu AGE/SEX: 60/F OCCUPATION: Coolie 
FROM: 31/08/2012 TO: 27/09/2012 NO. OF DAYS TREATED:      27days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 1year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9100 cells/cumm     Albumin: Nil TC: 9900 cells/cumm     Albumin: Nil 
DC: P-56%   L-36%   E-8% Sugar: Nil DC:  P-58%   L-39%   E-3% Sugar: Nil 
ESR:  ½ hr: 18mm Deposits: NAD ESR:  ½ hr: 10mm Deposits: NAD 
          1 hr: 30mm MOTION           1 hr: 20mm MOTION 
Hb: 63.3% (9.4 gms%) Ova: - Nil Hb: 68% (10gms%) Ova:  - Nil 
MCV:   Cyst: - Nil MCV:   Cyst:  - Nil 
PCV:   Occult Blood: -Nil PCV:      Occult Blood: Nil 
Sugar(R): 92mgs%  Sugar(R): 90mgs%  
Urea: - 23 mgs %  Urea: - 21mgs %  
Cholesterol: 170 mgs%  Cholesterol: 174mgs%  
   Response:                                    Fair 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 38 IP.NO: 3522 NAME: Kaniyan AGE/SEX: 62/M OCCUPATION: Coolie 
FROM: 11/10/2012 TO: 07/11/2012 NO. OF DAYS TREATED:     26 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with palpitation 
during walking and tiredness present 
since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9500 cells/cumm Albumin: Nil TC: 9200 cells /cumm Albumin: Nil 
DC:  P-54%    L-34%   E-2% Sugar: Nil DC:  P-62%   L-36%  E-2% Sugar: Nil 
ESR:  ½ hr: 6mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 12mm MOTION           1 hr: 8mm MOTION 
Hb: 63.3%  (9.4gms%) Ova:   - Nil Hb: 76.7% (11.5 gms%) Ova:   - Nil 
MCV:  76 cumm Cyst:   - Nil MCV:  86 cumm   Cyst:   - Nil 
PCV:  40%  Occult Blood: -Nil PCV:   46%  Occult Blood: Nil 
Sugar(R): 90mgs%  Sugar(R): 88mgs%  
Urea:  24 mgs%  Urea: 24 mgs%  
Cholesterol: 180 mgs%  Cholesterol: 180mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 39 IP.NO: 3557 NAME: Mrs. Backiyathai AGE/SEX: 38/F OCCUPATION: Coolie 
FROM: 19/10/2012 TO: 16/11/2012 NO. OF DAYS TREATED:      27 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea, with Palpitation 
tiredness and hair fall present since 8 
months 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8100 cells/cumm     Albumin: Nil TC: 9200 cells/cumm     Albumin: Nil 
DC: P-60%   L-36%   E-4% Sugar: Nil DC:  P-61%   L-36%   E-3% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 4mm MOTION           1 hr: 8mm MOTION 
Hb: 68% (10.2gms%) Ova: - Nil Hb: 78% (11.7gms%) Ova:  - Nil 
MCV:   Cyst: - Nil MCV:  -   Cyst:  - Nil 
PCV:   Occult Blood: -Nil PCV:   -   Occult Blood: Nil 
Sugar(R): 115mgs%  Sugar(R): 122mgs%  
Urea: - 23mgs %  Urea: - 22mgs %  
Cholesterol: 193mgs%  Cholesterol: 192mgs%  
   Response:                                    Good 
 
DRUG: Kaandha chenduram 100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 40 IP.NO: 3803 NAME: Kannammal AGE/SEX: 37/F OCCUPATION: Coolie 
FROM: 08/11/2012 TO: 05/12/2012 NO. OF DAYS TREATED:      days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
Pt. complaints dyspnoea with 
palpitation during walking and tiredness 
present since 1 year 
 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7800 cells/cumm Albumin: Nil TC: 7900 cells /cumm Albumin: Nil 
DC:  P-64%    L-34%   E-2% Sugar: Nil DC:  P-65%   L-34%  E-2% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: few pus cells ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 16mm MOTION           1 hr: 8mm MOTION 
Hb: 61%(9.7grms) Ova:   - Nil Hb: 78% (11.7 gms%) Ova:   - Nil 
MCV: Cyst:   - Nil MCV:     Cyst:   - Nil 
PCV:    Occult Blood: -Nil PCV:     Occult Blood: Nil 
Sugar(R): 68 mgs%  Sugar(R): 69mgs%  
Urea:  26 mgs%  Urea: 25 mgs%  
Cholesterol: 159 mgs%  Cholesterol: 150mgs%  
   Response:                                  Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 



















